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introduction
End stage renal disease (ESRD) is the final stage of chronic kidney disease, which can 
be caused by a multitude of factors. The ultimate treatment is a kidney transplant, but 
unfortunately, to date, demand exceeds supply. In 2015, 544 patients with ESRD were 
on the waiting list for a kidney transplant in the Netherlands1. These patients are in need 
of dialysis, they are transplantable, meaning that they are medically fit to undergo a 
surgical procedure and there are possibilities for the implantation of a donor kidney. 
The patients on the waiting list usually do not have a potential living donor, and are 
dependent on deceased donation. This is unfortunate, first of all, because not enough 
deceased donor kidneys are available to treat every patient on the waiting list, but more 
importantly, living kidney donation is associated with significantly better recipient 
outcomes2.
Aside from the patients on the waiting list, there is a large number of patients with 
renal disease who are still preemptive, i.e., they are not yet undergoing dialysis, but their 
renal function is declining towards ESRD stadium. A key priority in the treatment of these 
patients is the prevention of dialysis by means of a preemptive kidney transplantation. 
In the Netherlands, patients are eligible to undergo preemptive kidney transplantation 
when estimated glomerular filtration rate (eGFR) reaches 20% or less of normal func-
tion. Preemptive kidney transplantation has been amply proven to improve recipient 
outcome, with regard to lifespan of the transplant, a lower rejection rate, a lower rate 
of perioperative cardiovascular mortality, and a lower overall rate of cardiovascular 
complications3-7. Preemptive kidney donation is mainly performed in patients with liv-
ing donors, but in selected cases this is also possible with a deceased donor kidney, 
such as in patients with a PD catheter or AV fistula who have not yet started dialysis or in 
patients with rare blood types.
In some cases, a living donor is available, but not a match for the intended recipient 
due to incompatible AB0-bloodtypes or the presence of anti-donor HLA antibodies. To 
enable these recipients to get a transplant, and to realize more transplantations, paired 
kidney exchange programs (PKE) were created8. The Dutch PKE program was developed 
in 2004 between all eight Dutch transplant centers with the aim to facilitate cross-over 
kidney transplantations9, 10. In 2015, 21 kidneys were donated within the PKE program. 
Aside from helping patients with non-matching living donors receive a donor kidney, 
the PKE program also helps to shorten the waiting list. If a non-matching donor cannot 
be paired to another couple’s recipient, the possibility to include an anonymous donor 
(“unspecified donor”) in the equation was introduced in 2014, and in 2015, an additional 
nine kidneys were transplanted in a so-called “altruistic exchange transplantation”1. The 
recipient with the non-matching donor receives a kidney from the unspecified donor, 
and the recipient’s donor donates a kidney to a matching patient from the national 
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waiting list. Since the start of the PKE program in 2004, a total of 263 patients have been 
transplanted through this program11.
If the paired-exchange program does not result in a suitable match,improvements in 
immunosuppressive medication in the recipient, advanced possibilities for immune-
absorption and plasma-pheresis, allowing AB0-incompatible transplantation, and even 
the availability of a new generation of monoclonal antibodies to allow HLA-incompatible 
transplantation have facilitated donation, even if blood type(“AB0-incompatible dona-
tion”) or HLA type (“HLA-incompatible donation”)  does not match. 
These are, in a nutshell, the possibilities for kidney transplantation. Although living 
donation is regarded to be a safe and feasible operation, and it has been demonstrated 
to significantly improve recipient outcome, it has one major disadvantage: a living do-
nor is needed who is exposed to a surgical intervention with no direct medical benefit. 
Performing this procedure goes against the Hippocratic oath (“primum non nocere” - 
first, do no harm), and the decision must be carefully considered and justifiable in each 
individual case. It is therefore of the utmost importance that the transplant community 
can guarantee the highest quality of the procedure itself, but also of every aspect of 
donor education, preparation and follow-up.
Live donor nephrectomy – History and development
The very first successful donor nephrectomy (and the following transplantation) took 
place at the Peter Bent Brigham Hospital in Boston, USA, in 195412. The procedure was 
performed by Joseph E. Murray, and John Hartwell Harrison. At this stage, the procedure 
was nowhere near the minimally invasive techniques employed today: it was done 
through a large incision, resecting one or more ribs to gain access to the retroperitone-
ally located kidney. On February 8th, 1995 the first laparoscopic living donor nephrec-
tomy was performed by Lloyd Ratner and Louis Kavoussi at the Johns Hopkins Bayview 
Medical Center in Baltimore, USA13. Since then, the live donor nephrectomy has evolved 
enormously. More and more procedures were performed using the laparoscopic tech-
nique, and by now this has become the gold standard in many transplant centers 14-17. 
Over the years, many modifications have been made to the laparoscopic technique to 
further improve its safety and efficacy. In 1998 the hand-assisted approach (HAL) was 
first described by Wolf 18. This technique allowed for the introduction of the surgeon’s 
hand, mainly through the pfannenstiel incision used to retrieve the kidney. Advantages 
of the hand-assisted technique include the ability to use tactile feedback, to achieve 
less blood loss, shorter warm ischemia times, and reduction of overall operative time19. 
A disadvantage could be that HAL is more invasive, and patients may experience more 
postoperative pain and a longer convalescence period, as compared to those operated 
purely laparoscopically. However, a number of studies comparing these two procedures 
found no substantial differences in warm-ischemia time, blood loss, hospital stay or 
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complication rate20-25, and currently both techniques are employed, and preference 
varies per center. In addition to the laparoscopic, transperitoneal technique, the retro-
peritoneoscopic technique was first described in 1995 by Yang et al26. Although this was 
still somewhat of a hybrid procedure between open- and minimally invasive surgery, the 
technique seemed promising, and was further modified and described by other authors 
with good results27, 28. An advantage of this technique is that during the entire proce-
dure, the peritoneum remains intact. The risk of damage to for instance bowel, spleen 
or other intraperitoneal organs is thus minimized. As with every laparo- or endoscopic 
procedure, there is a learning curve, and ample experience with laparoscopic procedures 
is vital. Hand-assisted retroperitoneoscopic donor nephrectomy (HARP) is an excellent 
alternative, developed and described by Jonas Wadstrom providing more control whilst 
still performing minimally invasive surgery29. Advantages of the HARP technique have 
been recently described in two randomized controlled trials (RCT), being a shorter warm 
ischemia time, shorter skin-to-skin time and fewer intraoperative events30, 31. These four 
techniques are all used on a fairly regular basis, and preferences vary per surgeon or 
center. In addition, the mini-open donor nephrectomy is used, and can be considered as 
a minimally invasive approach as well 32. In the last decade, even more specialized tech-
niques have become available. The most frequently employed is the single port donor 
nephrectomy (Laparoendoscopic Single Site, LESS). Positive results have been reported 
in a number of articles33-35, but whether it will prove to have significant advantage over 
“traditional” techniques remains to be seen. Other modifications that have been intro-
duced are the robot assisted donor nephrectomy36-41, which is currently mainly used in 
trials, and the natural orifice donor nephrectomy (NOTES). Of the latter, only a handful 
of case reports have been published42-44, and whether this technique will eventually be 
implemented as common practice is debatable.
donor selection, extended criteria donors and additional possibilities
As the laparoscopic donor nephrectomy evolved and became a fully implemented 
surgical procedure, practice began to change with regard to the selection and approval 
of potential donors. When first introduced, only genetically-related donors (first degree) 
were allowed to donate a kidney, but this was later expanded to include more distant 
genetically related donors, spouses, and friends. Although this is still true for some 
countries (e.g. Germany 45), in others anonymous donation, nowadays called unspecified 
donation46, has been legalized47-49.
Also, medical criteria for the acceptance of potential donors have changed enormously. 
On its introduction, almost every comorbidity was one too many and donors were more 
often rejected than accepted. But since much more information on the actual short- and 
long term risks of live kidney donation has become available the procedure has been 
generally considered to be safe. Therefore, so-called “extended criteria living donors” are 
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increasingly being accepted as living kidney donors50. The term “extended criteria living 
donors” comprises a multitude of (medical) conditions in which donation is considered a 
possibility, even though opinions still vary among transplant professionals. Examples of 
these conditions/circumstances are hypertension51, 52, obesity51, 53-55, vascular multiplic-
ity56, 57 and women of childbearing age58. It has to be underlined that each donor has to 
be regarded as an individual, and the decision whether to accept a donor or not has to 
follow a tailored approach. Technical considerations also play a part in the acceptance of 
potential donor, and some of these factors can also be described under ECD. During the 
implementation of the laparoscopic technique, it was quite custom to only retrieve the 
left kidney, mainly because of the longer renal vein. Multiple authors have since dem-
onstrated that the right kidney can in fact be safely retrieved, and functional outcomes 
in the recipient were comparable to those who had received a left donor kidney 59-61, 
and may be even preferable because it is easier to recover than the left kidney, and the 
risk of splenic lacerations is decreased62. Vascular multiplicity (i.e. more than one renal 
vein and/or artery) has been a reason for rejection in many cases. But again, it has been 
demonstrated repeatedly that the retrieval and implantation of a donor kidney with one 
or more veins or arteries is not associated with a negative outcome in either the donor 
or the recipient50, 56, 57.
complications and adverse events
Complication rates after live donor nephrectomy are relatively low, and the most devas-
tating one, mortality, is reported to occur only sporadically63, 64. A recent study reporting 
on nearly 15,000 live donor nephrectomies (96% laparoscopic) found an overall compli-
cation rate of 16.8%. Clavien Dindo grade II and higher events were encountered in 8.8% 
of donors, grade III or higher in 2.5%, and grade IV or higher in only 2.5%65. The most 
common complications were gastrointestinal (4.4%), bleeding (3.0%), respiratory (2.5%) 
and surgical/anesthesia-related injuries (2.4%). The in-hospital mortality in this study 
was reported as 0.007% (one donor).
Although it has been established that short-term complications after live kidney 
donation are mostly mild in nature, and severe complications are rare, this cannot be 
stated with the same certainty for long-term complications. It is challenging to present 
long-term risks since many uncertainties and different views exist regarding this matter. 
Although much research has been done to assess the absolute risk of End Stage Renal 
Disease (ESRD), the opinion among health care professionals regarding this risk still 
varies 66-69. It used to be believed that kidney donors had no increased risk of ESRD70. 
Then, new data became available presenting a high relative, but low absolute risk of 
ESRD66, 69. Recent research suggests that in specific populations, the risk of ESRD is in-
deed significantly increased after donation, in one study even up to 5.3 times higher 
than the general population71-73. Even though these are qualitatively well designed 
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studies with large sample sizes, there’s a methodological problem that is not easy to 
overcome: choosing the perfect control group. It is debatable whether living donors 
should be compared to the general population, since they are a highly selected sub-
group in near-perfect health. The ideal control group would be made up out of people 
who were approved for living kidney donation, but did, for a non-medical reason, not 
donate. But these individuals are sparse, and not always easy to find. Still, it has been 
demonstrated that specific donor characteristics are indeed associated with a greater 
long-term risk of ESRD, when compared to individuals from general population stud-
ies with the same characteristics: in one large model-based study, the highest risk was 
estimated for young, black kidney donors. Male donors had a slightly higher risk than 
female donors, and so had current smokers71. In addition, other long-term risks need to 
be further investigated, for instance, risk of gestational hypertension in female kidney 
donors50, 58, 74, 75. Future research and long-term follow-up of living kidney donors will 
eventually shed more light on this topic.
Live donor nephrectomy in the netherlands – facts and figures
All in all, living kidney donation has gained in popularity over the last years, and with 
good reason. Every patient with a living donor means one less patient on the waiting 
list, and the recipient will greatly benefit from a living donor kidney.
In 2015, 983 kidney transplantations were performed in the Netherlands: 470 kidneys 
came from a deceased donor, 513 transplantations were performed using a living donor 
(52%) 1. At the Erasmus MC, University Medical Center in Rotterdam, harboring the 
largest live donor kidney transplant program in Europe, 45% of all living donor kidney 
transplantations are performed preemptively.
This high percentage of living kidney donations in The Netherlands is unique in the 
world76. In the United States, 41% of all transplanted kidneys in 2015 came from liv-
ing donors77. Although living kidney donation has been legalized and implemented in 
nearly all countries, and numbers have increased over the last years, the Netherlands 
still have a leading role when it comes to this procedure (31 living donors per million 
of population76, with more than half of all kidney transplants involving a living donor. 
The described Dutch PKE program is one of the most successful paired kidney exchange 
programs worldwide9, 10, and many trials assessing the surgical procedure for the live 
donor nephrectomy have been initiated in the Netherlands31, 59, 78, 79.
informed consent
Although live kidney donation has been widely accepted, because the benefits for the 
recipients far outweigh the risks for the donors, we need to keep in mind that donors 
are not patients. They are healthy individuals, undergoing a surgical procedure for 
the benefit of others. If for whatever medical or psychological reason donation seems 
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contraindicated, the potential donor should be rejected. But not only medical or 
psychosocial factors play a role in the selection process of living kidney donors. Every 
medical professional, legalist or ethicist agrees that the decision to donate (consent) 
should be voluntary, free from coercion and informed. The first two are not always easy 
to prove, but efforts should be made to ensure these criteria are indeed met. The last 
item, informed, is the one item that we can, at least partly, control.
There are great differences in informed consent procedures between different coun-
tries, and even between different regions within a country. These differences begin with 
national legislation practices80-82. Spanish law for example, dictates that consent for live 
donation has to be obtained, documented and signed in the presence of a judge 83, 
while in Greece at least two witnesses have to sign a declaration of consent84. In the 
Netherlands, the law on organ donation stems from May 1996 and is quite lenient on 
the matter of live organ donation. Consent has to be obtained in writing, signed and 
dated85. This is further documented in the EU Directive (EU Directive 2010/53/EU for 
Living Organ Donation Practice)86, 87.
But differences in practice also exist on more local levels. There are many discrepan-
cies in the procedure itself, provided information and the manner in which consent is 
obtained between different countries, transplant centers and even transplant profes-
sionals within one center68, 88. To deliver the highest quality of care in live kidney dona-
tion, more uniformity in the informed consent procedure is mandatory. This first and 
foremost regards the contents, but it also includes timing, and documentation. Who 
should obtain informed consent? The information provision process is a team effort of 
the whole transplant team, so who should be in charge? Since the surgeon is the one 
responsible for the actual procedure, it makes sense that consent is obtained áfter the 
donor has been seen by him. On the other hand, the screening process itself may reveal 
unwanted information, which may also warrant informed consent. Maybe the informed 
consent process should indeed be a process, with different “stop-or-go” moments along 
the way, which should all be properly documented, dated and signed. “Who” and “how” 
are mainly logistic items, and these should be quite easy to arrange. The “what” part 
is more complex, and deserves some additional attention. As medical professionals 
involved in the education of and care for living donors, we have an obligation to fully in-
form them about the details, risks and possible complications of the live donor nephrec-
tomy, and the long-term consequences of the donation itself, so that they can make a 
balanced decision, but also, to prepare them for the procedure and the post-operative 
course. But when are donors optimally informed? There are many uncertainties when it 
comes to information provision and informed consent, in patients in general, let alone 
in living kidney donors. What information do they need, which details are vital in their 
educational process? And at what stage during this educational process should the 
actual informed consent be obtained?
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According to a national guideline on information provision for elective surgical pro-
cedures, those complications with an incidence of 1% or more and those with severe 
consequences have to be disclosed89. But does this suffice for living donors? Seen in 
light of the fact that donors are healthy at the start of the procedure, every complication 
or adverse event is one too many. Obviously, it is impossible to prevent each and every 
complication from happening, even with the strictest safety precautions. But the least 
we can do is inform donors of the possibility of these complications. Some infrequent 
complications may be quite disconcerting to a donor who has no idea these adverse 
events are in fact quite “normal” (e.g. testicular pain, neuropathy).
There is, however, another aspect of informed consent that has to be taken into account 
when it comes to living kidney donors. Some studies have demonstrated that donors 
do not always use the same decision-making strategy as patients. Instead of carefully 
weighing risks and benefits of a procedure, and then deciding whether to go through 
with it or not, many donors decide to donate upon the first moment of hearing of the 
possibility90-92. Most of them do not change their mind, regardless of the information 
provided during the educational process. More importantly, it has been suggested that 
they do not really hear the details about complications or risks, they only use provided 
information to confirm their decision93, although more recent studies do bring some 
nuance to this statement94.
A handful of studies that have been performed regarding donors’ knowledge about 
the donation procedure in general indeed show deficits, especially regarding (long-
term) complications95. In addition, a number of authors published self-reported donor 
experiences with the informed consent procedure, which also demonstrated a substan-
tial lack of understanding, especially of possible complications96, 97. But whether these 
deficits in knowledge are due to lack of education or lack of comprehension remains 
to be debated. Either way, the transplant team should make an effort to reduce these 
knowledge deficits. Some steps have already been taken, by introducing a home-based 
educational program for a selected donor population, which has shown to improve gen-
eral knowledge regarding living donation and willingness to donate (up to five times 
more)98. Standardization of the informed consent procedure is another way to further 
improve donor education, and many authors believe that this is a crucial step in the 
process of refining the quality of care for living kidney donors.
aims and outLine of tHis tHesis
part i – the informed consent procedure
The first aim of this thesis was to assess the current situation regarding the informed 
consent procedure for live donor nephrectomy. What strategies are currently being 
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employed with regards to donor education, disclosed information, timing of informed 
consent, and documentation? In the first part of this thesis, these aspects of the informed 
consent procedure in live donor nephrectomy are evaluated.
First of all, a systematic review of the available literature was performed to summarize 
the available information on the informed consent procedure for live donor nephrectomy. 
Information was extracted regarding the procedure itself, details about the contents of 
provided information, timing, legal framework and donor experience (chapter 2). There 
are some guidelines regarding informed consent for surgical procedures. As previously 
stated, general consensus is that every complication with an incidence of >1% should 
be disclosed, in addition to those complications with severe consequences89. So, which 
complications would that be for the live donor nephrectomy? In chapter 3, a meta-
analysis was performed assessing all possible short-term complications after minimally 
invasive live donor nephrectomy. The first part consisted of a descriptive systematic 
review, providing an overview of all encountered complications after minimally invasive 
live donor nephrectomy. The second part depicts the results of the actual meta-analysis, 
comparing the different techniques currently employed for minimally invasive live 
donor nephrectomy with regards to short-term complications. To gain insight in  which 
complications were actually mentioned to potential living donors by kidney transplant 
surgeons across the country, a web-based survey was created (chapter 4). All surgeons 
involved in live kidney donation in the Netherlands were invited to complete this sur-
vey, which contained questions regarding personal experience, operative technique, 
disclosure of short- and long term complications, and the informed consent procedure 
employed in the different transplant centers.
part ii – donor- and patient Knowledge & satisfaction
The second aim of this thesis was to assess donor- and patient knowledge of provided 
information during the educational process leading up to informed consent, and their 
satisfaction with the informed consent procedure.
The first thing to keep in mind when testing donor knowledge is the hypothesis that 
donors may not go through the same decision-making process as patients. Instead 
of carefully balancing all risks and benefits of a surgical procedure and then deciding 
whether or not to proceed with it, it has been proposed that donors use moral, or 
emotional reasoning, and make up their mind upon the first moment of hearing of the 
possibility to donate90-93. Many do not change their mind regardless of the waiting pe-
riod, or which information they receive; they rather focus on positive aspects to reaffirm 
their decision93. The latter aspect is indeed confirmed by some donors reporting the 
postoperative realization that they were “blinded”, or “heard what they wanted to hear”, 
and not quite as informed as they had believed to be prior to surgery96. 
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The first chapter of the second part of this thesis describes the results of the pilot 
study on donor knowledge (chapter 5). This study consists of 46 living kidney donors, 
whose preoperative surgical outpatient visits were observed and scored by means 
of a preset checklist. Informers (attending surgeons, surgical fellows and specialized 
nurses) received an informer score of a maximum of 20 points. Donors were asked to 
complete a pop quiz-style questionnaire directly after the consult, and again on the day 
of admission for the donor nephrectomy. Questions regarded the surgical technique, 
short- and long term complications, duration of admission and duration of convales-
cence. They could also score a maximum of 20 points. Additional baseline characteristics 
were collected and used for correlation purposes. Six to twelve weeks postoperatively, 
all donors received an evaluation and satisfaction questionnaire. After completion of 
the pilot study, a nationwide prospective study was initiated to further assess donor 
knowledge. The protocol for this study is outlined in chapter 6. The protocol was cre-
ated in a multidisciplinary working group, including surgeons, nephrologists, urologists, 
and a psychologist, all involved in living donor kidney transplantation. The study was 
designed as an inventory project, and had multiple aims. First of all, we wanted to assess 
whether the differences reported in our survey study were indeed present, or whether it 
was just a matter of reporting bias. If the first was true, something might have to change. 
Uniformity should be pursued, especially seen in light of the successful paired kidney 
exchange program (PKE) in the Netherlands (5.1% of all live donor nephrectomies are 
within the PKE program)11. Standard policy involves donors traveling to the recipient’s 
center for surgery, but receiving education in their own center. Most donors visit the 
outpatient clinic of the other center prior to surgery, and are seen by the local surgeon 
on the day of admission for donor nephrectomy. If information received in their own 
center differs greatly from information received on in the “new” center this could be 
quite troubling for the donor. To evaluate current practice in informed consent proce-
dures, 378 potential kidney donors were recruited prior to receiving any information 
in one of the eight Dutch transplant centers. A second cohort of 226 donors (including 
29 donors who had also already been included in the first cohort)was included on the 
day of admission for donor nephrectomy. Both were asked to complete the pop-quiz 
with questions regarding surgical technique, short- and long-term complications and 
duration of admission and convalescence, providing extensive information about donor 
comprehension. chapter 7 describes the results of the nationwide inventory- and donor 
knowledge study.
Finally, a general discussion on the contents of this thesis is presented in chapter 
8. chapter 9 outlines future perspectives with regard to informed consent procedures 
in live donor nephrectomy, but also in other (elective) surgical procedures. A sum-
mary is provided in English and Dutch in chapter 10 . chapter 11 comprises a list of 
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abstract
background Informed consent in live donor nephrectomy is a topic of great interest. 
Safety and transparency are key items, getting increasingly more attention from media 
and healthcare inspection. Since live donors are not patients, but healthy individuals 
undergoing elective interventions, they justly insist on optimal conditions and guaran-
teed safety. Although transplant professionals agree consent should be voluntary, free 
of coercion and fully informed, there is no consensus on which information should be 
provided, and how donors’ comprehension should be ascertained.
methods Comprehensive searches were conducted in Embase, Medline OvidSP, Web-
of-Science, PubMed, CENTRAL (The Cochrane Library 2014, issue 1) and Google Scholar, 
evaluating the informed consent procedure for live kidney donation. The methodology 
was in accordance with the Cochrane Handbook for Interventional Systematic Reviews 
and written based on the PRISMA statement.
results The initial search yielded 1009 hits from which 21 papers fell within the scope 
of this study. Procedures vary greatly between centers and transplant professionals vary 
in information they disclose. Although research has demonstrated that donors often 
make their decision based on moral reasoning rather than balancing risks and benefits, 
providing them with accurate, uniform information remains crucial, as donors report 
feeling misinformed about or unprepared for donation. Although a standardized pro-
cedure may not provide the ultimate solution, it is vital to minimize differences in live 
donor education between transplant centers.
conclusion There is a definite need for a guideline on how to provide information and 
obtain informed consent from live kidney donors, to assist the transplant community in 
optimally preparing potential donors.
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introduction
With very low complication and mortality rates, live donor nephrectomy is a safe, low-
risk surgical procedure. In contrast to patients, living donors are (generally) healthy 
individuals in whom a vital organ is removed for the benefit of others. It is of the utmost 
importance that any patient is correctly informed about the specific details, risks and al-
ternatives of a procedure, but the unique character of the live donor nephrectomy may 
warrant an extra vigilant approach to the informed consent process. Relevance further 
increases since extended criteria donors (e.g. overweight/obese donors, older donors, 
donors with hypertension and/or vascular multiplicity/anomalies) are increasingly be-
ing accepted. These individuals could be more prone to complications, and potential 
donors must be well aware of the risks involved with their upcoming procedure 1.
Every physician, ethicist or legalist will agree that a person giving consent should be 
“fully informed”, “free of coercion” and “competent”2, but there is no consensus on details 
to be provided during the process, nor the manner in which these should be delivered 
and documented. In 2011, the Advisory Committee on Organ Transplantation (ACOT) 
released a document with recommendations for the informed consent procedure in liv-
ing organ donors in the United States (US). Although not legally binding, the committee 
recommended that each hospital involved in live organ donation should use a stan-
dardized informed consent form, adjusted to regional legislation. The document also 
provides a list of items that should be included in the educational process 3. These forms 
have not yet been implemented in all transplant centers, but at least written and signed 
consent is mandatory in many 4. Unfortunately, the European situation differs from the 
American one. There are no European or nationwide guidelines, nor are there legal docu-
ments providing structured details on the informed consent procedure. Although there 
are many different policies and guidelines outlining matters that should be disclosed to 
potential donors, details are often not specified 5, 6. The actual documentation of consent 
also differs regionally; Spanish law for example, dictates that consent for live donation 
has to be obtained, documented and signed in the presence of a judge 7, while in Greece 
at least two witnesses have to sign a declaration of consent8.
These differences make it impossible for healthcare professionals to practice a uniform 
strategy and it is challenging to determine which patient has received which informa-
tion. Recent data from our group demonstrate that when tested on their knowledge, a 
large number of living kidney donors underestimate the complications and risks of live 
donor nephrectomy. Surman et al. published similar findings in renal and liver trans-
plant patients, revealing significant conceptual limitations to their knowledge about 
their postoperative situation, underlining the importance of adequate preoperative 
education 9. Comparable results are demonstrated in other studies, where donors report 
varying degrees of (dis)satisfaction with and misunderstanding of provided information 
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10. The question is raised whether the necessary information has not been provided cor-
rectly, whether donors simply not understand or remember it, or, as has been proposed 
by some, whether they selectively filter information and thus miss particular risks associ-
ated with donation. Standardizing the informed consent procedure will help us better 
understand and address this. In light of ever-growing demands for safety, transparency 
and documentation within the healthcare system, it can be expected that a standard-
ized procedure will be legally mandatory in the near future.
The aim of this systematic review is to make an assessment of the informed consent 
procedure as it is described in the available literature, with regards to disclosed infor-
mation, timing, documentation and donor comprehension of, and satisfaction with 
provided information. We hereby hope to address shortcomings and create the basis 
for a standardized procedure. In addition we will propose a concept to confirm donors’ 
comprehension of the provided information.
metHods
All aspects of the Cochrane Handbook for Interventional Systematic Reviews were 
followed, and the paper was written according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement11. No review protocol was 
written in advance.
Literature search strategy
A comprehensive search was performed on January 17th 2014 in Embase, Medline 
OvidSP, Web-of-Science, PubMed, CENTRAL (The Cochrane Library 2014, issue 1) and 
Google Scholar. No date limits were used, so that no potentially relevant articles would 
be missed. Detailed search strings for each database are provided in Appendix 1, no 
other limits were applied. All references were screened by two independent reviewers 
(KK, JAL). If any discrepancies in inclusion or exclusion occurred, a senior investigator 
was consulted (FJMFD). Study selection was accomplished through three phases of 
screening. During the first phase, the following types of studies were excluded: pub-
lished conference abstracts and articles not presenting empirical research or reviews 
(e.g. personal commentary, letters to the editor). During the second phase, abstracts 
were reviewed for relevance, and the full-text articles were obtained. In the last next 
phase, full-text articles were reviewed; requirements for inclusion were a description of 
the informed consent procedure in live donor nephrectomy. Manual reference checks 
were performed to search for potentially missing studies. No authors were contacted to 
provide full-text articles, since all included articles were obtained in full-text. Articles not 
written in English were excluded to prevent translational bias.
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data extraction and critical appraisal
Data extraction was performed by two authors (KK, JAL). Again, if any discrepancies oc-
curred, consensus was reached after consulting a senior investigator (FJMFD). The level of 
evidence of each paper was established using the Grades of Recommendation, Assessment, 
Development and Evaluation (GRADE) tool12. The GRADE approach defines the quality of 
a body of evidence by consideration of risk of bias (methodological quality), directness of 
evidence, heterogeneity, precision of effect estimates and risk of publication bias.
resuLts
Out of 1009 papers identified in the initial search, 21 studies fell within the scope of 
the search protocol, consisting of 13 original articles and eight reviews. No additional 
studies were included after manually scrutinizing reference lists. The PRISMA flow dia-
gram for systematic reviews is presented in Figure 1. Unfortunately, the quality of the 
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figure 1- PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of 
the systematic literature search.
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included articles ranges from low to very low which can be explained by the fact that 
our systematic review consists of observational studies, automatically downgrading the 
level of evidence. The detailed assessment of the quality of the available evidence using 
the GRADE tool is presented in Figure 2.
figure 2 - Summary of findings table of included evidence about the informed consent procedure in live 
donor nephrectomy, generated by the GRADE tool.
informed consent process
Reviews
Table 1 summarizes the results of eight reviews published between 1971 and 201210, 13-20 
including the country of origin and year of publication.
The main concern with informed consent in live organ donation is that hardly any 
research has been performed on the subject. Despite the importance of informed con-
sent emphasized by all authors and the advice to implement standardized procedures 
documenting donors’ understanding of all risks and benefits, most hospitals have not 
yet done so, nor are there mandatory statutes issued by governments to ensure that 
The informed consent procedure
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table 1. Results of eight review articles investigating informed consent in living kidney donation
author, year, 
country, LKd rate 
(%)a
General contents Key topic conclusion
Gordon, 2012
USA (43%)
Informed consent 
procedure
Living kidney 
and liver 
donors
Deficiencies in disclosure resulting in unmet 
information needs and poor comprehension of risks
Variability in transplant centers
Greater efforts are needed to improve the informed 
consent procedure
Ciszek, 2012
Poland (4%)
Ensuring donor 
safety
Living kidney 
donors
Standardized informed consent form should be 
introduced, expressing donors’ full recognition of 
risks and benefits.
It should enumerate types of info to be provided. 
Both verbal and written consent should be 
mandatory.
Include non-medical specialists in process of 
information provision.
Mismanaged communication may result in serious 
misconceptions and risks for donors and team 
members.
Petrini, 2010
Italy (NK)
Informed consent Living kidney 
donors
Comparison of research subjects with donors can 
improve informed consent procedure
Rigorous framework is crucial
Absolutely free and informed consent is illusory 
but continuous efforts have to be made to improve 
current situation
Validation of informed consent should be rigorous 
yet not overburdening
Valapour, 2008
USA (45%)
Understanding and 
validity of informed 
consent
Living kidney 
donors
Small number of empirical studies
Donors may not be fully informed at time of giving 
consent
Donor understanding of consequences of donation 
is an important area of investigation to improve 
informed consent process
Mazaris, 2006
United Kingdom 
(32%)
Ethical issues in 
kidney donation
All aspects 
of kidney 
donation
Only thoroughly informed donor can make voluntary 
decision
Intense debate on ethical issues in transplant 
community
Agreement would protect potential donors and 
ensure future of living kidney donation
Kallich, 1994
USA (38%)
Informed consent 
procedure, law, 
policy and ethics
Living organ 
donors
Transplant community needs to implement a series 
of policies and procedures that protect donors’ right 
to make informed choice
Adams, 1987
USA (NK)
Informed consent, 
liability, medical 
ethics
All living 
organ donors
Donors should have all information a reasonable 
person would want plus any individual specific 
needs
Consent obtained based on misrepresentation 
or nondisclosure is invalid and may be seen as 
battery, but these days failure to disclose nature, 
risks or alternatives is mainly seen as professional 
negligence
Organ donor should enjoy as much protection as 
medical research subject
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hospitals live up to certain standards. Various authors compare living organ donors 
to medical research subjects17-19, 21. Although they are essentially not that different in 
undergoing a medical procedure for the benefit of others, for the latter, strict rules and 
regulations apply and every research project is subject to extensive analysis by an inde-
pendent Institutional Review Board (IRB)17, 19. It can be assumed that no IRB would ever 
approve kidney removal as part of a research trial21. Multiple authors state that donors, 
contrary to research subjects, may not make a decision by carefully weighing risks and 
benefits but rather by emotional or moral reasoning13, 15, 22, 23. Fellner describes that there 
seems to be a discrepancy between what the potential kidney donor experiences dur-
ing the screening period and what the medical team generally assumes. Instead of a 
deliberate balancing of risks and benefits, a simple yes-or-no decision is followed by an 
extensive waiting period and a feeling of having to defend the decision13. Some authors 
believe that donors do not actually perceive all the information given to them, but 
rather focus on positive aspects to reaffirm their decision15. The question has been raised 
whether they actually understand all information provided to them, and it is argued that 
potential donors may not be fully informed at the time of consent10, 14, 15, 17, 20. Although 
this theory is somewhat confirmed by donors retrospectively reporting that they did 
not feel adequately informed about (some) aspects of kidney donation10, 17, it has to be 
taken into account that the concept of live kidney donation has changed drastically 
since the 1970s. The live donor nephrectomy itself has been fully implemented in the 
general practice and much more information has become available regarding outcome 
and possible peri- and postoperative complications. Due to these developments live 
kidney donation has gained ground over the past decades, and numbers are increas-
ing worldwide; this merits a revisited opinion on information disclosure and consent. 
Although the informed consent process has evolved alongside the surgical procedure 
in an attempt to incorporate the most up to date knowledge and transfer it to potential 
donors in an understandable fashion, it still has to be brought to perfection. In addition, 
table 1. Results of eight review articles investigating informed consent in living kidney donation 
(continued)
author, year, 
country, LKd rate 
(%)a
General contents Key topic conclusion
Fellner, 1971
USA (NK)
Psychological 
aspects of donor 
selection
Living kidney 
donors
Discrepancy between what the medical profession 
assumes the kidney donor experiences during the 
screening period and the actual perception.
Most donors decide to donate immediately after 
being asked, special situation that cannot be 
compared to normal decision making
Initial decision has to be defended throughout 
waiting period for surgery
aLiving kidney donation rates in country of origin at time of publication
LKD – live kidney donation; NK – not known
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authors worry that psychosocial and financial aspects are neglected in the informed 
consent procedure, which is often led by medical specialists16, 17. More research is needed 
to gain insight in what information should be provided to potential donors, by whom 
and in which manner to ensure optimal support in the decision making process, thereby 
safeguarding their autonomy10, 17.
Original papers
Thirteen original papers were identified (1970 – 2013). Table 2 provides an overview of 
the main characteristics and results of these studies, as well as the country of origin. 
Only a few studies have been performed assessing the informed consent procedure in 
live kidney donation. Most are surveys (N=5) among either medical professionals (N=3) 
or donors (N=2), or material (i.e. educational information, consent forms) or procedure 
analysis (N=4). In accordance with the reviews, considerable variations were observed 
between transplant centers and in some centers information provision was even deemed 
inadequate24. In one survey, a little over half of the respondents reported mentioning a 
certain risk of developing kidney failure but another 42% told donors that this risk was 
none-existent or left it out completely25. Similar differences were encountered by other 
authors26, highlighting once again the need for a standardized procedure. Although 
these differences can be at least partially attributed to lack of evidence regarding the 
medical risks donors are exposed to after nephrectomy, it is alarming that potential 
donors receive different information in different centers.
Gordon showed that some donors did not feel accurately informed about the post-
operative risks and possible complications by the transplant team21. Fellner however, 
reported that all donors felt the information-giving process was more than adequate23. 
Valapour et al.27 described that although some donors did report a lack of understand-
ing of especially long-term (i.e. 48%), psychological (31%) and financial risks (68%), this 
did not influence their theoretical willingness to donate again or negatively affect their 
experience, supporting Fellner’s earlier conclusion that the decision making process in 
donors may differ from that in patients22, 23, 27, which was later confirmed by Simmons et 
al. 28.
contents of informed consent
Authors agree that whilst medical aspects of donation are usually well covered, psy-
chosocial and financial aspects are much less frequently discussed24, 25, 29. Worsened 
familial relations associated with live kidney donation are reported in a small number 
of cases and up to 25% of donors deal with adverse financial effects30. The possibility 
of positive psychological outcomes are mentioned in about three quarters of centers, 
whereas negative aspects are often neglected25. Parekh et al. describe that informed 
consent in US centers is mainly obtained by surgeons (74%). In non-US centers surgeons 
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are responsible for approximately 50% of cases25. Housawi et al. presented similar rates 
with surgeons obtaining consent in 70% of donors26. Table 3 demonstrates items that 
should, according to current literature and our own experience, be incorporated in a 
standardized informed consent procedure for live donor nephrectomy, and by whom 
they should be provided.
Many brochures and informed consent forms appear to be quite difficult to read. Gordon 
et al31 assessed 332 informed consent forms demonstrating an average college freshman 
reading level. This stands in marked contrast to recommendations that patient educa-
tion materials should be written at an average of 5th-8th-grade primary school reading 
levels. Seeing this in perspective of our own living donor population, this may seem a 
bit harsh. The median age of our population is currently 53 years, and a recent cohort 
table 3. Elements to be included in a standardized informed consent procedure
category information details
surgical information Mortality
Major complications
Minor complications
Duration of hospital stay
Organ damage
Bleeding
Infectious complications
Thromboembolic complications
Pain
Minor infectious complications
medical information Screening procedure
Long term effects
Risks of living with one kidney
Follow up
Chronic pain
Hypertension
Proteinuria
Kidney failure
Cardiovascular disease
Risk of malignancy in remaining 
kidney
Kidney trauma
psychosocial 
information
Inflicted stress
Depression
Benefits
Potential impact on lifestyle
financial information Expenses to be borne by donor
Potential impact on ability to obtain health- and life insurance
Potential impact on ability to future employment
other information Voluntary nature
Legitimate ways out
Recipient benefits
Risk of graft loss in recipient
Alternative donation procedures
Sick leave duration
Better quality kidney
Shorter waiting time
The informed consent procedure
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demonstrates that 56% of our donors have received further education after primary 
school (Timmerman et al., unpublished data)1. Still, every donor needs to understand 
all provided information, and if nearly half of the population has only gone to primary 
school, college reading levels may be too difficult.
Timing of information and consent
Authors agree that information should be repetitive and provided at an early stage 10, 17.
Although most centers use presumed consent for the evaluation process, the Cen-
ters for Medicare and Medicaid Services (CMS) require programs to have two separate 
informed consent processes; one for the screening period and one for the actual donor 
nephrectomy, the latter already being employed in most centers 25, 29. Many donors 
report that they decided to donate a kidney the first moment they heard about the 
option 22, 23, prior to receiving any information about the risks of the procedure. It is even 
more striking that none of them changed their mind after going through the extensive 
screening process. It is recommended that specific details of provided information are 
carefully documented upon each donor-contact. Although donor understanding is still 
not guaranteed, there will at least be more insight into the information-giving process.
Legal aspects
The manner of providing information to (potential) donors and the method of acquiring 
informed consent is dependent on the local legal situation. Policies and laws vary enor-
mously between different countries 32, 33, and in the US even between different states29. 
In some regions, the donor’s signed informed consent is sufficient29, while others require 
witnesses or even a public authority to be present at the time of consent7, 8, 33. Even 
though informed consent is a standard requirement for live organ donation in most 
countries, some require additional justification33. In the Netherlands, the law on organ 
donation stems from May 1996 and is quite lenient on the matter of live organ donation. 
Consent has to be obtained in writing, signed and dated. This is further documented in 
the EU Directive (EU Directive 2010/53/EU for Living Organ Donation Practice)34 which 
requires Member States to adhere to minimum standards in live organ donation (van 
Assche et al, submitted)2.
Donor experience
Few studies discuss donors’ experience with the informed consent procedure 21, 27, 30 
and most are descriptive, retrospective studies or surveys. Fellner reports very positive 
results in early studies dating back to the seventies, with all interviewed donors report-
ing the experience to be “the most meaningful of their lives” 22, 23. More recent studies 
demonstrate that donors generally feel well informed and most of them would be 
willing to donate again with the information at hand 27, 30. Nonetheless, some donors 
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do report various degrees of dissatisfaction with and misunderstanding of provided 
information. Gordon et al. 21 published numerous living donor experiences. For some 
donors, it was the most meaningful experience of their lives; others look back on the 
ordeal with mixed feelings. Many donors felt, at least to some degree, unprepared for 
(adverse) postoperative events. Two donors reported a negative experience with donor 
education and informed consent: complication and mortality rates and long term risks 
were inadequately described as were life style adjustments and risks for the recipient. 
Another donor reports a similar experience, where she feels that “everything she learned 
about live kidney donation, she learned after her surgery”, and regrets the blind trust she 
put in the transplant team. Yet another donor criticizes the media and medical industry 
for “only promoting the happily-ever-after stories”, failing to investigate or share nega-
tive donor experiences. Another recurring statement in the donors’ narratives was the 
postoperative realization that they were ‘blinded’ and thereby not quite informed at the 
time of giving consent: “I acknowledged my understanding, but never actually believed 
the rules applied to me”, or: “I thought my consent was informed, but I eagerly heard 
what I wanted to hear – that I was eligible to donate”.
discussion
With regulations in health care becoming ever more strict, transplant teams are forced to 
reevaluate current practice concerning patient safety and informed consent, especially 
in living organ donors undergoing surgery for the benefit of others. Donor education, 
leading up to informed consent, needs to be carried out according to certain standards.
We performed a systematic review of the available literature to assess the existence 
and contents of these standards and whether transplant centers have actually imple-
mented such procedures in their daily practice. We have included original articles as well 
as other reviews, thus creating a “meta-review” of the available literature. To the best of 
our knowledge, ours is the first article that actually bundles all available evidence on the 
informed consent procedure in live kidney donation. This is therefore the first overview 
article that can serve as a basis for creating a standardized procedure. Although many 
authors touch on the subject, most do not actually describe the contents of the informed 
consent procedure. Little research has been performed, and available data shows a great 
deal of variation in practice between different hospitals 25, 26, and even between different 
team members within one organization. Similar results were encountered when infor-
mation brochures and informed consent forms from different centers were analyzed. In 
addition, these forms proved to be of an average college freshman reading level, which 
is much higher than the recommended level of 5th-8th grade primary school 31.
The informed consent procedure
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The most alarming finding however was the fact that, although a minority, some 
donors reported feeling misinformed, in some cases to such a degree that they felt the 
transplant team had lied to them regarding possible complications, long-term results 
and recipient outcome 21. These donor experiences are unacceptable and pose a threat 
to the success of a living donor transplant program. It is our responsibility to safeguard 
the informed consent procedure for live kidney donation by ensuring that potential do-
nors are well educated and prepared for their upcoming procedure and postoperative 
course.
Although standardizing the informed consent procedure is a noble aim, there will 
inevitably be variations due to cultural, religious and educational differences between 
donors. Still, a standardized procedure will serve as a guideline, and alterations can be 
made according to the local population. Additional features can further support the 
educational system, and adjustments can be made according to local needs. Appoint-
ing independent donor advocates or involving a home-based educational team in the 
process could be of great value 35-37.
Another point of interest is the fact that we cannot change the way donors perceive 
the information laid upon them. Fellner was the first to demonstrate that most donors 
made the decision to donate upon the first moment of hearing of the option, and none 
of the interviewed donors had changed their mind after learning about all the risks as-
sociated with donating a kidney 22, 23. At the time these studies were conducted, live 
donation was performed only in family members. Donors may therefore have felt more 
pressure to donate because there were fewer options for their loved ones. Still, more 
recent studies confirm Fellner’s earlier findings and although much more knowledge 
is available regarding the nephrectomy, its outcomes and possible adverse events it is 
again suggested that donors do not actually use the provided information to make a 
deliberate decision, carefully weighing risks and benefits in a process eventually leading 
up to consenting or declining, but rather to reassure them that they have indeed made 
the right call 15.
There are, unfortunately, few studies reporting on donor experience regarding educa-
tion and consent in live kidney donation. In the field of live liver donation a little more 
information is available, but results vary: some studies report donors’ knowledge of 
the risks and benefits to be “good to very good”, while some others report significant 
gaps in their knowledge 38. Available information on kidney donors is anecdotal and no 
reliable conclusions can be drawn, but it does give some insight in their perception of 
the information process. Although most donors considered donating to be a positive 
and meaningful experience and the main proportion would repeat the procedure if 
given the chance, quite a large percentage of donors report not being fully informed 
about (certain aspects of ) the procedure 21, 27. Some donors report being well informed 
but simply thinking that the mentioned risks would not apply to them 21. This not only 
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further underlines the importance of adequate documentation to determine whether 
all donors have indeed received all the necessary information, it also warrants a new 
strategy to confirm donor comprehension. To assess whether the provided information 
has actually reached donors, a pop-quiz could be administered to them at different 
moments in their screening process. A prospective trial using short questionnaires 
with open questions is currently being conducted in our center, to assess whether this 
provides accurate information regarding donor comprehension. This will give us more 
insight in which items of the informed consent process are covered adequately, and 
which need more specific attention. This then will guide us in creating a standardized 
procedure.
One of the foreseen problems with the incorporation of a standardized information- 
and consent process is the heterogeneity of the potential donor pool. Striving for a 
worldwide standard format will therefore be virtually impossible, in light of political, 
cultural and religious differences between countries and even populations within 
one geographical area. A standardized format can serve as a basis and alterations can 
be made according to the local situation. Another objection physicians may have to 
the implementation of a standardized procedure is the extra labor that mandatory 
documentation will add to their workload. However, 82% of surveyed transplant centers 
worldwide would be willing to adopt centralized consent templates, with US centers 
being slightly more willing than non-US centers (79% vs 84%, p<0.001) 25.
Limitations
A limitation and one of the major issues of this review, is the fact that the available 
evidence is rather subjective and descriptive. Since donation procedures vary between 
regions, countries and centers39, as do informed consent procedures, published data is 
subject to interpretation in light of local practice. The contents of the informed consent 
procedure, and the manner in which information is provided, is dependent on local 
legislation and opinions on for instance ethics and religion. These opinions vary over 
time and per country, or even per region within a country39, 40. Since the included studies 
comprise a wide time range and geographical area, results must be seen in perspective 
of these differences. In addition, local statistics on live donation, especially live donor 
nephrectomy complication rates and success rates in recipients may influence not only 
the way medical practitioners inform potential donors, but also the way that donors 
perceive this information, and how they experience the donation process in general.
For this systematic review we have only included living kidney donors, opposed to 
including all potential donors (i.e. liver, lung). While the process of informed consent in 
live liver- or lung donation is in many aspects similar to live kidney donation, complica-
tion rates in the former two are far greater than those in live kidney donation.
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In addition, the geographical distribution of live liver and lung donation is different 
from live kidney donation. Although there are significant differences between countries 
regarding live kidney donation rates, this is still a much more common procedure. Live 
kidney donation was the first form of live donation to be performed, and informed con-
sent procedures for the other organs may even be based on the procedures developed 
for kidney donation. Even so, the (also scarce) literature on informed consent in organ 
donation other than kidney similarly concludes that there are many variations in policy, 
opinions and donor comprehension, and consensus on best clinical practice is lacking38.
There are obviously many more ethical issues that should be addressed regarding live 
kidney donation, and may deserve attention during donor education and the informed 
consent procedure, but which are not included in this systematic review. Medical 
practitioners should ascertain themselves that there are no signs of coercion, and that 
the decision to donate is indeed voluntary. There is also the matter of paid donation, 
a currently much debated issue, on which opinions differ greatly 41, 42. However, these 
issues do not quite fall within the scope of this review and are therefore not pursued 
any further.
Looking at the assessment of the quality of the included studies, using the GRADE 
tool, we conclude that the evidence of each included study ranges from very low to low. 
Since the GRADE tool is primarily useful for assessment of interventional studies, the 
evidence scale is automatically downgraded since the published literature consists only 
of observational studies. Creating a protocol for a randomized controlled trial regarding 
the informed consent procedure is difficult and at risk for bias, and this has to the best of 
our knowledge not yet been initiated. It would, however, drastically improve the quality 
of evidence regarding this procedure.
In conclusion, it is clear that a standardized informed consent procedure for live donor 
nephrectomy is much needed to ensure donor safety and satisfaction. It is to be ex-
pected that this will become legally mandatory, thereby protecting donors as well as 
physicians. It will further aid the transplant community in systematically providing and 
documenting information that will optimally prepare potential donors for the procedure 
and postoperative course. Once implemented it will serve as a basis in donor education 
and greatly benefit donors as well as medical practitioners.
The success of implementing a standardized procedure relies on input from transplant 
professionals from different centers and preferably different countries involved in live 
kidney donation. If an international working group were to be set up, local and regional 
protocols and guidelines could be combined to form a solid concept. The authors would 
like to invite those interested in participating in such a working group to contact us, 
preferably through email correspondence.
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appendix i – searcH strinGs used in different databases
embase.com
(‘informed consent’/de OR (((inform* OR form*) NEAR/3 consent*) OR ((duty OR duties) 
NEAR/3 warn*)):ab,ti) AND (‘living donor’/de OR ((living OR live OR related OR altruist*) 
NEAR/3 (donor* OR donation* OR transplant*)):ab,ti)
medline ovidsp
(“informed consent”/ OR (((inform* OR form*) ADJ3 consent*) OR ((duty OR duties) ADJ3 
warn*)).ab,ti.) AND (“living donors”/ OR ((living OR live OR related OR altruist*) ADJ3 
(donor* OR donation* OR transplant*)).ab,ti.)
cochrane
((((inform* OR form*) NEAR/3 consent*) OR ((duty OR duties) NEAR/3 warn*)):ab,ti) 
AND (((living OR live OR related OR altruist*) NEAR/3 (donor* OR donation* OR 
transplant*)):ab,ti)
web-of-science
TS=(((((inform* OR form*) NEAR/3 consent*) OR ((duty OR duties) NEAR/3 warn*))) AND 
(((living OR live OR related OR altruist*) NEAR/3 (donor* OR donation* OR transplant*))))
pubmed as publisher
((((inform*[tiab] OR form*[tiab]) AND consent*[tiab]) OR ((duty[tiab] OR duties[tiab]) 
AND warn*[tiab]))) AND (((living[tiab] OR live[tiab] OR related[tiab] OR altruist*[tiab]) 
AND (donor*[tiab] OR donation*[tiab] OR transplant*[tiab]))) NOT medline[sb]
Google scholar
“informed consent”|”duty to warn” “living|live|related|altruistic donor|donation|transpla
ntation”|”living|live|related|altruistic kidney donor|donation|transplantation”
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abstract
background Minimally-invasive live donor nephrectomy has become a fully imple-
mented and accepted procedure. Donors have to be well educated about all risks and 
details during the informed consent process. For this to be successful, more information 
regarding short-term outcome is necessary.
methods A literature search was performed, and all studies discussing short-term com-
plications after minimally-invasive live donor nephrectomy were included. Outcomes 
evaluated were intra- and postoperative complications, conversions, operative and 
warm ischemia times, blood loss, length of hospital stay, pain score, convalescence, 
quality of life and costs.
results 190 Articles were included in the systematic review, 41 in the meta-analysis. 
Conversion rate was 1.1%. Intraoperative complication rate was 2.3%, mainly bleeding 
(1.5%). Postoperative complications occurred in 7.3% of donors, including infectious 
complications (2.6%), of which mainly wound infection (1.6%) and bleeding (1.0%). 
Reported mortality rate was 0.01%. All minimally-invasive techniques were comparable 
with regard to complication- or conversion rate.
conclusion The employed techniques for minimally-invasive live donor nephrectomy 
are safe and associated with low complication rates and minimal risk of mortality. These 
data may be helpful to develop a standardized, donor-tailored informed consent proce-
dure for live donor nephrectomy.
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introduction
Live donor nephrectomy is considered to be a safe, low risk procedure, fully implement-
ed in many transplant centers worldwide. There are many different surgical techniques 
for this procedure, and preference differs between centers1, 2. Although the traditional 
open technique is still employed, minimally-invasive procedures should be recom-
mended as the gold standard, since morbidity is reduced and quality of life improved3-5. 
Modifications to the laparoscopic technique have been introduced, including the ret-
roperitoneoscopic approach (RDN), hand-assistance (HALDN/HARP) and robot-assisted 
approach as well as the single incision laparoscopic donor nephrectomy (LESS). More 
recently, the first cases of natural orifice transluminal endoscopic surgery (NOTES) live 
donor nephrectomy have been reported, with transvaginal kidney extraction6-8. With 
the introduction of these techniques, a great number of studies, including randomized 
controlled trials, have been performed to assess their value, safety and efficacy. Still, 
there doesn’t seem to be one technique that evidently stands out from the rest, and 
preferences vary among surgeons and centers (as seen in a recent survey among kidney 
transplant surgeons, Kortram et al, unpublished). Overall, complication rates are low and 
mortality occurs only sporadically 9, 10. However, if a healthy donor is not well informed 
and experiences complications related to the procedure anger and distress may occur, 
negatively affecting the outcome for this patient as well as the living donation program. 
Therefore, donors must be well educated during the informed consent process. A key 
condition for the successful employment of donor education and informed consent is 
the availability of a complete overview of the specific details and risks of the operative 
techniques.
Little research has been performed regarding the specific contents of the informed 
consent procedure, and there are no well-designed studies on how donors experience 
the informed consent and the educational process11. Available evidence is quite subjec-
tive, and if anything, suggests that some donors report feeling misinformed, in a single 
incidence to such a degree that the donor felt the transplant team had withheld the 
truth about possible complications, long-term results and recipient outcome12. On the 
other hand, providing more information doesn’t necessarily improve donors’ compre-
hension of details and risks of the procedure13-15.
The current project has two major objectives. First, to provide a systematic review of 
all available evidence on informed consent including all information regarding short 
term outcome of minimally-invasive live donor nephrectomy focusing on the incidence 
of individual complications. Second, to conduct a meta-analysis comparing the different 
procedures for live donor nephrectomy and complications. By creating a clear overview 
of the incidence of complications and (serious) adverse events, evidence-based infor-
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mation can be provided to potential donors, thereby further optimizing our educational 
and informed consent process for the live donor nephrectomy.
materiaLs and metHods
All aspects of the Cochrane Handbook for Interventional Systematic Reviews were fol-
lowed and the study was written according to the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) statement16 for Randomized Controlled Trials 
and the Meta-analysis of Observations Studies in Epidemiology (MOOSE) guidelines17 
for observational studies. The initial review protocol was registered in the PROSPERO 
database with number CRD4201404170 (www.crd.york.ac.uk/PROSPERO/).
Literature search strategy
A comprehensive search was performed with the help of a biomedical information 
specialist on September 24th 2014, and updated on March 8th 2016, in Embase, Medline 
OvidSP, Web-of-Science, PubMed, CENTRAL and Google Scholar (Figure 1). No date limits 
were used. Search strings for each database are provided in Appendix 1, no other limits 
were applied during the search. During screening, only articles written in English were 
included to prevent any misinterpretations of data. All references were screened by two 
independent reviewers (KK, FJMFD). If any discrepancies occurred, a third investigator 
was consulted (JNMI). Study selection was accomplished through two phases. During 
the first phase, titles and abstracts were reviewed for relevance, and full-text articles 
were obtained. Published abstracts were included if they contained detailed information 
regarding complications. During the second phase, full-text articles were reviewed. Case 
reports, commentaries and letters were excluded. Survey studies and studies describing 
results from national databases were excluded to prevent double inclusion of donors. 
Studies mentioning short-term complications after minimally invasive live donor ne-
phrectomy were eligible for inclusion. If a full text article corresponding to a published 
meeting abstract was available, the abstract was disregarded. The same strategy was 
employed for preliminary results of which definitive results were also available. If data 
was unclear or pooled for different techniques or indications the authors were contacted 
to provide source data. Authors were also contacted when study cohorts of two or more 
publications seemed to overlap. If no response was obtained after two reminders, articles 
were excluded if data was pooled for different nephrectomy indications, or if the classic 
open technique was included in their cohort. In some articles, with evident overlapping 
cohorts, inclusion was based on a number of criteria. Preferably, the most recent pub-
lication or the largest cohort of patients was included. However, in some cases a dated 
publication contained more details and it was therefore decided to include the paper 
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with the greatest evidential value. If operative techniques were pooled, articles were 
included in the systematic review but not in the meta-analysis. Systematic reviews and 
meta-analyses were carefully screened for already published/background information 
but were not included in the data-analysis process. All references of included full text 
articles were manually scrutinized to ensure that no relevant articles were missed.
All articles were used for the systematic review part of this project; only those that 
compared (or mentioned, within one cohort) two or more different minimally-invasive 
live donor nephrectomy techniques were included in the meta-analysis.
data extraction and critical appraisal
Data extraction was performed by two authors (KK, FJMFD). Again, if any discrepancies 
occurred, consensus was reached after consulting a third investigator (JNMI). Data was 
collected on study design, population, operative technique, procedural details and 
complications. A list of all possible complications was created prior to the start of data 
extraction, and if complications came up that weren’t included these were added to the 
checklist. All intra- and postoperative complications and conversions were scored, as 
well as mortality. Conversions from LESS to multiport laparoscopy or a hand-assisted 
procedure or from pure laparoscopy/retroperitoneoscopy to hand-assisted were not 
scored in this analysis. If an article only described specific complications, all other com-
plications were scored as “unknown”. If however the description of complications was 
detailed (for instance split to minor and major) but some “common” complications were 
not listed in an article, it was assumed these did not occur in that specific population and 
were scored as “zero”. Less frequently mentioned complications like (but not limited to) 
testicular pain and thigh numbness were scored as unknown. Mortality was scored as 
“none” or the number of fatalities, when this was literally stated. It was scored as “none 
assumed” when for instance “no (other) major complications occurred”, or when no do-
nors were missing in follow-up data. All other cases were scored as “unknown”. A number 
of other outcome measures were scored, namely operative time, estimated blood loss, 
warm ischemia time, length of stay, readmissions, length of convalescence, pain score, 
analgesic requirement, quality of life and costs.
The level of evidence of each paper included in the meta-analysis was established us-
ing the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) 
tool18. The GRADE approach defines the quality of a body of evidence by consideration 
of risk of bias (methodological quality), directness of evidence, heterogeneity, precision 
of effect estimates and risk of publication bias (supplementary figure 1).
statistical analysis
For the systematic review individual complications were presented as absolute values 
and percentages. Continuous factors were provided in means and range.
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A meta-analysis was performed using Review Manager version 5.3 (The Nordic Co-
chrane Center, Copenhagen, Denmark). Random effects models were used to account 
for possible clinical heterogeneity. Results were presented in forest plots with risk ratios 
(RR). Overall effects were determined using the Z-test, and results were presented in 
risk ratios. Ninety-five percent confidence intervals (CI) of these values were given and 
P-values <0.05 were considered statistically significant. Heterogeneity between studies 
was assessed by three methods. First, a Tau2 test and an X2 test were conducted for sta-
tistical heterogeneity, with P<0.1 being considered statistically significant. In addition, 
I2 statistics were used to assess clinical heterogeneity, using a cut-off point of 35%. The 
number of donors in each study group weighted group means. Sensitivity analyses were 
performed for all outcome measures per comparison, first isolating only randomized 
trials, then excluding all retrospective studies. Studies with substantially more weight 
than others were also left out to assess different effects.
resuLts
Out of 2168 unique articles identified in the search, 205 fell within the scope of our 
predetermined search. However, there were substantial issues with 20 of these publi-
cations; i.e. evidently overlapping cohorts, no specification of complications (i.e. only 
overall percentages or grades) or pooled data for different nephrectomy indications. 
Five authors provided us with source data, and the other articles were excluded accord-
ing to the criteria stated in the methods section. A total of 190 articles remained for the 
systematic review19-208. There were a great number of publications that addressed two 
or more operative techniques but pooled complications. Two authors provided us with 
source data, and the other articles were excluded from the meta-analysis part of this 
review. Forty-one remained for inclusion in the meta-analysis. Supplementary figure 1 
depicts the flowchart of the literature search.
The included articles originated from transplant centers worldwide. A table providing 
an overview of the number of included articles per country is included as supplemen-
tary table 1.
part 1 – systematic review of complications after minimally-invasive live donor 
nephrectomy
The studies comprised a total of 32.038live donor nephrectomies. Table 1 shows the 
distribution of these donors over the different techniques.
For this part of the review, complications were not divided over the different operative 
techniques. The purpose was to provide an overview of which complications occur, and 
in which frequency.
Complications after donor nephrectomy
53
  
Records identified through  
Embase database 
(n = 982) 
Sc
re
en
in
g 
In
cl
ud
ed
 
El
ig
ib
ili
ty
 
Id
en
tif
ic
at
io
n Additional records identified 
through other sources 
(n = 3002) 
Records after duplicates removed 
(n = 1911) 
Records screened on title/abstract 
(n = 1911) 
Records excluded 
(n = 1531) 
Full-text articles assessed 
for eligibility 
(n = 380) 
Full-text articles excluded 
(n = 206) 
 
- Published meeting abstracts 
without details (44) 
- Preliminary results of which 
final results also included (25) 
- Language o/t English (25) 
- Complications not mentioned 
(18) 
- Published abstract of which 
full text also included (17) 
- Non-empirical research (13) 
- Open procedures only (12) 
- Double cohort (12) 
- National database/survey (7) 
- Non-donor nephrectomies (6) 
- Recipients only (5) 
- Full text not available (3) 
- Irrelevant (2) 
- Long term results only (1) 
- Case report (1) 
- Removed after data request 
(15) 
 
Studies included in 
systematic review 
(n = 174) 
Studies included in  
meta-analysis 
(n = 37)  
Full-text articles excluded 
(n=138) 
 
- No comparison of techniques 
(134)  
- Pooled data (removed after 
data request) (4) 
 
 
+ 1 overlapping cohort, excluded 
from systematic review 
 
 
figure 1 – PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of 
the systematic literature search.
table 1. Distribution of 32.038 live donors over the different operative techniquesa
procedure n (%)
Laparoscopic
Hand-assisted laparoscopic
Retroperitoneoscopic
Hand-assisted retroperitoneoscopic
Single-port laparoscopic (LESS)
Robot-assisted laparoscopic
Mini-open
Natural orifice transluminal endoscopy (NOTES)
18.374 (57.4)
8.112 (25.3)
1.107 (3.7)
1.300 (3.8)
1.214 (3.8)
417 (1.3)
1.436 (4.5)
78 (0.2)
a. Although we know the exact numbers for each of the procedures, results are, unfortunately, not always split 
over the different operative techniques
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Conversion
Conversion to a traditional open technique was mentioned in 160 articles (84%). The 
overall conversion rate was 1.1% (table 2). The reason for conversion could not be deter-
mined in all cases; reasons were provided in 288 of a total of 316 conversions (91%). Elec-
tive conversions for adhesions, vascular anomalies or failure to progress were scored, 
although these were not considered to be complications. Conversions for bleeding or 
injury to other organs were also scored as intra-operative complications.
table 2. Conversions, intra- and postoperative complications, reinterventions and mortality after 
minimally-invasive live donor nephrectomy.
no of articles no of 
nephrectomies
no of events %
conversion (aLL)
 Emergent
 Bleeding
 Injury other organs
160
149
145
149
28.376
27.694
27.694
27.694
316
189
185
4a
1.1
0.7
0.7
0.01
intraoperative complications (aLL)
 Bleeding
 Injury other organs
 Spleen
 Bowel
 Bladder
 Liver
 Adrenal gland
 Other
173
175
153
151
153
151
151
151
151
27.776
27.776
26.440
26.440
26.440
26.440
26.440
26.440
26.440
612
391
221
97
49
12
14
22
27b
2.2
1.5
0.8
0.4
0.2
0.05
0.05
0.08
0.1
postoperative complications (aLL) 187 30.970 2174 7.0
Bleeding (ALL)
 Requiring transfusion
 Requiring intervention
176
175
173
30.443
29.443
29.878
290
128
60
1.0
0.4
0.2
Injury to other organs (ALL)
 Bowel
 Spleen
 Bladder
 Pancreas
170
170
167
167
167
28.562
28.562
28.074
28.074
28.074
26
14
6
3
3
0.09
0.05
0.02
0.01
0.01
Infectious complications (ALL)
 Wound infection
 Abscess
 Urinary tract infection
 Pneumonia
 Thoracic Empyema
 Infectious – otherc
 Fever e.c.i.
163
158
152
141
153
104
111
55
26.729
25.650
25.910
23.573
25.808
19.845
19.785
11.095
697
405
19
105
148
1
12
71
2.6
1.6
0.07
0.4
0.6
0.01
0.06
0.6
Cardiopulmonary complications
 Cardiovascular
 Cerebrovascular
 Pneumothorax
 Pulmonary – otherd
148
149
150
113
25.431
25.475
25.842
20.436
18
1
36
71
0.07
0.004
0.1
0.3
Thromboembolic complications 146 23.574 39 0.2
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Complications
Table 2 provides an overview of all encountered complications and their incidence. There 
were many different definitions for intra-operative bleeding. Some authors regard it as 
a complication only if total blood loss exceeded 500 ml while others set the limit at 300 
ml. Some studies only listed bleeding as a complication when an additional interven-
tion (i.e. extra clip, suture or even conversion) was necessary and some authors did not 
specify at all. The need for blood transfusion was stated in 168 articles. Injury to other 
organs was stated in most articles, however the action taken to repair this remained 
unclear in the majority thereof. Table 3 sums up the postoperative complications. The 
reported complications vary between studies. While some authors report every adverse 
event from nausea to severe complications requiring surgical reintervention, others only 
mention specific types of- or major complications.
table 2. Conversions, intra- and postoperative complications, reinterventions and mortality after 
minimally-invasive live donor nephrectomy. (continued)
no of articles no of 
nephrectomies
no of events %
Gastro-intestinal complications
 Ileus
 Small bowel obstruction
 Chylous ascites
 GI-bleed
 GI-othere
138
58
78
88
62
24.958
13.854
17.564
16.022
12.399
187
30
81
5
115
0.7
0.2
0.5
0.03
0.9
Other complications
 Fascial defect
 Testicular swelling/pain/epididymitis
 Thigh numbness
 Pain
 Remnant kidney function disorder
 Urinary retention
 Drug reaction
 Other general complicationsf
121
63
51
61
41
100
38
101
22.532
14.390
11.235
12.062
8.681
19.537
7.065
20.030
3692
32
95
24
100
2
194
0.2
0.6
0.3
0.8
0.3
0.5
0.03
1.6
mortality 142 25.116 3 0.01
surgical reinterventions 163 28.516 165 0.6
a. Injury to other organs included spleen (2), bowel (1), mesentery (1)
b. Other organs/structures include: , pancreas (4), gallbladder (1), diaphragm (18), mesentery (4)
c. Other infectious complications included sepsis (3), pyelonephritis (1), phlebitis (8)
d. Other pulmonary complications included atelectasis (35), respiratory distress (13), pulmonary edema 
(8), pleural effusion (10), hypoxia (5)
e. Other GI complications included gastroenteritis (58), pancreatitis (11), constipation (13), liver function 
disorder (24), appendicitis (4), cholecystitis (2), gastric ulcer (3)
f. Other general complications included: Seroma (68), neuropathy/neurapraxia (23), subcutaneous 
emphysema (18), ocular complications (16), rhabdomyolysis (12), skin complications (16), electrolyte 
disorder (8), urethral injury (12), headache (4), ear haematoma (1), parotitis (1), depression (5), vertigo (1)
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Mortality
Mortality within 30 days is very rare after live donor nephrectomy. Of the 190 included 
studies, mortality was reported in 65 (34%, N=16.604 nephrectomies). In 77 additional 
articles (8.512 nephrectomies), it was assumed that no mortality occurred based on com-
plication rates and follow up. In the remaining 46 articles (24%, 6.922 nephrectomies) 
the occurrence of mortality couldn’t be reliably deduced. In the remaining population of 
27.816, only three deaths were reported, adding up to an overall reported mortality rate 
after live donor nephrectomy of 0.01%.
Surgical Reinterventions
A total of 165 surgical reinterventions were reported (0.6%). But as with mortality, not 
every article clearly stated it; in 27 articles reinterventions were not mentioned (N=3.522 
procedures). In addition, 4% of studies (N=6, 12 cases), that did mention reoperations 
did not specify the indication therefor, and some other studies provided indications 
for some, but not all reinterventions (N=14 cases). Whether reoperation was done via 
laparoscopy or laparotomy was unclear in the majority of studies. Most reoperations 
were due to bleeding or to evacuate a hematoma (N=61, 37%). Small bowel obstruction 
due to internal or port-side hernia, or entrapment in a suture was the reason for reinter-
vention in 26 cases (16%). Other indications for reintervention were wound infection or 
dehiscence (9), bowel injury (7), fascial dehiscence (7), splenectomy (5), appendectomy 
(4), , orchidectomy due to torsion or ischemia (3), chylous ascites (3), pancreatic injury 
(2), retrieval of corpus alienum (2), abscess drainage (1), bladder injury (1), ovariectomy 
table 3. Overview of additional intra- and postoperative parameters during and after minimally-invasive 
live donor nephrectomy.
parameter population (n) value
intra-operative parameters
Operative time (minutes, mean, range)
Warm ischemia time (minutes, mean, range)
Blood loss (milliliters, mean, range)
postoperative parameters
Length of stay (days, mean, range)
Pain (VAS-score, mean, range)
 Day 1
 Discharge
 Outpatient clinica
Readmissions
Duration of convalescence (days, mean, range)
Postoperative Quality of Life (SF36, mean, range)bc
22.594
18.544
17.489
22.898
1.004
757
488
3.084
2.363
787
194.3 (78 – 320)
3.7 (0.7 – 8.7)
147 (15 – 545)
3.8 (0.6 – 13)
4.1 (0.37 – 8)
2.2 (2 – 5)
1.3 (0.8 – 1.25)
95 (3.1%)
24.1 (4 – 60)
68.2 (34,5 – 90.5)
a. Values are reported at a time interval of 14-30 days postoperatively
b. Quality of life was assessed at a time interval of 1 – 6 months. The majority of studies assessed this 
between 4 and 6 weeks, one study at 3 months and one at 6 months postoperatively.
c. One additional study used the WHOQOL instead of the SF36 (n=50 donors), reporting a mean value of 
72.8, range 69.4-76.2.
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(1), perforated duodenal ulcer (1), vocal cord injury (1).. In addition, five laparotomies 
were performed due to abdominal pain, but no abnormalities were encountered during 
surgery.
Other outcome measures
Intraoperative parameters were described in nearly all articles. Unfortunately, operative 
time, warm ischemia time, blood loss, length of stay and duration of convalescence 
were provided in means and medians, as was the visual analog scale for postoperative 
pain. Since the majority of data was given in means (80%), those in medians were dis-
regarded. Table 3 provides an overview of these extra parameters. Convalescence was 
defined differently in the included articles, ranging from return to daily activities to full 
physical function. These definitions were combined. Analgesic use, although described 
with fair regularity, was documented in many different ways, regarding drugs, dosage or 
days or even hours of use.. Overall costs were not often reported, but if so these varied 
enormously. The broad spectrum of inclusion dates and countries may very well account 
for this.
part 2 - meta-analysis
Forty-one articles were included in the meta-analysis. Comparisons were made between 
pure laparo- and retroperitoneoscopic procedures and hand-assisted procedures, 
laparoscopic procedures and retroperitoneoscopic procedures, multiport and single-
port procedures, and all of these together versus mini-open donor nephrectomy. Two 
retrospective, small-populated studies comparing the robotic technique with any of the 
other techniques were found in our search, and one RCT. Unfortunately; complications in 
the RCT were only mentioned in Clavien-Dindo scales, and the individual complications 
could not be determined209. This technique was therefore left out of the meta-analysis.
The main finding was that there were only few significant differences between the 
minimally-invasive techniques.
Hand-assistance
Nineteen articles compared laparo- and/or retroperitoneoscopic procedures with and 
without hand assistance; three randomized controlled trials (RCT)30, 64, 99, four prospec-
tive43, 65, 69, 208 and eleven retrospective studies38, 41, 54, 92, 116, 117, 139, 151, 152, 177, 179. A total of 777 
procedures were performed with, and 1465 without hand assistance, but since not all 
studies mentioned every outcome, total numbers vary per outcome measure. Conver-
sion rate (1.5 versus 2.1%), and overall intra- (6.2 versus 5.7%) and postoperative (9.9 vs 
10.3%) complication rates and surgical reinterventions (0.6 versus 0.7%) were compa-
rable between the two groups. The only difference, although not statistically significant, 
found between these two techniques was intraoperative bleeding (defined as every 
58
Chapter 3    
bleeding mentioned by the author that exceeded “normal expected blood loss”), which 
was more frequently encountered after hand-assisted procedures: 4.0 versus 3.9%, RR 
1.52 (95% CI 0.95-2.43), p=0.08 (Figure 2).
Laparoscopic versus retroperitoneoscopic donor nephrectomy
Seven articles compared laparoscopic with retroperitoneoscopic techniques, two 
RCTs64, 99, two prospective65, 132 and three retrospective studies41, 152, 163. A total of 311 
procedures were retroperitoneoscopic, 1159 laparoscopic. Conversion (1.6 versus 2.0%), 
overall intra- (4.5 versus 5.6%) and postoperative complications (9.6 versus 12.2%) were 
again comparable between techniques. None of the individual intra- or postoperative 
complications showed statistically significant differences.
Multiport versus single port donor nephrectomy
Ten studies were identified comparing single- with multiport procedures; three 
RCTs27, 107, 149, one prospective study194, and six retrospective series20, 31, 47, 144, 183, 205. In 
total, 764 single port procedures were compared to 1214 laparoscopic procedures. 
Conversions were rare in these studies; only 2 occurred (0.1%), both in multiport donor 
nephrectomies, of which one was elective and one emergent due to bleeding. Intra- 
(0.9% in both groups) and postoperative (6.5 versus 5.2%) complications were again 
comparable, as were reinterventions (0.1 versus 0.9%). Postoperative pain was slightly 
more often described after LESS donor nephrectomies (2.7 versus 0.8%, RR 3.56, 95% CI 
0.90-14.11, p=0.07). , other pulmonary complications (i.e. pleural effusion, atelectasis, 
figure 2 - Intraoperative bleeding compared between handassisted and pure laparoscopic/
retroperitoneoscopic procedures.
Complications after donor nephrectomy
59
respiratory distress, pulmonary edema or hypoxia) were more frequently reported after 
LESS donor nephrectomy; 1.5 versus 0%, RR= 7.51, p=0.03 (95% CI 1.25-44.94).
Mini-open versus laparoscopic donor nephrectomy
All articles comparing the mini-open technique with either one of the endoscopic 
techniques (i.e. laparo- , retroperitoneoscopic, with or without hand-assistance) with 
the exception of single port donor nephrectomies were included in this comparison. 
There was one study that compared retroperitoneoscopic procedures to mini-open 
procedures, and seven additional studies were identified comparing mini-open donor 
nephrectomies to laparoscopic ones. A total of 323 mini-open procedures were com-
pared to 288 endoscopic procedures. This group comprised three RCTs85, 133, 210 and five 
prospective studies 50, 115, 128, 195, 198. Intraoperative complications were more frequently 
seen in laparoscopic procedures; 8.2 versus 3.4%, RR 2.45, 95% CI 1.13-5.35, p=0.02) 
(0.99-1.08), p=0.1 (Figure 3).
This difference was mostly based on intraoperative organ damage, which demonstrat-
ed a trend in favor of open procedures; 0 versus 2.8%, RR 5.18 (95% CI 0.91-29.35), p=0.06 
(Supplementary figure 2). When sensitivity analysis was performed and only RCTs were 
included, the significant difference / trend disappeared (p=0.09 and 0.1 respectively).
Overall postoperative complication rate was comparable, but nonetheless much 
higher than described for the other techniques (17 versus 23%). The design of the 
included studies, only RCTs and prospective series, might account for this finding. The 
incidence of pneumonia was significantly higher after open procedures: 6.3 versus 3.3%, 
RR2.48 (95% CI 1.05-5.87), p=0.04 (figure 4).
figure 3 - Intraoperative complications compared between laparoscopic/ retroperitoneoscopic and 
miniopen procedures.
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However, when performing sensitivity analysis, this difference was largely based on 
one study. When this group was left out of the forest plot analysis, results were quite 
comparable between procedures (2.0 versus 1.3%, RR1.32, p=0.73 for pneumonia). 
Pneumothorax was not more often seen after either procedure; 0.6% for mini-open 
procedures (n=1) and 1% for scopic procedures (n=2). The surgical reintervention rate 
was comparable 0.6% for mini-open procedures versus 1.8% for scopic ones, but this 
difference was not statistically significant.
All in all, none of the employed minimally-invasive techniques for live donor nephrec-
tomy stand out from the rest.
discussion
Our study is, to the best of our knowledge, the first to extensively score all complica-
tions after minimally-invasive live donor nephrectomies and compare outcomes of all 
different techniques. A great number of minimally-invasive live donor nephrectomies 
were included from different countries all over the world. There was no significant 
heterogeneity encountered in the included studies. Short-term complication rates were 
comparable between different techniques currently employed for live donor nephrec-
tomy, and not one of the techniques stood out from the rest. In the included studies, 
the pure laparoscopic approach was used in the majority of cases (57.4%). This may not 
be an adequate portrait of the current situation, in which the hand-assisted approach is 
favored in many cases1. It is possible that some authors did indeed use hand-assistance, 
but did not explicitly mention this in their article. No statistically significant differences 
were found in this meta-analysis comparing laparoscopic donor nephrectomies with 
and without hand-assistance. The overall postoperative complication rate found in the 
systematic review part of our study (7.0%) is lower than the complication rates found in 
some of the meta-analyses (12.2% for retroperitoneoscopic techniques when compared 
to laparoscopic techniques and 23% for laparoscopic procedures when compared to 
mini-open procedures, which, in turn, had 17% complications). This may imply under 
figure 4 - Pneumonia compared between laparoscopic/ retroperitoneoscopic and miniopen procedures.
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reporting of complications in the systematic review part, which mainly consisted of 
retrospective case series. Complications were mentioned, but were not always the main 
outcome measure of the study. In the meta-analyses, only those studies that compared 
two or more techniques were included, and the focus was on complications in most 
studies. Conversions (316 overall) were described in a total of 160 articles. Unfortunately, 
complications were not specified for converted and non-converted donors in most stud-
ies, so whether the conversion itself had any negative influence on the post-operative 
course or convalescence period remains unknown.
If we would adhere to our national guideline, according to which only those complica-
tions with an incidence of greater than 1% or those with severe consequences have 
to be disclosed to patients undergoing any surgical procedure211, we would only be 
obliged to mention intra- and postoperative bleeding, conversion, wound infection 
(and possibly overall infectious complications) and ileus. In addition, the possibility of a 
reintervention and mortality should be mentioned, regardless of their incidence. But is 
this really enough to ensure that a potential living kidney donor is optimally prepared 
and able to make a well-informed decision? Rare complications like damage to other 
organs, or cardiovascular events may or may not necessary have “severe consequences”, 
so should these be mentioned or not? And even though many other complications are 
also infrequent, and may not have significant medical consequences, they may be very 
relevant for donors. Prolonged pain, testicular complaints, neuropathies can be quite 
disconcerting to a donor who has no idea these adverse events are in fact quite “normal”.
Limitations
This systematic review and meta-analysis has a number of significant limitations. None 
of the articles provided a complete overview of all complications, events and conse-
quences. Some focused on intra-operative complications, others on specific postop-
erative complications. Conversion was mentioned in most, while mortality was actually 
mentioned in only 31% of the articles. The overall quality of reported data was quite low, 
and it was interesting to see the differences in portraying complications and adverse 
events.
Most studies are retrospective case series, some prospective and only 16 included 
studies were randomized controlled trials. The definition of complications in general, 
and especially individual complications, is bound to vary. Not every surgeon considers 
every adverse event to be a complication, and results are presented in that light. Overall, 
major complications were more often reported than minor complications, possibly lead-
ing to an underestimation of the latter. Even the definitions of frequently encountered 
and considered “standard” complications like bleeding or wound infection vary among 
authors. Some specify bleeding as the need for transfusion, or a specific amount of blood 
loss, but often (especially intraoperative) bleeding is not defined. When bowel or splenic 
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injuries were encountered, it was often not stated whether resection was necessary. In 
addition, less frequently encountered complications like testicular complaints or thigh 
numbness were not mentioned in many articles, raising the question whether they did 
not occur, or weren’t reported. Overall complications rates varied greatly between differ-
ent studies, and it is to be expected that complications are underreported.
Second, even though we’ve used all available channels to obtain as much unique data 
as possible, we were still dependent on the quality of published studies. Many studies 
included donor nephrectomies using different operative techniques, but pooled their 
complication data. We were able to obtain split data for a small number of these. In 
the majority of cases, data were no longer available or no response from the authors 
was received. For this reason, a number of studies could not be included in the meta-
analysis, resulting in a smaller population for analysis. In addition, we had to exclude a 
number of studies presenting pooled data for different nephrectomy indications (other 
than kidney donation). Reversely, even though we applied strict exclusion criteria for 
overlapping cohorts, a small number of donors will inevitably have been analyzed in 
more than one included cohort.
Mortality after live donor nephrectomy is a catastrophic complication that is rarely 
reported. The largest cohort addressing donor mortality is reported by Segev et al.9, who 
found 25 donor deaths within 90 days after 80.347 live donor nephrectomies (0.03%). 
These were United States donors, after conventional open donor nephrectomy as well 
as minimally-invasive procedures, and donor death was established by checking the 
Social Security Death Master File. Cause of death was not reported, and even though a 
matched cohort of non-operated adults demonstrated lower mortality rates, this mortal-
ity rate of 0.03% cannot, with entire certainty, be attributed to live donor nephrectomy 
alone. In our systematic review, a reported mortality rate of 0.01% was found. Whether 
this is an under- or overestimate remains unclear. Based on the available literature, we 
do know that donor deaths still occur, and that vascular complications are often not 
published212, 213. We therefore used strict criteria during data extraction. Mortality was 
scored when it was literally stated, or when the authors stated that “no complications” 
or no “major complications” occurred. In addition, if follow-up data were presented and 
none of the donors were missing, it was concluded that they had not died. Using these 
criteria, mortality was scored as inconclusive in 48 articles. If no deaths would have oc-
curred in these populations, overall mortality rate would be 0.01%. Thus, we state that 
the actual mortality rate after live donor nephrectomy will be in the range of 0.01-0.1%.
Our article presents an extensive overview of different outcome measures, with 
emphasis on complication rates after minimally invasive live donor nephrectomy. Even 
though there is a risk of publication bias, due to the number of included procedures 
this overview will still provide quite a representable situation of current clinical practice. 
Based on these results, we may state that all employed techniques for minimally invasive 
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live donor nephrectomy are safe and associated with low risks of complications and an 
even lower risk of mortality. This allows the transplant surgeon to choose this technique 
with which he or she is most comfortable, and which best suits the intended donor. 
This form of tailor-made live donor nephrectomy fits perfectly into the current trend of 
shared elective surgical decision making.
acKnowLedGements
The authors thank WM Bramer, biomedical information specialist, for his help in con-
ducting the systematic literature search. The authors also thank the five authors that 
provided their source data to be included in this review.
64
Chapter 3    
references
 1. Klop, K.W.J., et al., Attitudes among surgeons towards live-donor nephrectomy: A european update. 
Transplantation, 2012. 94(3): p. 263-268.
 2. Lennerling, A., et al., Living organ donation practices in Europe. Transplantation, 2012. 94: p. 151.
 3. Janki, S., F.J. Dor, and I.J. JN, Surgical aspects of live kidney donation: an updated review. Front Biosci 
(Elite Ed), 2015. 7: p. 346-65.
 4. Nanidis, T.G., et al., Laparoscopic versus open live donor nephrectomy in renal transplantation: A 
meta-analysis. Ann Surg, 2008. 247(1): p. 58-70.
 5. Wilson, C.H., et al., Laparoscopic versus open nephrectomy for live kidney donors. Cochrane Data-
base Syst Rev, 2011(11): p. CD006124.
 6. Allaf, M.E., et al., Laparoscopic live donor nephrectomy with vaginal extraction: initial report. Am J 
Transplant, 2010. 10(6): p. 1473-7.
 7. Pietrabissa, A., et al., Robotic-assisted laparoscopic donor nephrectomy with transvaginal extraction 
of the kidney. Am J Transplant, 2010. 10(12): p. 2708-11.
 8. Kaouk, J.H., et al., Transvaginal hybrid natural orifice transluminal surgery robotic donor nephrec-
tomy: First clinical application. Urology, 2012. 80(6): p. 1171-1175.
 9. Segev, D.L., et al., Perioperative mortality and long-term survival following live kidney donation. 
JAMA, 2010. 303(10): p. 959-66.
 10. Ratner, L.E. and P.R. Sandoval, When disaster strikes: Death of a living organ donor. Am J Transplant, 
2010. 10(12): p. 2577-2581.
 11. Kortram, K., et al., The need for a standardized informed consent procedure in live donor nephrec-
tomy: A systematic review. Transplantation, 2014. 98(11): p. 1134-1143.
 12. Gordon, E.J., Living Organ Donors’ Stories:(Unmet) Expectations about Informed Consent, Outcomes, 
and Care. Narrative Inquiry in Bioethics, 2012. 2(1): p. 1-6.
 13. Fellner, C., Renal transplantation and the living donor. Decision and consequences. Psychother 
Psychosom, 1976. 27(3-6): p. 139-143.
 14. Fellner, C.H. and J.R. Marshall, Kidney donors: The myth of informed consent. The American Journal 
of Psychiatry, 1970.
 15. Valapour, M., The live organ donor’s consent: is it informed and voluntary? Transpl Rev, 2008. 22(3): 
p. 196-199.
 16. Liberati, A., et al., The PRISMA statement for reporting systematic reviews and meta-analyses of 
studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol, 2009. 
62(10): p. e1-34.
 17. Stroup, D.F., et al., Meta-analysis of observational studies in epidemiology: a proposal for reporting. 
Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 2000. 283(15): p. 
2008-12.
 18. Brozek, J.O.A., Schünemann H, GRADEpro Computer Program 3.6 for Windows ed.
 19. Abrahams, H.M., et al., Technique, indications and outcomes of pure laparoscopic right donor ne-
phrectomy. J Urol, 2004. 171(5): p. 1793-1796.
 20. Afaneh, C., et al., Comparison of laparoendoscopic single-site donor nephrectomy and conventional 
laparoscopic donor nephrectomy: donor and recipient outcomes. Urology, 2011. 78(6): p. 1332-
1337.
 21. Afaneh, C., et al., Is right-sided laparoendoscopic single-site donor nephrectomy feasible? Urology, 
2011. 77(6): p. 1365-1369.
 22. Ahearn, A.J., et al., Experience with laparoscopic donor nephrectomy among more than 1000 cases: 
Low complication rates, despite more challenging cases. Arch Surg, 2011. 146(7): p. 859-864.
 23. Alberts, V., et al., Fast track hand-assisted laparoscopic donor nephrectomy: A randomized clinical 
trial. Transplantation, 2014. 98: p. 607.
 24. Alcaraz, A., et al., Early Experience of a Living Donor Kidney Transplant Program. Eur Urol, 2006. 
50(3): p. 542-548.
Complications after donor nephrectomy
65
 25. Altinel, M., et al., Open versus laparoscopic donor nephrectomy: perioperative parameters and graft 
functions. Transplant Proc, 2011. 43(3): p. 781-786.
 26. Andonian, S., et al., Laparoendoscopic Single-site Pfannenstiel Donor Nephrectomy. Urology, 2010. 
75(1): p. 9-12.
 27. Aull, M.J., et al., A randomized, prospective, parallel group study of laparoscopic versus laparoendo-
scopic single site donor nephrectomy for kidney donation. Am J Transplant, 2014. 14(7): p. 1630-
1637.
 28. Bachmann, A., et al., Complications of retroperitoneoscopic living donor nephrectomy: Single center 
experience after 164 cases. World J Urol, 2008. 26(6): p. 549-554.
 29. Baldan, N., et al., Laparoscopic live donor nephrectomy: single center experience. Transplantation …, 
2007.
 30. Bargman, V., et al., Randomized trial of laparoscopic donor nephrectomy with and without hand 
assistance. J Endourol, 2006. 20(10): p. 717-722.
 31. Barth, R.N., et al., Single-port donor nephrectomy provides improved patient satisfaction and equiva-
lent outcomes. Ann Surg, 2013. 257(3): p. 527-533.
 32. Berends, F.J., et al., Technical considerations and pitfalls in laparoscopic live donornephrectomy. Surg 
Endosc, 2002. 16(6): p. 893-898.
 33. Bergman, S., et al., “First, do no harm”: monitoring outcomes during the transition from open to 
laparoscopic live donor nephrectomy in a Canadian centre. Can J Surg, 2008. 51(2): p. 103-110.
 34. Berney, T., et al., Laparoscopic and open live donor nephrectomy: A cost/benefit study. Transplant Int, 
2000. 13(1): p. 35-40.
 35. Bhattu, A., et al., Robotic donor nephrectomy. J Endourol, 2014. 28: p. A298.
 36. Biancofiore, G., et al., Perioperative management for laparoscopic kidney donation. Minerva Aneste-
siol, 2003. 69(9): p. 681-686, 686-689.
 37. Boorjian, S., et al., Right laparoscopic live donor nephrectomy: A single institution experience. Trans-
plantation, 2004. 77(3): p. 437-440.
 38. Branco, A.W., et al., A Comparison of Hand-Assisted and Pure Laparoscopic Techniques in Live Donor 
Nephrectomy. Clinics, 2008. 63(6): p. 795-800.
 39. Breda, A., et al., Complications of laparoscopic living donor nephrectomy and their management: The 
UCLA experience. Urology, 2007. 69(1): p. 49-52.
 40. Brockmann, J.G., N. Senninger, and H.H. Wolters, Living donor of the kidney - Open - Video. Langen-
beck’s Arch Surg, 2007. 392(3): p. 219-225.
 41. Broers, E.M.P., et al., Decreasing operating times and complication rates after laparoscopic donor 
nephrectomy by different techniques in highly experienced surgical teams. Eur Urol Suppl, 2013. 
12(1): p. e493-e494.
 42. Brown, S.L., et al., Laparoscopic live donor nephrectomy: a comparison with the conventional open 
approach. J Urol, 2001. 165(3): p. 766-769.
 43. Buell, J.F., et al., Right donor nephrectomy: A comparison of hand-assisted transperitoneal and 
retroperitoneal laparoscopic approaches. Transplantation, 2004. 77(4): p. 521-525.
 44. Buell, J.F., et al., Are concerns over right laparoscopic donor nephrectomy unwarranted? Ann Surg, 
2001. 233(5): p. 645-651.
 45. Buell, J.F., et al., Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional 
laparoscopic living-donor nephrectomy. Am J Transplant, 2002. 2(10): p. 983-988.
 46. Buresley, S., M. Samhan, and M. Al-Mousawi, Kuwait Experience in Laparoscopic Donor Nephrec-
tomy: First 80 Cases. Transplant Proc, 2007. 39(4): p. 813-815.
 47. Canes, D., et al., Laparo-Endoscopic Single Site (LESS) versus Standard Laparoscopic Left Donor 
Nephrectomy: Matched-pair Comparison. Eur Urol, 2010. 57(1): p. 95-101.
 48. Cannon, R.M., et al., Laparoscopic living kidney donation at a single center: An examination of donor 
outcomes with increasing experience. Am Surg, 2011. 77(7): p. 911-915.
 49. Capocasale, E., et al., Incidence, Diagnosis, and Treatment of Chylous Leakage After Laparoscopic Live 
Donor Nephrectomy. Transplantation, 2012. 93(1): p. 82-86.
66
Chapter 3    
 50. Castillon-Vela, I., et al., Prospective non randomized study comparing open donor nephrectomy 
(ODN), minimally invasive open donor nephrectomy (MIDN) and laparoscopic donor nephrectomy 
(LDN). Transplantation, 2000. 69(8): p. S402-S402.
 51. Chandak, P., et al., How safe is hand-assisted laparoscopic donor nephrectomy? Results of 200 live 
donor nephrectomies by two different techniques. Nephrol Dial Transplant, 2009. 24(1): p. 293-297.
 52. Chin, E.H., et al., The First Decade of a Laparoscopic Donor Nephrectomy Program: Effect of Surgeon 
and Institution Experience with 512 Cases from 1996 to 2006. Journal of the American College of 
Surgeons, 2009. 209(1): p. 106-113.
 53. Cho, H.J., et al., How safe and effective is routine left hand-assisted laparoscopic donor nephrectomy 
with multiple renal arteries? A high-volume, single-center experience. Transplant Proc, 2012. 44(10): 
p. 2913-2917.
 54. Choi, S.W., et al., Hand-assisted and pure laparoscopic living donor nephrectomy: A matched-cohort 
comparison over 10 years at a single institute. Clin Transplant, 2014.
 55. Chueh, S.J., B. Sankari, and J.S. Jones, Safety and technical considerationsof laparoendoscopic single 
site (LESS) live donor nephrectomy in a small-volumetransplant center. J Endourol, 2011. 25: p. A84.
 56. Chung, M.S., et al., Hand-assisted laparoscopic right donor nephrectomy: safety and feasibility. 
Korean J Urol, 2010. 51(1): p. 34-39.
 57. Cohen, A.J., et al., Lessons learned from the introduction of a robotic assisted donor nephrectomy 
program. Am J Transplant, 2011. 11: p. 73.
 58. Crane, C., et al., Are there anatomical barriers to laparoscopic donor nephrectomy? ANZ J Surg, 2010. 
80(11): p. 781-785.
 59. Dalla Valle, R., et al., Laparoscopic donor nephrectomy: short learning curve. Transplant Proc, 2006. 
38(4): p. 1001-1002.
 60. Desai, M.R., et al., Outcome of renal transplantation with multiple versus single renal arteries after 
laparoscopic live donor nephrectomy: a comparative study. Urology, 2007. 69(5): p. 824-827.
 61. Diner, E.K., et al., Right laparoscopic donor nephrectomy: The Washington Hospital Center experi-
ence. Urology, 2006. 68(6): p. 1175-1177.
 62. Disick, G.I.S., et al., Critical Analysis of Laparoscopic Donor Nephrectomy in the Setting of Complex 
Renal Vasculature: Initial Experience and Intermediate Outcomes. Journal of Endourology, 2009. 
23(3): p. 451-455.
 63. Dolce, C.J., et al., Laparoscopic versus open live donor nephrectomy: outcomes analysis of 266 con-
secutive patients. Surg Endosc, 2009. 23(7): p. 1564-1568.
 64. Dols, L.F.C., et al., Randomized controlled trial comparing hand-assisted retroperitoneoscopic versus 
standard laparoscopic donor nephrectomy. Transplantation, 2014. 97(2): p. 161-167.
 65. Dols, L.F.C., et al., Optimizing left-sided live kidney donation: Hand-assisted retroperitoneoscopic as 
alternative to standard laparoscopic donor nephrectomy. Transplant Int, 2010. 23(4): p. 358-363.
 66. Dong, J., et al., Retroperitoneal Laparoscopic Live-Donor Nephrectomy: Introduction of Simple Hand-
Assisted Technique (Without Hand Port). Transplantation Proceedings, 2011. 43(5): p. 1415-1417.
 67. Duchene, D.A., et al., Laparoscopic donor nephrectomy at a low volume living donor transplant 
center: Successful outcomes can be expected. Journal of Urology, 2003. 170(3): p. 731-733.
 68. Duchene, D.A., et al., Successful outcomes of older donors in laparoscopic donor nephrectomy. J 
Endourol, 2010. 24(10): p. 1593-1596.
 69. El-Galley, R., et al., Donor nephrectomy: A comparison of techniques and results of open, hand as-
sisted and full laparoscopic nephrectomy. J Urol, 2004. 171(1): p. 40-43.
 70. Fisher, P.C., et al., 200 consecutive hand assisted laparoscopic donor nephrectomies: evolution of 
operative technique and outcomes Review. J Urol, 2006. 175(4): p. 1439-1443.
 71. Flowers, J.L., et al., Comparison of open and laparoscopic live donor nephrectomy. Ann Surg, 1997. 
226(4): p. 483-489; discussion 489-490.
 72. Friedersdorff, F., et al., Outcomes after laparoscopic living donor nephrectomy: comparison of two 
laparoscopic surgeons with different levels of expertise. BJU Int, 2013. 111(1): p. 95-100.
 73. Fronek, J., et al., Hand assisted retroperitoneoscopic live donor nephrectomy with no side/anatomy 
exclusions: Single centre experience with 139 cases. Transplantation, 2014. 98: p. 605.
Complications after donor nephrectomy
67
 74. Geffner, S., et al., Robotic-assisted laparoscopic donor nephrectomies: Early experience and review of 
the literature. Journal of Robotic Surgery, 2011. 5(2): p. 115-120.
 75. Gimenez, E., et al., Laparoendoscopic single site live donor nephrectomy: Initial experience. J Urol, 
2010. 184(5): p. 2049-2053.
 76. Gorodner, V., et al., Routine left robotic-assisted laparoscopic donor nephrectomy is safe and effective 
regardless of the presence of vascular anomalies. Transpl Int, 2006. 19(8): p. 636-640.
 77. Gures, N., et al., Comparison of the right and left laparoscopic live donor nephrectomies: a clinical 
case load. Eur Rev Med Pharmacol Sci, 2013. 17(10): p. 1389-1394.
 78. Hagen, S.M., et al., Robot-assisted live kidney donation: The Rotterdam experience. Transplant Int, 
2011. 24: p. 340.
 79. Hakim, N., et al., A Fast and Safe Living Donor “Finger-Assisted” Nephrectomy Technique: Results of 
359 Cases. Transplant Proc, 2010. 42(1): p. 165-170.
 80. Harper, J.D., et al., Experience with 750 consecutive laparoscopic donor nephrectomies—is it time to 
use a standardized classification of complications? The Journal of …, 2010.
 81. He, B., et al., Laparoscopic donor nephrectomy. ANZ journal of …, 2011.
 82. Heimbach, J.K., S.J. Taler, and M. Prieto, Obesity in living kidney donors: clinical characteristics and 
outcomes in the era of laparoscopic donor nephrectomy. American journal of …. 2005: Wiley Online 
Library.
 83. Hensman, C., G. Lionel, and P. Hewett, Laparoscopic live donor nephrectomy: the preliminary experi-
ence. Australian and New …, 1999.
 84. Hoda, M.R., et al., Prospective, nonrandomized comparison between right- and left-sided hand-
assisted laparoscopic donor nephrectomy. Transplant Proc, 2011. 43(1): p. 353-356.
 85. Hofker, H.S., et al., A randomized clinical trial of living donor nephrectomy: A plea for a differentiated 
appraisal of mini-open muscle splitting incision and hand-assisted laparoscopic donor nephrectomy. 
Transplant Int, 2012. 25(9): p. 976-986.
 86. Horgan, S., Minimally invasive donor nephrectomy using a supra-pubic approach: Initial clinical 
experience. Surg Endosc Interv Tech, 2010. 24(1): p. S700-S701.
 87. Hsu, T.H.S., et al., Renovascular complications of laparoscopic donor nephrectomy. Urology, 2002. 
60(5): p. 811-815.
 88. Hu, J.C., et al., Determinants of laparoscopic donor nephrectomy outcomes. Eur Urol, 2014. 65(3): p. 
659-664.
 89. Hubert, J., et al., Robotic-assisted laparoscopic living donor nephrectomies: Experience in 100 cases. 
Int J Med Rob Comput Assisted Surg, 2011. 7: p. 20.
 90. Hung, C.J., et al., Kidney grafts with multiple renal arteries is no longer a relative contraindication 
with advance in surgical techniques of laparoscopic donor nephrectomy. Transplant Proc, 2012. 
44(1): p. 36-38.
 91. Jacobs, S.C., et al., Laparoscopic donor nephrectomy: The University of Maryland 6-year experience. 
Journal of Urology, 2004. 171(1): p. 47-51.
 92. Johnson, M.W., et al., Technique of right laparoscopic donor nephrectomy: a single center experience. 
Am J Transplant, 2001. 1(3): p. 293-295.
 93. Kapoor, A., et al., Outcomes of laparoscopic donor nephrectomy in the presence of multiple renal 
arteries. Urol Ann, 2011. 3(2): p. 62-65.
 94. Kercher, K., et al., Hand-assisted laparoscopic donor nephrectomy minimizes warm ischemia. Urol-
ogy, 2001. 58(2): p. 152-155.
 95. Kessaris, N. and S. Heap, Adopting the retroperitoneal approach to live donor nephrectomy-confes-
sions of a converted surgeon! Transplant Int, 2013. 26: p. 251.
 96. Khan, I., et al., Hand assisted laparoscopic donor nephrectomy, outcomes and complications-a single 
center study in a developing country. Transplantation, 2014. 98: p. 607.
 97. Khauli, R.B., et al., A controlled sequential evaluation of open donor nephrectomy versus classical and 
modified laparoscopic donor nephrectomy: An update. Transplant Proc, 2005. 37(7): p. 2944-2946.
 98. Kim, B.S., et al., Chylous Ascites as a Complication of Laparoscopic Nephrectomy. Journal of Urology, 
2010. 184(2): p. 570-574.
68
Chapter 3    
 99. Klop, K.W.J., et al., Can right-sided hand-assisted retroperitoneoscopic donor nephrectomy be advo-
cated above standard laparoscopic donor nephrectomy: A randomized pilot study. Transplant Int, 
2014. 27(2): p. 162-169.
 100. Kohei, N., et al., Retroperitoneoscopic Living Donor Nephrectomy: Experience of 425 Cases at a Single 
Center. Journal of Endourology, 2010. 24(11): p. 1783-1787.
 101. Kok, N.F.M., et al., Mini-incision open donor nephrectomy as an alternative to classic lumbotomy: 
evolution of the open approach. Transpl Int, 2006. 19(6): p. 500-505.
 102. Kok, N.F.M., et al., Laparoscopic kidney donation: The impact of adhesions. Surg Endosc Interv Tech, 
2008. 22(5): p. 1321-1325.
 103. Koning, J.L., et al., Ocular complications after open and hand-assisted laparoscopic donor nephrec-
tomy. Urology, 2011. 77(1): p. 92-96.
 104. Ku, J.H., et al., Hand-assisted laparoscopic and open living donor nephrectomy in Korea. Int J Urol, 
2005. 12(5): p. 436-441.
 105. Kumar, A., et al., Analysis of 1000 cases of laparoscopic donor nephrectomy from a developing coun-
try. Transplantation, 2010. 90: p. 547.
 106. Kuo, P.C., L.B. Johnson, and J.V. Sitzmann, Laparoscopic donor nephrectomy with a 23-hour stay: a 
new standard for transplantation surgery. Ann Surg, 2000. 231(5): p. 772-779.
 107. Kurien, A., et al., First prize: Standard laparoscopic donor nephrectomy versus laparoendoscopic 
single-site donor nephrectomy: A randomized comparative study. J Endourol, 2011. 25(3): p. 365-
370.
 108. Lai, I.R., et al., Hand-assisted versus total laparoscopic live donor nephrectomy: comparison and 
technique evolution at a single center in Taiwan. Clin Transplant, 2010. 24(5): p. E182-187.
 109. Lallas, C.D., et al., The development of a laparoscopic donor nephrectomy program in a de novo renal 
transplant program: Evolution of technique and results in over 200 cases. JSLS, 2006. 10(2): p. 135-
140.
 110. LaMattina, J., et al., Five year experience with single-port donor nephrectomy as a standardized ap-
proach. Transplantation, 2014. 98: p. 602.
 111. Lee, Y.S., et al., The feasibility of solo-surgeon living donor nephrectomy: Initial experience using 
video-assisted minilaparotomy surgery. Surg Endosc Interv Tech, 2010. 24(11): p. 2755-2759.
 112. Lenaghan, D., et al., Laparoscopic live donor nephrectomy: A review of 50 consecutive cases. BJU Int, 
2010. 105: p. 29.
 113. Leventhal, J.R., et al., Laparoscopic live donor nephrectomy-Is it safe?: Analysis of 80 consecutive 
cases and comparison with open nephrectomy. …, 2000.
 114. Leventhal, J.R., et al., A decade of minimally invasive donation: Experience with more than 1200 
laparoscopic donor nephrectomies at a single institution. Clin Transplant, 2010. 24(2): p. 169-174.
 115. Lewis, G.R.R., et al., A comparison of traditional open, minimal-incision donor nephrectomy and 
laparoscopic donor nephrectomy. Transplant Int, 2004. 17(10): p. 589-595.
 116. Lind, M.Y., et al., Right-sided laparoscopic live-donor nephrectomy: is reluctance still justified? Trans-
plantation, 2002. 74(7): p. 1045-1048.
 117. Lucas, S.M., et al., Comparison of donor, and early and late recipient outcomes following hand as-
sisted and laparoscopic donor nephrectomy. J Urol, 2013. 189(2): p. 618-622.
 118. Ma, L., et al., Retroperitoneoscopic live-donor nephrectomy: 5-year single-center experience in China. 
Int J Urol, 2010. 17(2): p. 158-162.
 119. Maartense, S., et al., Hand-assisted laparoscopic live donor nephrectomy. Br J Surg, 2004. 91(3): p. 
344-348.
 120. Maione, G., et al., Laparosopic hand-assisted living donor nephrectomy: The niguarda experience. 
Transplant Proc, 2005. 37(6): p. 2445-2448.
 121. Melcher, M.L., et al., More than 500 consecutive laparoscopic donor nephrectomies without conver-
sion or repeated surgery. Arch Surg, 2005. 140(9): p. 835-840.
 122. Milner, J.E., et al., Outcomes of 250 consecutive laparoscopic living donor nephrectomies using the 
Dindo-Clavien complication classification system. Am J Transplant, 2010. 10: p. 540.
 123. Minnee, R.C., et al., Comparison of hand-assisted laparoscopic and open donor nephrectomy in living 
donors. Int J Urol, 2008. 15(3): p. 206-209.
Complications after donor nephrectomy
69
 124. Minz, M., et al., Comparison of transumbilical and conventional (pfannenstiel) laparoscopic donor 
nephrectomy. Transplantation, 2012. 94: p. 1110.
 125. Mitre, A.I., et al., Laparoscopic nephrectomy in live donor. Int Braz J Urol, 2004. 30(1): p. 22-28.
 126. Mjoen, G., et al., Minimally invasive living donor nephrectomy - introduction of hand-assistance. 
Transplant International, 2010. 23(10): p. 1008-1014.
 127. Mohan Rao, M. and C.H. Russell, Laparoscopic live donor nephrectomy. ANZ J Surg, 2005. 75(1-2): p. 
6-9.
 128. Morrissey, P.E., et al., Keeping up with the Jones’s: Open donor nephrectomy in the laparoscopic era. 
Transplant Proc, 2004. 36(5): p. 1285-1287.
 129. Muthu, C., et al., The Auckland experience with laparoscopic donor nephrectomy. New Zealand Med 
J, 2003. 116(1178).
 130. Narita, S., et al., Outcome of right hand-assisted retroperitoneoscopic living donor nephrectomy. 
Urology, 2006. 67(3): p. 496-500; discussion 500-491.
 131. Neipp, M., et al., Living donor nephrectomy: Flank incision versus anterior vertical mini-incision. 
Transplantation, 2004. 78(9): p. 1356-1361.
 132. Ng, C.S., et al., Right retroperitoneal versus left transperitoneal laparoscopic live donor nephrectomy. 
Urology, 2004. 63(5): p. 857-861.
 133. Nicholson, M.L., et al., Randomized clinical trial of laparoscopic versus open donor nephrectomy. Br J 
Surg, 2010. 97(1): p. 21-28.
 134. O’Brien, B., et al., Safety of nephrectomy in morbidly obese donors. Exp Clin Transplant, 2012. 10(6): 
p. 579-585.
 135. Odland, M.D., et al., Initial experience with laparoscopic live donor nephrectomy. Surgery, 1999. 
126(4): p. 603-607.
 136. Oyen, O., et al., Laparoscopic versus open living-donor nephrectomy: Experiences from a prospective, 
randomized, single-center study focusing on donor safety. Transplantation, 2005. 79(9): p. 1236-
1240.
 137. Pandarinath, S.R., et al., Transperitoneal laparoscopic left versus right live donor nephrectomy: Com-
parison of outcomes. Indian J Urol, 2014. 30(3): p. 256-260.
 138. Paul, A., et al., Current concepts in transplant surgery: laparoscopic living donor of the kidney. Lan-
genbecks Archives of Surgery, 2007. 392(5): p. 501-509.
 139. Percegona, L.S., et al., Hand-assisted laparoscopic donor nephrectomy: comparison to pure laparo-
scopic donor nephrectomy. Transplant Proc, 2008. 40(3): p. 687-688.
 140. Peters, T.G., S.M. Repper, and M.C. Vincent, One hundred consecutive living kidney donors: modern 
issues and outcomes. Clinical …, 2002.
 141. Posselt, A.M., et al., Laparoscopic right donor nephrectomy: a large single-center experience. Trans-
plantation, 2004. 78(11): p. 1665-1669.
 142. Potter, S.R., Single-Surgeon Laparoscopic Donor Nephrectomy and Renal Transplantation. Urology, 
2006. 68(5): p. 947-951.
 143. Power, R.E., et al., Laparoscopic vs open living donor nephrectomy: A contemporary series from one 
centre. BJU Int, 2006. 98(1): p. 133-136.
 144. Ramasamy, R., et al., Comparison of complications of laparoscopic versus laparoendoscopic single 
site donor nephrectomy using the modified Clavien grading system. J Urol, 2011. 186(4): p. 1386-
1390.
 145. Ratner, L.E., R.A. Montgomery, and L.R. Kavoussi, Laparoscopic live donor nephrectomy: the four 
year Johns Hopkins University experience Review. Nephrol Dial Transplant, 1999. 14(9): p. 2090-
2093.
 146. Rawlins, M.C., et al., Learning laparoscopic donor nephrectomy safely: a report on 100 cases. Arch 
Surg, 2002. 137(5): p. 531-534; discussion 534-535.
 147. Renoult, E., et al., Robot-assisted laparoscopic and open live-donor nephrectomy: a comparison of 
donor morbidity and early renal allograft outcomes. Nephrol Dial Transplant, 2006. 21(2): p. 472-
477.
 148. Richards, G., et al., Hand-assisted laparoscopic donor nephrectomy using only 5 mm ports. J Endou-
rol, 2010. 24: p. A54.
70
Chapter 3    
 149. Richstone, L., et al., Pfannenstiel laparoendoscopic single-site (LESS) vs conventional multiport lapa-
roscopic live donor nephrectomy: A prospective randomized controlled trial. BJU Int, 2013. 112(5): p. 
616-622.
 150. Rocca, X., et al., Laparoscopic nephrectomy: safe and comfortable surgical alternative for living 
donors and for good results of graft function. Transplant Proc, 2005. 37(8): p. 3349-3350.
 151. Ruiz-Deya, G., et al., Open donor, laparoscopic donor and hand assisted laparoscopic donor nephrec-
tomy: a comparison of outcomes. J Urol, 2001. 166(4): p. 1270-1273; discussion 1273-1274.
 152. Ruszat, R., et al., Retroperitoneoscopic donor nephrectomy: donor outcome and complication rate in 
comparison with three different techniques. World J Urol, 2006. 24(1): p. 113-117.
 153. Saad, S., et al., Laparoscopic live donor nephrectomy for right kidneys: Experience in a German com-
munity hospital. Surg Endosc, 2008. 22(3): p. 674-678.
 154. Sadek, M.A., et al., Right laparoscopic live-donor nephrectomy. J Endourol, 2010. 24: p. A372-A373.
 155. Samarasekera, D., et al., Laparoscopy, dorsal lumbotomy and flank incision live donor nephrectomy: 
comparison of donor outcomes. Can Urol Assoc J, 2013. 7(1-2): p. E69-73.
 156. Sawatzky, M., et al., Is right laparoscopic donor nephrectomy right? Surg Endosc Interv Tech, 2009. 
23(6): p. 1321-1325.
 157. Schnitzbauer, A.A., et al., Mini-incision for strictly retroperitoneal nephrectomy in living kidney dona-
tion vs flank incision. Nephrol Dial Transplant, 2006. 21(10): p. 2948-2952.
 158. Seong, I.S., et al., Comparison of hand-assisted laparoscopic and open donor nephrectomy: A single-
center experience from South Korea. J Endourol, 2005. 19(1): p. 58-62.
 159. Shirodkar, S.P., et al., Living donor nephrectomy: University of miami technique and current results. 
Arch Esp Urol, 2010. 63(3): p. 163-170.
 160. Simforoosh, N., et al., Comparison of laparoscopic and open donor nephrectomy: A randomized 
controlled trial. BJU Int, 2005. 95(6): p. 851-855.
 161. Sinh, T., et al., Retroperitoneal laparoscopic living donor nephrectomy: A simple technique in Cho Ray 
Hospital. Urology, 2011. 78(3): p. S179.
 162. Siqueira Jr, T.M., et al., Major complications in 213 laparoscopic nephrectomy cases: The Indianapolis 
experience. Journal of Urology, 2002. 168(4 I): p. 1361-1365.
 163. Srivastava, A., N. Gupta, and A. Kumar, Evolution of the technique of laparoscopic live donor ne-
phrectomy at a single center: Experience with more than 350 cases. Urol Int, 2008. 81(4): p. 431-436.
 164. Srivastava, A., et al., Subcostal versus transcostal mini donor nephrectomy: Is rib resection responsible 
for pain related donor morbidity. J Urol, 2003. 170(3): p. 738-740.
 165. Stifelman, M.D., et al., Hand assisted laparoscopic donor nephrectomy: A comparison with the open 
approach. J Urol, 2001. 166(2): p. 444-448.
 166. Su, L.M., et al., Laparoscopic live donor nephrectomy: Trends in donor and recipient morbidity follow-
ing 381 consecutive cases. Ann Surg, 2004. 240(2): p. 358-363.
 167. Sudhindran, S., et al., Initial experience with laparoscopic donor nephrectomies. Transplant Proc, 
2004. 36(7): p. 1901-1902.
 168. Sulser, T., et al., Retroperitoneoscopic living-donor nephrectomy: first clinical experiences in 19 opera-
tions. J Endourol, 2004. 18(3): p. 257-262.
 169. Sundaram, C.P., et al., Complications after a 5-year experience with laparoscopic donor nephrectomy: 
The Indiana University experience. Surg Endosc Interv Tech, 2007. 21(5): p. 724-728.
 170. Taber, D.J., et al., No difference between smokers, former smokers, or nonsmokers in the operative 
outcomes of laparoscopic donor nephrectomies. Surg Laparosc Endosc Percutan Tech, 2009. 19(2): 
p. 153-156.
 171. Tanabe, K., et al., Retroperitoneoscopic live donor nephrectomy: extended experience in a single 
center. Transplant Proc, 2004. 36(7): p. 1917-1919.
 172. Taweemonkongsap, T., et al., Laparoscopic live-donor nephrectomy: a comparison with the open 
technique and how to reach quality standards: a single-center experience in Thailand. Transplant 
Proc, 2011. 43(10): p. 3593-3598.
 173. Troppmann, C., et al., Increased transplantation of kidneys with multiple renal arteries in the 
laparoscopic live donor nephrectomy era: Surgical technique and surgical and nonsurgical donor and 
recipient outcomes. Arch Surg, 2001. 136(8): p. 897-907.
Complications after donor nephrectomy
71
 174. Tsoulfas, G., et al., Laparoscopic living donor nephrectomy: Is there a difference between using a left 
or a right kidney? Transplant Proc, 2012. 44(9): p. 2706-2708.
 175. Tsuchiya, N., et al., Hand-assisted retroperitoneoscopic nephrectomy for living kidney transplanta-
tion: initial 44 cases Review. Urology, 2004. 64(2): p. 250-254.
 176. Ueda, E., et al., Clinical characteristics and outcomes of donor nephrecomy for obese living kidney 
donor’s. Transplantation, 2012. 94: p. 1082-1083.
 177. Ungbhakorn, P., et al., Comparative outcomes of open nephrectomy, hand-assisted laparoscopic 
nephrectomy, and full laparoscopic nephrectomy for living donors. Transplant Proc, 2012. 44(1): p. 
22-25.
 178. Van der Merwe, A. and C.F. Heyns, Retroperitoneoscopic live donor nephrectomy: review of the first 
50 cases at Tygerberg Hospital, Cape Town, South Africa. S Afr J Surg, 2014. 52(2): p. 53-56.
 179. Velidedeoglu, E., et al., Comparison of open, laparoscopic, and hand-assisted approaches to live-
donor nephrectomy. Transplantation, 2002. 74(2): p. 169-172.
 180. Villeda-Sandoval, C.I., et al., Hand-assisted laparoscopic versus open donor nephrectomy: a 
retrospective comparison of perioperative and functional results in a tertiary care center in Mexico. 
Transplant Proc, 2013. 45(9): p. 3220-3224.
 181. Wadstrom, J., et al., Introducing hand-assisted retroperitoneoscopic live donor nephrectomy: Learn-
ing curves and development based on 413 consecutive cases in four centers. Transplantation, 2011. 
91(4): p. 462-469.
 182. Waller, J.R., et al., Living kidney donation: a comparison of laparoscopic and conventional open 
operations. Postgrad Med J, 2002. 78(917): p. 153-157.
 183. Wang, G.J., et al., Laparoendoscopic single site live donor nephrectomy: Single institution report of 
initial 100 cases. J Urol, 2011. 186(6): p. 2333-2337.
 184. Waxman, S.W. and H.N. Winfield, Complications of laparoscopic renal surgery. J Endourol, 2010. 
24(3): p. 381-383.
 185. Wilson, C.H., et al., Comparison of laparoscopic and open donor nephrectomy: UK experience. BJU 
Int, 2005. 95(1): p. 131-135.
 186. Wolf Jr, J.S., et al., Prospective, case matched comparison of hand assisted laparoscopic and open 
surgical live donor nephrectomy. J Urol, 2000. 163(6): p. 1650-1653.
 187. Wolf Jr, J.S., et al., Randomized controlled trial of hand-assisted laparoscopic versus open surgical, live 
donor nephrectomy. Transplantation, 2001. 72(2): p. 284-290.
 188. Yang, S.L., et al., Minimal incision living donor nephrectomy: improvement in patient outcome. Urol-
ogy, 2002.
 189. Yoshimura, K., et al., Retroperitoneoscopic living related-donor nephrectomy: clinical outcomes of 50 
consecutive cases and comparison with open donor nephrectomy. J Endourol, 2005. 19(7): p. 808-
812.
 190. Alessimi, A., et al., LESS living donor nephrectomy: Surgical technique and results. Urol Ann, 2015. 
7(3): p. 361-365.
 191. Amit, B., et al., Robotic assisted laparoscopic living donor nephrectomy. Indian J Urol, 2015. 31: p. 
S106.
 192. Biglarnia, A.R., Retroperitoneoscopic Hand-Assisted Live Donor Nephrectomy - a Single Center Experi-
ence. Ann. Saudi Med., 2013. 33(2): p. S86-S90.
 193. Cavdaroglu, O., et al., Laparascopic Donor Nephrectomy Is Safe for Extremely Old Donors and Pro-
vides a Good Outcome for Their Recipients. Transplant Proc, 2015. 47(5): p. 1296-1298.
 194. Cho, H.J., et al., Laparoendoscopic Single-Site Plus One-Port Donor Nephrectomy: Analysis of 169 
Cases. J Laparoendosc Adv Surg Techn, 2015. 25(8): p. 636-641.
 195. Kanashiro, H., et al., Comparison between laparoscopic and subcostal mini-incision for live donor 
nephrectomy. Einstein, 2010. 8(4): p. 456-460.
 196. Kashiwadate, T., et al., Right versus left retroperitoneoscopic living-donor nephrectomy. Int Urol 
Nephrol, 2015. 47(7): p. 1117-1121.
 197. Kim, B.S., et al., Hybrid technique using a Satinsky clamp for right-sided transperitoneal hand-assisted 
laparoscopic donor nephrectomy: comparison with left-sided standard hand-assisted laparoscopic 
technique. Urology, 2014. 84(6): p. 1529-1534.
72
Chapter 3    
 198. Kroencke, S., et al., Anterior vertical mini-incision vs. retroperitoneoscopic nephrectomy in living 
kidney donation: A prospective study on donors’ quality of life and clinical outcome. Clin Transplant, 
2015. 29(11): p. 1029-1038.
 199. Kumar, A., et al., Complications following transperitoneal hand-assisted laparoscopic donor 
nephrectomy-experience of first 141 cases. Transplant Int, 2015. 28: p. 640.
 200. Paraskeva, P., et al., Readmission within 30 days post hand assisted laparoscopic donor nephrectomy. 
Transplant Int, 2015. 28: p. 217.
 201. Peri, L., et al., Perioperative outcome and female sexual function after laparoscopic transvaginal 
NOTES-assisted nephrectomy. World J Urol, 2015. 33(12): p. 2009-2014.
 202. Rajab, A. and R.P. Pelletier, The safety of hand-assisted laparoscopic living donor nephrectomy: The 
Ohio State University experience with 1500 cases. Clin. Transplant., 2015. 29(3): p. 204-210.
 203. Rogers, A., et al., Donor safety can be maintained when training surgeons in laparoscopic donor 
nephrectomy in a sequential manner, within a team environment. Transplant Int, 2015. 28: p. 290.
 204. Song, G., et al., Kidney laterality and the safety of hand-assisted live donor nephrectomy: Review of 
1000 consecutive cases at a single center. Urology, 2015. 85(6): p. 1360-1366.
 205. Stamatakis, L., M.A. Mercado, and J.M. Choi, Comparison of laparoendoscopic single site (LESS) and 
conventional laparoscopic donor nephrectomy at a single institution. Bju …. 2013: Wiley Online 
Library.
 206. Sureka, S.K., et al., Prevention of Orchialgia After Left-Sided Laparoscopic Donor Nephrectomy - A 
Prospective Study. J Endourol, 2015. 29(6): p. 696-699.
 207. Treat, E.G., et al., Evolution of laparoscopic donor nephrectomy technique and outcomes: A single-
center experience with more than 1300 cases. Urology, 2015. 85(1): p. 107-112.
 208. You, D., et al., Transition From Hand-Assisted to Pure Laparoscopic Donor Nephrectomy. 2015.
 209. Bhattu, A.S., et al., Robot-assisted laparoscopic donor nephrectomy vs standard laparoscopic donor 
nephrectomy: A prospective randomized comparative study. J Endourol, 2015. 29(12): p. 1334-1340.
 210. Kok, N.F.M., et al., Comparison of laparoscopic and mini incision open donor nephrectomy: Single 
blind, randomised controlled clinical trial. Br Med J, 2006. 333(7561): p. 221-224.
 211. Legemaate, J. Informed Consent. 2001; Available from: http://www.nvpc.nl/uploads/
stand/63Richtlijn%20Informed%20Consent.pdf.
 212. Janki, S., et al., Vascular management during live donor nephrectomy: an online survey among 
transplant surgeons. Am J Transplant, 2015. 15(6): p. 1701-7.
 213. Friedman, A.L., T.G. Peters, and L.E. Ratner, Regulatory failure contributing to deaths of live kidney 
donors. Am J Transplant, 2012. 12(4): p. 829-834.
Complications after donor nephrectomy
73
appendix i – searcH strinGs used in different databases
embase.com
(‘kidney donor’/de OR ‘living donor’/de OR ((kidney OR renal OR nephrect* OR living OR 
live) NEAR/3 (donor* OR donat*)):ab,ti) AND (nephrectomy/de OR uninephrectomy/de 
OR (nephrectom* OR uninephrectom*):ab,ti) AND (‘crossover procedure’/de OR ‘double-
blind procedure’/de OR ‘randomized controlled trial’/de OR ‘single-blind procedure’/de 
OR ‘prospective study’/de OR review/de OR ‘systematic review’/de OR ‘meta analysis’/de 
OR (random* OR factorial* OR crossover* OR (cross NEXT/1 over*) OR ((doubl* OR singl*) 
NEXT/1 blind*) OR assign* OR allocat* OR prospectiv* OR review OR ‘meta analysis’ OR 
metaanalysis):ab,ti ) NOT ([animals]/lim NOT [humans]/lim)
medline (ovidsp)
(“living donors”/ OR ((kidney OR renal OR nephrect* OR living OR live) ADJ3 (donor* 
OR donat*)).ab,ti.) AND (nephrectomy/ OR (nephrectom* OR uninephrectom*).ab,ti.) 
AND (Randomized Controlled Trial.pt. OR Controlled Clinical Trial.pt. OR “Prospective 
Studies”/ OR review.pt. OR Meta-Analysis.pt. OR (randomized OR placebo OR randomly 
OR trial OR groups OR prospectiv* OR review OR “meta analysis” OR metaanalysis).ab,ti.) 
NOT (Animals/ NOT Humans/)
cochrane
(((kidney OR renal OR nephrect* OR living OR live) NEAR/3 (donor* OR donat*)):ab,ti) 
AND ((nephrectom* OR uninephrectom*):ab,ti)
web-of-science
TS=((((kidney OR renal OR nephrect* OR living OR live) NEAR/3 (donor* OR donat*))) 
AND ((nephrectom* OR uninephrectom*)) AND (random* OR factorial* OR crossover* 
OR (cross NEAR/1 over*) OR ((doubl* OR singl*) NEAR/1 blind*) OR assign* OR allocat* OR 
prospectiv* OR review OR “meta analysis” OR metaanalysis) NOT (animal* NOT human*))
scopus
TITLE-ABS-KEY((((kidney OR renal OR nephrect* OR living OR live) W/3 (donor* OR 
donat*))) AND ((nephrectom* OR uninephrectom*)) AND (random* OR factorial* OR 
crossover* OR (cross W/1 over*) OR ((doubl* OR singl*) W/1 blind*) OR assign* OR al-
locat* OR prospectiv* OR review OR “meta analysis” OR metaanalysis) AND NOT (animal* 
AND NOT human*))
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pubmed publisher
(((kidney[tiab] OR renal[tiab] OR nephrect*[tiab] OR living[tiab] OR live[tiab]) AND 
(donor*[tiab] OR donat*[tiab]))) AND ((nephrectom*[tiab] OR uninephrectom*[tiab])) 
AND ((randomized[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] 
OR prospectiv*[tiab] OR review[tiab] OR “meta analysis”[tiab] OR metaanalysis[tiab])) 
AND publisher[sb]
Google scholar
“kidney|renal donor|donors” nephrectomy randomized|randomised|randomly|trial|prospe
ctive|review|”meta analysis” “surgical|operative|nephrectomy complication|complications”
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1. Hand-Assisted versus Pure Laparoscopic Live Donor Nephrectomy
Quality assessment
Quality
№ of studies Study design Risk of bias Inconsistency Indirectness Imprecision
Other 
considerations
18
3 RCTs
4 Pros cohorts
11 Retro cohorts
not serious not serious not serious not serious none
⨁⨁◯◯
LOW 
2. Retroperitoneoscopic versus Laparoscopic Live Donor Nephrectomy
Quality assessment Quality
№ of studies Study design Risk of bias Inconsistency Indirectness Imprecision
Other 
considerations
7
2 RCTs
2 Pros cohorts
2 Retro cohorts 
not serious not serious serious 1 not serious none
⨁◯◯◯
VERY LOW 1
3. Single-Port (LESS) versus Multiport Laparoscopic Live Donor Nephrectomy
Quality assessment Quality
№ of studies Study design Risk of bias Inconsistency Indirectness Imprecision
Other 
considerations
9
3 RCTs
1 Pros cohort
5 Retro cohorts
not serious not serious serious 2 not serious none
⨁◯◯◯
VERY LOW 2
4. Mini-open versus Laparoscopic Live Donor Nephrectomy
Quality assessment Quality
№ of studies Study design Risk of bias Inconsistency Indirectness Imprecision
Other 
considerations
6
3 RCTs
3 Pros cohorts not serious not serious serious 3 not serious none
⨁◯◯◯
VERY LOW 3
RCT – Randomized Controlled Trial, Pros – Prospective, Retro – Retrospective
1. Hand-assisted techniques are compared to pure techniques in all articles, however in some the pure technique is done laparoscopically while in other the pure technique is 
the retroperitoneoscopic procedure.
2. In one study hand-assisted laparoscopic donor nephrectomy was compared to LESS donor nephrectomy, in one study the defined technique for multiport procedure was not 
specified. The other seven studies compared pure laparoscopic donor nephrectomy to LESS donor nephrectomy. 
3. One study compared hand-assisted laparoscopic donor nephrectomy to mini-open donor nephrectomy, where the others compared pure laparoscopic donor nephrectomy to 
mini-open donor nephrectomy.
supplementary figure 1 – GRADE table of quality of evidence for studies included in meta-analysis
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supplementary figure 2 - Forest plot analysis for postoperative ileus after laparoscopic donor 
nephrectomy with or without hand-assistance.
supplementary figure 3 - Forest plot analysis for intraoperative organ damage after mini-open and 
laparoscopic live donor nephrectomies.
supplementary table 1. Country of origin of 190 included studies, percentages between brackets.
country number of articles included
Argentina
Australia
Belgium
Brazil
Canada
Chile
China
Czech Republic
France
Germany
Greece
India
Iran
Italy
Japan
Korea
Kuwait
Lebanon
Mexico
Netherlands
Norway
New Zealand
Pakistan
South Africa
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
United Kingdom
USA
Vietnam
1 (0.5)
6 (3.2)
1 (0.5)
4 (2.1)
5 (2.6)
1 (0.5)
2 (1.1)
1 (0.5)
2 (1.1)
8 (4.2)
1 (0.5)
10 (5.3)
1 (0.5)
5 (2.6)
7 (3.7)
11 (5.8)
1 (0.5)
1 (0.5)
1 (0.5)
13 (6.8)
2 (1.1)
1 (0.5)
1 (0.5)
1 (0.5)
3 (1.6)
2 (1.4)
3 (1.6)
2 (1.1)
1 (0.5)
3 (1.6)
12 (6.3)
76 (40)
1 (0.5)
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abstract
introduction Living kidney donors comprise a unique group of “patients”, undergoing 
an operation for the benefit of others. The informed consent process is therefore valued 
differently. Although this is a team effort, the surgeon is responsible for performing the 
donor nephrectomy, and often the one held accountable, should adverse events occur. 
Although there is some consensus on how the informed consent procedure should be 
arranged, practices vary. The aim of this study was to evaluate the surgical informed 
consent procedure for live donor nephrectomy, with special regards to disclosure of 
complications.
methods A web-based survey was sent to all kidney transplant surgeons (n=50) in 
eight transplant centers with questions regarding the local procedure and disclosure of 
specific details.
results Response rate was 98% (n=49), of which 32 (65%) were involved in living donor 
education; overall, transplant- (50%), vascular- (31%), and abdominal surgeons (13%), 
and urologists (6%) performed donor nephrectomies in the eight centers. Informed 
consent procedures varied, ranging from assumed to signed consent. Bleeding was the 
only complication every surgeon mentioned. Risk of death was always mentioned by 16 
surgeons (50%), sometimes by 13 (41%), three surgeons (9%) never disclosed this disas-
trous complication. Reported mortality rates ranged from 0.003% to 0.1%. Mentioning 
frequencies for all other complications varied.
conclusion Important complications are not always disclosed during the surgical in-
formed consent process for live donor nephrectomy. Informed consent procedures vary. 
To optimally prepare living kidney donors for the procedure, a standardized informed 
consent procedure for live donor nephrectomy is highly recommended.
Surgical information disclosure
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introduction
Living kidney donors comprise a unique group of “patients”, undergoing an operation 
for the benefit of others. Even though the surgical technique for the live donor nephrec-
tomy is fully implemented, and associated with low complication rates, the burden 
of responsibility may feel different to surgeons operating on living donors instead of 
actual patients 1. Every patient needs to be fully informed about the details and risks of 
a procedure, but because surgeons may have an increased fear of inflicting unneces-
sary injury and expectation of perfection with living donors 1, the informed consent 
procedure is valued differently. To enable donors to make a fully informed decision, it is 
the transplant team’s responsibility to provide them with all the necessary information. 
This is a joint effort of the whole transplant team, but the surgeon is the one responsible 
for the donor nephrectomy, and is often the last in the chain of information providers. 
In addition, should adverse event occur, the surgeon is often the one held responsible. 
He should therefore ensure that the donor has been informed about all essential details 
and risks either by providing these himself or confirming that the rest of the team has 
done so. There should be no doubt about the donor’s consent, and the transplant team 
should confirm the voluntary and informed nature hereof 2.
There are many uncertainties when it comes to information provision and informed 
consent, in patients in general, let alone living kidney donors. What information do they 
need, which details are vital in their educational process? And at what stage during this 
educational process should the actual informed consent be obtained? In addition, the 
manner in which informed consent should be documented is a much-debated subject. 
In the Netherlands, the law on organ donation stems from May 1996. Consent has to 
be obtained in writing, signed and dated. But the contents of information provision are 
not stated in any legal document, although some specifications can be found in the 
EU Directive, requiring Member States to adhere to minimum standards in live organ 
donation3. In the United States, a more detailed guideline is available 4, but compliance 
with this guideline varies.
A recent systematic review demonstrated that there is no consensus on how the 
informed consent procedure in live donor nephrectomy should be arranged5. There 
are many discrepancies in the procedure itself, provided information and the man-
ner in which consent is obtained between different countries, transplant centers and 
even transplant professionals within one center. Previous surveys have demonstrated 
that transplant professionals vary in information and details they provide to potential 
donors6, 7. It has been suggested that donors as well as transplant professionals would 
greatly benefit from a standardized informed consent procedure5, 8, and many agree that 
there is a need for a standardized informed consent procedure.
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The Netherlands have a leading role when it comes to live kidney donation with more 
than half of all kidney transplants involving a living donor. In 2014, 534 live donor ne-
phrectomies were performed out of a total of 1004 kidney transplantations (53.2%)9. Not 
every center employs the same surgical technique, which makes completely uniform 
information provision virtually impossible. Still, uniformity should be pursued, especially 
seen in light of the successful paired kidney exchange program (PKE) in the Netherlands 
(3.5% of all live donor nephrectomies are within the PKE program) 10. In contrast to some 
other countries, where the kidney is transported from the donor’s center to the recipi-
ent’s center, standard national policy in the Netherlands involves donors traveling to the 
recipient’s center for surgery, but receiving education in their own center. Most donors 
visit the outpatient clinic of the second center prior to surgery, and are seen by the lo-
cal surgeon on the day of admission for donor nephrectomy. If information received 
in “their own” center differs greatly from information received in the “new” center this 
could be quite troubling for the donor. Hospital logistics and local practice are bound 
to vary. But standardization of the contents of the informed consent procedure should 
be possible, and is expected to further improve this process for potential living kidney 
donors. The first step to create this standardized format is to assess the current situation. 
How is the informed consent procedure arranged in the eight Dutch kidney transplant 
centers? And which specific details are discussed with potential donors?
The aim of this study was to provide an overview of the current situation in the 
Netherlands with regard to the surgical part of the informed consent procedure. Special 
interest is addressed to the disclosure of different complications by transplant surgeons 
to potential donors.
materiaLs and metHods
To gain better insight in the information disclosed by kidney transplant surgeons, a 
web-based survey (supporting document I - appendix I) was created (SurveyMonkey, 
Palo Alto, CA, USA) and sent to all surgeons in the Netherlands who were, or had been 
in the past, involved in kidney transplantation, identified from prior surveys, registration 
details and by contacting the surgical kidney transplant program director in each center. 
Specialists included transplant, abdominal and vascular surgeons and urologists, both 
consultant surgeons and surgical fellows. Because the questionnaire was distributed to 
colleagues and included only questions regarding their own practice habits, no approval 
from the local ethics committee was obtained.
Questions were divided into four subgroups: personal experience, hospital logistics, 
contents of informed consent and the actual informed consent procedure. A list of (medi-
cal) items was created based on currently available literature 5, combined with our own 
Surgical information disclosure
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experience, that could be provided to potential donors during the informed consent pro-
cedure. These items included details regarding surgical technique (n=6, e.g. laparoscopy, 
hand-assistance, conversion), short- and long-term complications (n=22, e.g. bleeding, 
wound infection, mortality, incisional hernia, kidney failure), duration of admission and 
convalescence. For each possible complication, the respondents were given three op-
tions: “I always mention this complication to potential donors”, “I sometimes mention this 
complication to potential donors”, or “I never mention this complication to potential do-
nors”. Results were compared between center, type of surgeon, and personal experience.
Statistical analysis was performed using SPSS version 21. For continuous variables the 
student-t test or one way Anova was used. For nominal variables the Chi-square test 
was used, or the Fisher’s Exact test for small samples. A p-value of <0.05 was considered 
statistically significant.
resuLts
A total of 50 surgeons were invited to complete the survey and a response rate of 98% 
was reached (n=49). Of these respondents, 17 indicated they were not involved in the 
preoperative care for living kidney donors, 32 individual responses remained for analy-
sis; 28 consultants and four surgical fellows. Sixteen respondents were transplant-, ten 
were vascular-, four abdominal surgeons, and two were urologists. Five different tech-
niques for live donor nephrectomy are employed in the Netherlands: pure laparoscopic, 
hand-assisted laparoscopic (HAL), hand-assisted retroperitoneoscopic (HARP), robot 
assisted and mini-open. Not every center offers every technique. Two centers use only 
one technique, whereas the other six choose from two or more techniques. Only one 
center offers robotic assisted donor nephrectomy, the other techniques are available in 
at least two centers.
Hospital Logistics & informed consent
Informed consent procedures vary among centers, but even surgeons from the same 
center report different practices. All but two respondents evaluate the majority of po-
tential donors at the surgical outpatient clinic (94%), the remaining two respondents, 
from different centers, indicated that they only evaluated living donors the day before 
surgery. In all but one center the surgeon or urologist is responsible for the postopera-
tive in-hospital care for donors, the nephrologist in the remaining center. Postoperative 
outpatient care varies as well. With the exception of two centers all donors are invited 
for an outpatient clinic follow-up visit. In one center donors only receive a follow-up 
telephone call by the surgeon, and in the last center all follow-up appointments are 
arranged through the nephrology department.
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When asked about the actual informed consent procedure in their hospital, answers 
again varied. Respondents from three centers were unanimous about the manner in 
which informed consent was obtained; signed in two and explicit oral consent in the 
third. Only one center was also unanimous about the responsible party for obtaining 
consent, the other responses varied between nurse practitioner, surgeon or nephrolo-
gist. Answers from the other five centers differed among their respondents. Timing of 
informed consent also demonstrated some differences. Respondents from four centers 
were unanimous; two obtained consent prior to the surgical consult and two afterwards. 
In the other centers, respondents disagreed on whether consent was obtained prior to 
or after the surgical consult, or that there was no explicit informed consent at all.
contents of informed consent
The selected medical items and the frequency in which they were mentioned are dem-
onstrated in table 1.
table 1. Frequency of providing individual items during the surgical part of the informed consent 
procedure in live donor nephrectomy in percentages.
always sometimes never
Conversion to open procedure 84.5 6 9.5a
Short-term complications
 Bleeding
 Wound infection
 Pain
 Fatigue
 Damage to other organs
 Pneumonia
 Abscess
 Urinary tract infection
 Thromboembolic complications
 Testicular pain/swelling
 Cardiovascular complications
 Neurapraxia
 Neuropathy
100
97
84
53
50
44
31
31
28
25
15.5
12.5
6
-
3
6
22
31
28
28
34
34
22
44
40.5
47
-
-
9
25
19
28
41
34
38
53
40.5
47
47
Mortality 50 37.5 12.5
Long term complications
 Incisional hernia
 Kidney failure
 Chronic pain
 Hypertension and other
 cardiovascular complications
 Risks of living with one kidney:
 Smoking
 Obesity
 NSAIDs
 Antibiotics
59
47
28
13
37.5
19
15.5
13
28
28
44
34
22
47
37.5
22
13
25
28
53
40.5
34
47
66
a. Two of three respondents from a center that only employs (mini-)open procedures
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Bleeding was the only complication that every surgeon from every center always 
discloses to potential donors. Wound infection came in a close second with 31 surgeons 
always and one sometimes mentioning it. The most outstanding fact was that not all 
surgeons discussed the risk of death; only half (n=16) reported always telling donors 
about the possibility of dying, another 12 mentioned it sometimes and four never at 
all. In addition, surgeons provided different estimated mortality rates, ranging from 
0.003 – “<1%”. Long-term complications were overall less frequently reported than 
short-term complications. A little over half of the respondents (n=19) always mentioned 
the possibility of an incisional hernia, 15 mentioned the risk of kidney failure. Table 2 
lists additional complications or details that surgeons indicated to discuss with potential 
donors.
All surgeons discuss duration of admission and convalescence with potential donors. 
Timespans are comparable, ranging from one day to one week for hospital admission 
and two weeks to three months for convalescence.
Out of a possible 22 complications, surgeons mentioned a median of eight complica-
tions, always, to all donors (range 3-17). More short- than long-term complications were 
discussed (table 3).
table 2. Additional details that surgeons indicated to discuss with potential donors, and the frequency in 
which these were mentioned.
category details frequency
Short-term complications
Long-term complications
Other
Pain due to pneumoperitoneum
Damage to graft
Complications in recipient
Failure to implant kidney in recipient
Physical impairment
Graft failure (recipient)
Risks in case of pregnancy
Quality of life
Follow-up program
Intrinsic motivation/free choice
Trials
1
1
1
2
1
2
1
1
1
2
1
table 3. Distribution of mentioning frequencies for subgroups of complications (median, range).
always sometimes never
Overall
Short-term complications
Long-term complications
8 (3-17)
6 (3-12)
2 (0-8)
5 (0-13)
3 (0-8)
2.5 (0-7)
7 (0-17)
4 (0-11)
3.5 (0-7)
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We compared these frequencies between different subgroups; center, type of sur-
geon, subspecialization, number of procedures performed, and gender. One significant 
difference was observed in the short-term never group: Surgeons who performed <20 
donor nephrectomies on an annual basis never mentioned a median of six (mean 5.9) 
short-term complications to donors, surgeons who performed >20 procedures never 
mentioned three (mean 3.3) (p=0.04).
When comparing each individual complication between the different subgroups, a 
few statistically significant differences were observed which are demonstrated in tables 
4-7. Male- and female surgeons mentioned the same number of short-term complica-
tions, but remarkably, the risk of pain was significantly more often reported by men (92 
vs 63%, p=0.006). Transplant surgeons were the most likely to always mention risk of 
death (69%) versus 50% of vascular surgeons, and none of the abdominal surgeons or 
urologists.
table 4. Differences in mentioning frequencies between type of surgeons in percentages.
consultant
(n=28)
fellow
(n=4)
p-value
Median number of complications always 
disclosed (range)
8 (3-17) 7.5 (6-13) NS
A S N A S N
Complication
Pain
Pneumonia
Abscess
Thromboembolic complications
89
36
32
21
7
32
21
36
4
32
46
43
50
-
25
75
-
100
75
25
50
-
-
-
0.01
0.05
0.06
0.07
A – Always S – Sometimes N – Never
table 5. Differences in mentioning frequencies between surgeons’ subspecialization (in rounded 
percentages, unless otherwise defined).
transplant
(n=16)
vascular
(n=10)
abdominal
(n=4)
urologist
(n=2)
p-value
Median number of 
complications always 
disclosed (range)
9 (3-17) 7.5 (3-13) 6.5 (5-12) 9 (5-8) NS
a s n a s n a s n a s n
Complication
Death
Neuropathy
Urinary tract infection
69
60
56
31
50
25
-
44
19
50
-
10
20
30
30
30
70
60
-
-
-
75
100
75
25
-
25
-
50
-
100
-
50
-
50
50
0.03
0.03
0.06
A – Always S – Sometimes N – Never
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discussion
Informed consent is important for every surgical procedure. Every surgical professional 
agrees that a patient, or, potential donor must make an informed decision when it comes 
to undergoing surgery or donating a kidney. This implies that there is a basic level of 
knowledge we want patients or donors to have. Nonetheless, our study demonstrates 
that essential items are more than once left out of surgical donor education. Short-term 
complications are more thoroughly discussed by surgeons with potential donors than 
long-term complications, which could be explained by the fact that short-term compli-
cations are more frequently dealt with in surgeons’ daily practice, but information provi-
sion regarding short- and long-term complications was far from uniform. It needs to be 
further evaluated whether these deficits in information provision also lead to deficits in 
donors’ knowledge. Additional studies have been initiated to assess this11.
Sixteen of 32 surgeons reported always mentioning the risk of death to potential do-
nors, another 12 did so sometimes but four never told donors about the risk of dying. If 
a mortality rate was stated, this ranged from 1 in 30.000 to “less than 1 in 100”. Although 
rare, donor mortality has been reported in the literature12-16, and this may still be an 
underestimation of the actual mortality rate. The largest cohort is reported by Segev et 
al., who found 25 donor deaths within 90 days after 80.347 live donor nephrectomies 
(0.03%)16.
Differences in information provision were encountered between the eight centers. In 
some cases these differences could be easily explained; one center only employs the 
table 7. Differences in mentioning frequencies between personal number of donor nephrectomies 
performed on annual basis (in rounded percentages, unless otherwise defined).
<10
(n=3)†
10-20
(n=5)†
20-50
(n=20)†
>50
(n=2)†
p-value
Median number 
of complications 
always disclosed 
(range)
7 (4-10) 7 (3-10) 8 (3-17) 12.5 (8-17) NS
a s n a s n a s n a s n
Conversion
Complication
Cardiovascular
Testicular pain
Abscess
33.5
33
-
-
-
33
-
-
66.5‡
33
100
100
60
20
-
20
40
-
60
20
-
80
40
60
-
-
25
25
100
65
20
40
-
35
55
35
-
50
100
100
100
-
-
-
-
50
-
-
<0.001
0.03
0.04
0.09
† Two of 32 respondents indicated that although they were involved in living donor education they did 
not perform donor nephrectomies themselves.
‡ Both respondents who never discussed conversion came from a center that only offers open 
procedures.
A – Always S – Sometimes N – Never
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mini-open technique, and did thus not disclose details on laparoscopy or the possibil-
ity of conversion. But in other cases the discrepancy between centers was cause for 
concern. Our survey demonstrates that differences in education were also substantial 
between some professionals within one center.
If the information we provide is not uniform, and in some cases not even complete, 
we can never expect our donors to have all necessary knowledge to prepare them for 
donor nephrectomy. There are a few studies assessing donors’ general knowledge of the 
donation procedure and its risks, which conclude that there are at least some deficits 
17, 18. Some donors even admit that, when looking back, they felt unprepared and not 
well (enough) informed by the transplant team 19.
Striking results were also encountered with regards to the informed consent proce-
dure itself. Only three centers provided a unanimous answer to the question whether 
informed consent was assumed, obtained by explicitly asking, or signed. In the other 
centers, all options were mentioned at least once. A possible explanation is that the 
definition of informed consent may not be the same for everyone; in many centers, 
nephrologists obtain signed consent for donation, while surgeons obtain an additional, 
usually oral, consent for the actual nephrectomy. Still, these varied responses reflect a 
suboptimal situation regarding the informed consent procedure and may imply that 
surgeons don’t exactly know how the procedure is arranged in their own hospital. It has 
been recommended that the informed consent procedure should be a continuous pro-
cess with different evaluation moments and possibly even different consent moments 
along the way20. Implementing these separate informed consent moments for screening 
and donor nephrectomy in a standardized format would be a logical development.
This survey study has definite strengths. A response rate of 98% for a nationwide 
survey provides a reliable overview of the Dutch situation. Although there have been 
other studies that at least partly concur with our findings 6, 7, we cannot blindly assume 
that the same differences will be found in other European countries, let alone in other 
continents, where more detailed guidelines are available to guide the surgeon during 
information disclosure4, 21. Including international transplant surgeons would give us a 
better idea of how informed consent procedures are practiced abroad, but it is highly 
unlikely that a comparable response rate would be reached. Results may then be less 
reliable.
But even with this high response rate, our cohort still only comprises 32 individual 
surgeons involved in preoperative living kidney donor education, which is one of the 
main limitations of this study. In this small sample, statistical analyses are less valuable, 
especially for subgroup analyses. Another limitation is that as with every survey study, 
responses are not fully objective and subject to recall bias. Most questions are matrices 
or multiple choice and are naturally suggestive. We provided the answering options 
“always”, “sometimes” and “never”. The definition of “always” and “never” are clear, but 
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“sometimes” leaves room for interpretation. For one professional “sometimes” may mean 
“nearly always”, whereas for the other it means “hardly ever”.
We chose to only invite surgeons to complete the survey, even though the informed 
consent process is a joint effort of the whole transplant team, consisting of at least, but 
not limited to, a nephrologist, transplant coordinator and surgeon in most centers. If the 
surgeon hasn’t told the donor all the details, one of the other team members may have 
done so and the donor may still be well informed. Still, the surgeon is responsible for the 
surgical procedure, and is the last in the chain of information provision to the donor. He 
should therefore ensure that the donor has been informed of all essential details and 
risks by either providing these himself or confirming that the rest of the team has done 
so.
A final point of discussion is the fact that we only looked at living donor education. 
This is a very specific population, and the procedure is only performed in highly special-
ized transplant centers. However, it is often stated that informed consent is even more 
important in living donors, since they do not benefit from the procedure. If relevant 
complications are left out of donor education, it may well be assumed that this will also 
be the case in the educational process of other surgical patients. A number of studies as-
sessing the informed consent procedure in total knee- and hip arthroplasty candidates 
found similar results of low rates of disclosure and/or documentation of certain details 
and risks of the procedure 22-24. Our results are informative for every surgical professional, 
and may urge them to critically assess the informed consent procedure in their own area 
of expertise.
Even in the Netherlands, a small country with close connections between kidney trans-
plant surgeons, a large number of live kidney donations (31 per million of population 25), 
and frequent interactions due to a successful national PKE program 26, great variations 
exist in surgical donor education and informed consent procedures. Important risks and 
complications are not always discussed with potential donors.
There are a number of possible options to further improve information provision to 
potential donors, some of which have already been put to use. A standardized informed 
consent form has already been implemented, but this form does not include specific 
details. Nephrologists mainly use it, not as a checklist to guide the consultation, but 
rather to document informed consent at the end of it. Information evenings, leaflets and 
DVD material, and a home-based educational team for specific donor categories 27 are 
some of newly implemented educational strategies. None of these methods are applied 
consistently, and their informational value has yet to be determined. Although donation 
rates ánd general knowledge regarding living donation evidently increased after home 
based education27, this has not been investigated for other educational approaches. The 
basis for adequate donor knowledge lies in uniform information provision. Only then 
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can we test what donors really need, and understand, and identify aspects that need 
improving.
To ensure that every living kidney donor is prepared for their operation and postop-
erative course in the best possible way, a standardized informed consent procedure for 
the live donor nephrectomy is highly recommended. A nationwide inventory project 
has been initiated to achieve this11.
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appendix – i – enGLisH transLation of survey questions
surgical donor education and informed consent in Live Kidney donation.
question     1.
are you involved in the preoperative education of living kidney donors?
  Yes
  No → End of Survey
question      2.
do you perform live donor nephrectomies yourself?
  Yes
  No
question      2a.
if yes, how many live donor nephrectomies do you perform on an annual basis?
  0-10
  10-20
  20-50
  >50
question      3.
How often, and where, do you see donors preoperatively? (multiple answers 
possible)
  Standard preoperative outpatient clinic appointment
  On admission to the ward, the day before surgery
  On the day of surgery
  Other, please specify:  
 
 
question      4.
who is responsible for the postoperative care of living kidney donors during 
admission in your center?
  Nephrologist
  Surgeon
	  Other, please specify:  
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question      5.
How is the surgical follow-up arranged in your centrum, given that the procedure 
was uncomplicated?
  No surgical follow-up appointment
  Telephone follow-up visit
  One outpatient clinic visit
  Two outpatient clinic visits
  More than two outpatient clinic visits
  Other, please specify:  
 
 
question      6.
which techniques for live donor nephrectomy are employed in your center? 
(please choose all applicable options)
  Pure laparoscopic donor nephrectomy
  Hand-assisted laparoscopic donor nephrectomy
  Hand-assisted retroperitoneoscopic(HARP) donor nephrectomy
  Robot-assisted donor nephrectomy
  (Mini)- open donor nephrectomy
  Other, please specify:  
 
 
question      7.
which of the following aspects regarding operative techniques do you discuss 
with donors, and how often?
7A. Pure laparoscopic donor nephrectomy
 Always   Sometimes   Never
7B. Hand-assisted laparoscopic donor nephrectomy 
 Always   Sometimes   Never
7C. Hand-assisted retroperitoneoscopic(HARP) donor nephrectomy
 Always    Sometimes   Never
7D. Robot-assisted donor nephrectomy 
 Always   Sometimes   Never
7E. Mini)- open donor nephrectomy 
 Always   Sometimes   Never
7F. Conversion to open procedure 
 Always   Sometimes   Never
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question      8.
which short-term complications do you discuss with donors, and how often?
8A. Bleeding      
 Always   Sometimes   Never
8B. Wound infection     
 Always   Sometimes   Never
8C. Abscess      
 Always   Sometimes   Never
8D. Pneumonia      
 Always   Sometimes   Never
8E. Urinary tract infection    
 Always   Sometimes   Never
8F. Pain       
 Always   Sometimes   Never
8G. Damage to other organs    
 Always   Sometimes   Never
8H. Thromboembolic complications   
 Always   Sometimes   Never
8I. Cardiovascular complications    
 Always   Sometimes   Never
8J. Testicular pain     
 Always   Sometimes   Never
8K. Fatigue      
 Always   Sometimes   Never
8L. Neuropathy      
 Always   Sometimes   Never
8M. Neurapraxia     
 Always   Sometimes   Never
Open: Other, please specify  
 
 
question      9.
do you discuss the risk of mortality with donors?
  Always
  Sometimes
  Never
Surgical information disclosure
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question      9a.
Open: if yes, what mortality rate do you disclose?
 
 
 
question      10.
which long-term complications do you discuss with donors?
10A. Chronic pain    
 Always  Sometimes   Never
10B. Incisional Hernia     
 Always  Sometimes   Never
10C. Hypertension and other cardiovascular complications 
 Always  Sometimes   Never
10D. Renal failure     
 Always  Sometimes   Never
10E. Risks of living with one kidney: smoking  
 Always  Sometimes   Never
10F. Risks of living with one kidney: NSAIDs  
 Always  Sometimes   Never
10G. Risks of living with one kidney: antibiotics  
 Always  Sometimes   Never
10H. Risks of living with one kidney: obesity  
 Always  Sometimes   Never
Open: Other, please specify:  
 
 
question      11.
do you discuss duration of admission with donors?
  Yes, please specify:   days postoperatively
  No
question      12.
do you discuss duration of convalescence with donors?
  Yes, please specify: … weeks/months
  No
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question      13.
open question: do you discuss anything else with donoren? if yes, please 
specify:  
 
 
question      14.
How is informed consent for the procedure obtained in your center?
  Assumed consent after consult
  Explicitly asked oral informed consent
  Signed informed consent
Open: Other, please specify:  
 
 
question      15.
who is responsible for obtaining informed consent for donor nephrectomy in 
your center?
A. Surgeon
B. Nephrologist
C. Not applicable; no explicate informed consent
Open: Other, please specify:  
 
 
question      16.
when is informed consent obtained in your center?
  Prior to the surgical consult
  After the surgical consult
  Not applicable; no explicate informed consent
Open: Other, please specify:  
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abstract
introduction Donors report varying degrees of satisfaction with the information and 
preparation for live donor nephrectomy. Whether this stems from lack of education, or 
comprehension remains unclear. It is vital that donors receive all necessary details.
research Question How well are donors informed about the live donor nephrectomy 
procedure and possible adverse events during the surgical part of the informed consent 
procedure?
design Nine surgical transplant professionals were observed during the preoperative 
outpatient clinic visit of 46 potential living kidney donors. Provided information was 
scored using standardized checklists, team members received an “informer score”. 
Immediately after the consult, and again on the day of admission, donors received a 
pop-quiz testing their knowledge. Postoperatively an evaluation and satisfaction ques-
tionnaire was sent.
results Mean informer score was 12.5/20 (range 2-20). Mean donor score was 5.9/20 2-11. 
Donors scored best on duration of admission and convalescence, worst on long-term 
complications. Risk of mortality was disclosed by 91% of informers, but only reproduced 
by donors in 22% (clinic) and 14% (admission). Donors with younger children, a higher 
educational level and registered (post-mortem) donors scored significantly better. Mean 
donor satisfaction was 8.4/10 (4-10).
discussion There were marked variations between information provided by inform-
ers, important complications were not always disclosed. Overall donor scores were 
low. Whether donors are actually well enough informed at the time of giving consent 
remains debatable.
Donor knowledge & satisfaction - PILOT
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introduction
The informed consent procedure for live donor nephrectomy is ethically and legally 
obligatory but is not unambiguously defined in different institutes.1-4 To safeguard 
donor autonomy, they must be presented with all potential risks, to be able to decide 
whether they are willing to accept these. In addition, donors may also need information 
to feel more prepared for the donation procedure.5
Some authors postulated that living kidney donors do not actually absorb all informa-
tion provided to them, but rather focus on positive aspects to reaffirm their decision to 
donate.6 The question has been raised whether they actually remember and understand 
everything, and it is argued that potential donors may not be fully informed at the time 
of giving consent.5-9 Some donors have retrospectively reported not feeling adequately 
informed about certain aspects of kidney donation.5, 8, 10, 11 Whether this is due to lack of 
comprehension or lack of education is unclear, but transplant professionals may vary 
in the information they provide,12, 13 and potential complications and are not always 
disclosed.14
This PILOT study is one of the projects preceding in a nationwide initiative to further 
improve the informed consent procedure for live donor nephrectomy. The ultimate goal 
is to create a standardized format for this procedure, to assist transplant professionals in 
their daily clinical practice and to provide potential living kidney donors with all informa-
tion they need. To do so requires analysis of scientific evidence, but more importantly, of 
daily practice from the medical professional’s perspective as well as the donor’s.
This PILOT study is the first step in assessing the surgical part of the informed consent 
procedure in live donor nephrectomy. In addition, we tried to determine the best design 
and set-up for a nationwide study on informed consent in live donor nephrectomy.
metHods
Approval was obtained from the local ethics committee (Erasmus MC, MEC-2014-538, 
October 14th 2014). In our donor screening pathway, potential donors are first informed 
by a nephrologist and transplant coordinator and receive information by leaflet, DVD 
and website. Subsequently, they undergo a mandatory medical and psychological 
screening procedure and if no objections arise, they are referred for surgical screening. 
Potential donors, seen at the surgical outpatient clinic between September 1st 2014 and 
February 1st 2015, were asked to participate in this study.
After informed consent, one of two researchers observed the consultation and 
documented information disclosure using a standardized checklist (appendix A) using 
104
Chapter 5    
information from our own data and data available from literature, defining items that 
should be included in informed consent procedures for live kidney donation.4
Every surgical professional (“informer”) involved in preoperative living kidney donor 
education at our surgical outpatient clinic was included in this study. For every men-
tioned (informer) or recalled (donor) item one point was awarded and a maximum score 
of 20 could be obtained (Appendix A).
Donors received three questionnaires: the first two pop-quizzes testing knowledge of 
the upcoming procedure, administered immediately after the surgical outpatient clinic 
visit and again on the day of admission for donor nephrectomy. In addition, donors 
were asked to indicate how well they felt prepared for the donor nephrectomy. This was 
measured by means of a Visual Analogue Scale (VAS). A translated version of the pop-
quiz is available as supplementary material (Appendix B). The last questionnaire was an 
evaluation and satisfaction questionnaire, administered 6-12 weeks after surgery.
Additional data regarding the procedure, the postoperative course and adverse events 
were derived from medical charts.
donors
A total of 48 donors were seen during the inclusion period. One donor refused to partici-
pate, and one donor was not included because of a language barrier. Table 1 provides an 
overview of the remaining 46 donors’ baseline characteristics. Ten donors have not been 
scheduled for the operation as renal function of four preemptive recipients remained 
stable, four couples preferred to postpone the donation procedure (because of family 
obligations, work, and holidays), and one recipient and one donor have not yet been 
cleared by the anesthesiologist. This left 36 donors with a complete follow-up.
statistics
Statistical analysis was performed using SPSS version 21 and R version 3.1.2. Values are 
presented in means with standard deviation (SD) and, if relevant a range is provided. If 
absolute values were described (e.g. the number of complications mentioned), this was 
provided in a median with range.
Differences between informer scores and donor scores per type of informer were com-
pared by One-Way ANOVA. Residuals were tested, distribution was normal. To compare 
differences in mentioning frequencies of individual complications between pop-quizzes 
completed at the outpatient clinic and those on the ward on the day of admission, 
McNemar tests were performed. Only those donors who completed the questionnaire 
on both occasions were compared. The McNemar test compares the number of those 
who first scored positive (i.e. mentioned that specific complication), and then negative 
(i.e. did not mention that specific complication) with the number who first scored nega-
tive and then positive: if these numbers differ significantly from each other an increase 
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or decrease can be concluded. Differences between outpatient and admission donor 
scores were analyzed using the pairwise comparison t-test. A two-tailed p-value of <0.05 
was considered statistically significant. Multivariate analysis was performed using linear 
regression. All factors with a univariate p-value of <0.20 were included in the model, 
and were manually excluded based on their multivariate p-value. When predictors for 
donor scores were analyzed it was found that the residuals of linear regression were 
not normally distributed, thus the bootstrap method was used. Because SPSS does not 
allow overall p-values for categorical variables with more than two groups, which are 
needed for a stepwise procedure, we switched to R to find overall p-values per variable 
by combined Wald tests. None of the continuous variables had a non-linear effect.
resuLts
surgical consult
Nine medical professionals completed all consults; four attending surgeons, three surgi-
cal fellows and two specialist nurses. Disclosed information varied between informer 
type. Attending surgeons scored best with an average of 14.7 (±4.6) points, versus 11.1 
(±2.2) for fellows and 10.8 (±1.0) for nurses (supplementary table 1). Variations were 
observed between individual professionals (inter-informer variability, p<0.0001). There 
was no significant intra-informer variability.
table 1. Baseline characteristics of 46 living kidney donors (percentages between brackets unless 
otherwise defined).
outpatient clinic admission
Gender (M:F) 20:26 14:22
age (mean, SD, range) 54.6 (12.8, 27-75) 54.9 (12.3, 27-75)
type of donation(ref.15)
 Unspecified
 Specified direct
 Specified indirect
6 (13)
36 (78)
4 (9)
6 (17)
26 (72)
4 (11)
educational levela
 Lower
 Intermediate
 Higher
14 (30)
19 (41)
13 (28)
11 (30)
15 (42)
10 (28)
current employment
 Fulltime
 Part-time
 Retired
 Unemployed
16 (35)
13 (28)
11 (24)
6 (13)
11 (31)
12 (33)
8 (22)
5 (14)
income
 Below average
 Average
 Above average
13 (28)
26 (57)
7 (9)
11 (30)
19 (53)
6 (17)
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All professionals described the laparoscopic approach, including the pfannenstiel inci-
sion through which the kidney is removed. The possibility of conversion to open surgery 
was described in all but two consults (96%). A median of six short-term complications 
were disclosed (range 0-9). The risk of death was explicitly mentioned in 41 consults 
(91%). Long-term complications were only addressed in half of the cases (N=24, 52%). 
Table 2 provides an overview of mentioning frequencies of the individual complications 
by informers, and their equivalents by donors.
Duration of hospital admission was accurately described in 42 consults (91%), dura-
tion of convalescence in 31 (67%).
pop-quiz scores
The average time between surgical outpatient clinic visits and admission for the opera-
tion was 64 days (median 56, range 21-196). Mean overall donor score was 5.9 (±2.5) and 
5.7 (±2.2) at the clinic and on admission respectively. Donors scored best on duration of 
admission and convalescence, and worst on long-term complications (supplementary 
table 2). Mean outpatient scores and demographics did not differ between the 10 do-
nors that were not included in the admission cohort, and the 36 donors that were.
table 1. Baseline characteristics of 46 living kidney donors (percentages between brackets unless 
otherwise defined).
outpatient clinic admission
religion
 Catholicism
 Protestantism
 None
 Other
11 (24)
9 (20)
20 (44)
6 (13) b
8 (22)
7 (19)
17 (47)
4c (11)
Household constitution
 Alone
 With partner
 Alone with children <18
 Alone with children >18
 With partner and children <18
 With partner and children >18
 Otherd
9 (20)
20 (44)
1 (2)
2 (4)
10 (22)
3 (7) 
1 (2)
6 (17)
16 (44)
1 (3)
2 (6)
7 (19)
3 (8)
1 (3)
registered donorse
 Yes
 No
26 (57)
20 (44)
18 (50)
18 (50)
a. Lower: none or primary school, intermediate: high school or secondary vocational education, higher: 
university of applied sciences or university
b. Islam (1), Buddhism (1), Moluccan Evangelical (1), Christian (2), unspecified (1)
c. Islam (1), Buddhism (1) Christian (1), unspecified (1)
d. With brother
e. Donors who have completed their registration in the post-mortem donor registry, stating they want to be an 
organ donor
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Surgical technique
The majority of donors at the outpatient clinic described keyhole- or laparoscopic 
surgery (n=31, 67%), of which 13 (43%) added the pfannenstiel incision. Another three 
donors (6.5%) only mentioned the pfannenstiel incision. Only two donors (4%) recalled 
the possibility of conversion.
Short-term complications
Table 2 demonstrates how often individual complications were mentioned. Only ten 
(22%) donors mentioned the risk of death at the outpatient clinic versus five on ad-
mission (14%), four of whom had already mentioned it at the clinic. The remaining five 
donors that stated mortality at the outpatient clinic were not included in the admission 
group. Most complications were mentioned more often at the outpatient clinic than on 
table 2. Mentioning frequencies of individual complications by informers, outpatient donors (values 
whole cohort, and for the 36 donors who’ve completed both the outpatient as well as admission 
questionnaire) and admission donors, percentages between brackets.
complication informer
n=9
donor outpatient donor
admission
n=36
p-valueab
all 
donors
n=46
follow-up 
cohort
n=36
short term
Bleeding
Infectionc
 Wound
 UTI
 Pneumonia
Damage other organs
Pain
Thromboembolic
Cardiovascular
Death
44 (96)
45 (98)
40 (87)
31 (67)
39 (85)
15 (33)
21 (46)
38 (83)
6 (13)
41 (89)
27 (59)
29 (63)
18 (39)
9 (20)
12 (26)
0
7 (15)
12 (26)
2 (4)
10 (22)
21 (58)
22 (61)
13 (36)
9 (25)
10 (28)
0
5 (14)
10 (28)
1 (3)
5 (14)
18 (50)
25 (69)
11 (31)
6 (17)
6 (17)
0
11 (31)
0
1 (3)
5 (14)
0.63
0.58
0.77
0.51
0.22
-
0.03
<0.0001
NAd
NAd
Long term
Chronic pain
Hernia
Hypertension
Renal failure
Risks with one kidney
10 (22)
19 (41)
10 (22)
10 (22)
13 (28)
4 (9)
4 (9)
1 (2)
8 (17)
1 (2)
3 (8)
2 (6)
1 (3)
6 (17)
1 (3)
1 (3)
3 (8)
1 (3)
6 (17)
0
0.50
NAd
NAd
NAd
0.5
NA – Not Available
a. P-values are computed for the comparison of the 36 outpatient with admission values, informer 
values are not included in the analysis.
b. P-values are computed using McNemar’s test for the 36 donors that have completed both pop-
quizzes.
c. Some donors only mentioned “infection” and did not specify which type of infection. Numerous 
donors mentioned more than one type of infection.
d. For the 36 donors that completed both pop-quizzes McNemar’s couldn’t be computed because 
mentioning frequencies were the same for both groups.
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admission with the exception of pain: 31% on admission versus 15% at the outpatient 
clinic (p=0.03). Reversely; thromboembolic complications, being in the top five at the 
outpatient clinic, were not mentioned once on admission.
Long-term complications
Long-term complications were least mentioned by surgical professionals, and even 
less often by donors. At the outpatient clinic, 21 donors (46%) left this unanswered or 
answered with “unknown”. Seven donors (15%) only named fatigue or deterioration of 
physical condition. Eighteen donors (39%) actually mentioned one or more complica-
tions at the outpatient clinic, versus nine (25%) on admission.
Hospital admission and convalescence
Three donors at the clinic (6.5%) and one on admission (2.8%) indicated that they had 
no idea about their length of stay. Although some (n=3, 6.5%) slightly overestimated the 
duration of admission at the clinic (i.e. one week instead of 3-5 days), none of the donors 
underestimated this. On admission, duration of convalescence was answered correctly 
by the majority of donors (n=40, 87%). Two donors said to have “no idea” regarding 
convalescence, two were vague (“couple of weeks”) and two underestimated this (2-4 
weeks). On admission, results were again comparable with three donors having no idea 
and three underestimations.
preparation for surgery
The mean preoperative preparation score measured by the VAS (0-10) was 8.5 (±0.8) at 
the outpatient clinic and 8.6 (±1.0) on the day of admission.
When asked in retrospect postoperatively, mean preparation score was 8.4 (±1.2). The 
postoperative value for preparation did not vary between donors that had developed 
complications and those who had not, nor was it related to whether they had encoun-
tered any surprises during the peri- and postoperative course.
donor satisfaction
Donors were quite satisfied with the donation and informed consent procedure: mean 
8.4 (±1.2). No significant differences were observed between donor characteristics. A 
trend was observed that unspecified donors15 were more satisfied than specified donors 
(9.2 versus 8.2, p=0.09), and donors living with children under 18 were less satisfied than 
other donors (7.4 versus 8.6 and 8.7, p=0.06).
Thirteen donors (36%) developed one or more complications; wound infection (n=5), 
bleeding (n=2), nausea (n=2), pain (n=2) abscess (n=1), deep vein thrombosis (DVT) 
(n=1), gastric bleeding (n=1), electrolyte disorder (n=1). For eight complications, donors 
indicated they knew this complication could develop, but the remaining seven donors 
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said they had no idea that their complication could happen, even though some of these 
had in fact been disclosed during the preoperative consult. Satisfaction scores were 
comparable between donors with and without complications (8.3 versus 8.5). Whether 
donors were aware of the possibility of a specific complication or not was not of influ-
ence on satisfaction scores.
correlation between provided and reproduced information
While attending surgeons had the highest scores, donors informed by them had not. 
Donors informed by fellows scored significantly lower than the other two groups at 
the outpatient clinic as well as on admission (p= 0.03, 0.04 respectively, supplementary 
table 3). Donor scores were not significantly related to individual informer scores.
table 3. Uni- and multivariate analysis as performed using linear regression for all factors possibly 
influencing donor scores.
univariate
beta (95%ci)
univariate
p-valuea
multivariate
beta (95%ci)
multivariate
p-valuea
outpatient score (n=46)
factor
Female gender
Age
Relation donor – recipient
 (Specified)
Educational levelb
 Higher
 Intermediate
No current employmentc
Incomed
 Above average
 Average
Religione
 Christian 
 Other
Household constitutionf
 With kids
 Without kids
Registered Donor
Informerg
 Nurse
 Fellow
Feeling of preparation
1.22 (-0.17-2.60)
-0.05 (-0.09- -0.01)
-1.47 (-2.91-0.17)
1.78 (0-3.38)
0.59 (-1.02-2.10)
-0.39 (-1.72-1.02)
-1.32 (-3.71-1)
-0.65 (-2.17-0.99)
-0.03 (-1.60-1.44)
-0.78 (-1.67-3.30)
0.96 (-0.63- 2.68)
-1.4 (-3.15-0.36)
0.81 ( -0.72-2.19)
1.25 (-0.47-3.02)
-1.44 (-2.86- -0.07)
-0.36 (-1.16-0.73)
0.07
0.02
0.08
0.13
0.58
0.53
0.82
0.001
0.29
0.005
0.48
Removed
Removed
Removed
2.11 (0.61-3.53)
1.05 (-0.48-2.59)
-
-
-
2.11 (-1.47-2.54)
1.05 (-3.60-0.52)
-
2.11 (-0.80-3.40)
1.05 (-2.63-0.06)
-
Removed
Removed
Removed
0.02
-
-
-
0.003
-
0.02
-
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correlation between demographics and reproduced information
Table 3 demonstrates uni- and multivariate analysis for demographic- and other factors 
that could possibly be influencing donor scores.
For the outpatient scores, a higher education level was independently associated with 
a higher score (6.9 versus 5.7/5.1, p=0.02). Donors living with children younger than 18 
scored significantly higher (7.4 versus 6.4 and 5.0 respectively for the other two groups, 
p=0.003), but these donors were also significantly younger than the other two groups; 
mean age 42.9 versus 51.7 for donors living alone and 61.3 for those living with other 
table 3. Uni- and multivariate analysis as performed using linear regression for all factors possibly 
influencing donor scores. (continued)
univariate
beta (95%ci)
univariate
p-valuea
multivariate
beta (95%ci)
multivariate
p-valuea
admission score (n=36)
factor
Female gender
Age
Relation donor – recipient
 (Specified)
Educational levelb
 Higher
 Intermediate
No current employmentc
Incomed
 Above average
 Average
Religione
 Christian
 Other
Household constitutionf
 With kids
 Without kids
Registered Donor
Informerg
 Nurse
 Fellow
Feeling of preparation
Time interval outpatient –
 admission
-0.31 (-2-1.25)
-0.004 (-0.07-0.06)
-0.6 (-1.68-0.75)
1.88 (0.35-3.25)
0.78 (-0.83-2.3)
-0.44 (-2-1.09)
1.52 (-0.86-3.61)
-0.77 (-2.37- 0.70)
-0.14 (-1.62-1.42)
-1.94 (-3.88-0.03)
0.25 (-1.18-2.05)
-1.38 (-2.62- -0.13)
2.89 (1.68-3.96)
1.93 (-0.48-4.47)
-0.51 (-1.87- 0.93) 
-0.62 (-1.88-0.46)
-0.01 (-0.03-0.01)
0.69
0.84
0.37
0.04
0.53
0.11
0.16
0.07
0
0.16
0.12
0.27
-
-
-
Removed
-
Removed
Removed
0.60 (-0.73-2.02)
-0.89 (-2.19-0.72)
2.79 (1.78-3.92)
Removed
Removed
-
-
-
-
Removed
-
Removed
Removed
0.02
0
Removed
Removed
-
a. Uni- and multivariate p-values were computed using linear regression with bootstrap analysis
b. Educational level was split into three levels; higher, intermediate and lower. “Lower” was taken as 
baseline class
c. Employment was split into yes versus no.
d. Income was divided into below average, average or above average. “Below average” was taken as 
baseline class
e. Religion was divided into Christian, none and other. “None” was taken as baseline class
f. Household was divided into alone, with partner but without children, and with or without partner but 
with children <18 years. “Alone” was taken as baseline class
g. “Consulting surgeon” was taken as baseline class
Donor knowledge & satisfaction - PILOT
111
adults or children older than 18 (p<0.001). Donors informed by specialist nurses also 
scored better; 7.7 versus 6.4 and 5.0 (p=0.02). On admission, higher scores were again 
seen in donors living with children under 18 (p=0.02), and in donors who were registered 
as deceased donors (7.1 versus 4.2, p<0.0001).
discussion
Our study is the first that observed surgical consultations with living kidney donors, and 
correlated provided information with donors’ knowledge about the different aspects of 
live donor nephrectomy.
Although other knowledge tests have been used11, 16 none were as specific as ours. 
By observing the consult, there is no doubt about which donor has received which 
exact details. Our results demonstrate that, even within one transplant center, there are 
great variations in living kidney donor education during the surgical informed consent 
process. This is in accordance with the available literature:4, 12, 13 information provided 
during the surgical consult differs among healthcare professionals. In our study, attend-
ing surgeons provided more detailed information than fellows and specialist nurses. 
However, donors informed by nurses scored better than those informed by consultants. 
An explanation, although hypothetical, may be that fellows and surgeons use more 
complex terminology while nurses may take more time to explain different items. We 
did not take into account the format of communication and information provision, nor 
the time taken for a consult. Both aspects may definitely influence donor knowledge, 
and this may be a topic for future research.
Most donors feel adequately prepared for surgery and report high rates of satisfaction 
with the informed consent procedure. Nevertheless, when tested on their knowledge of 
surgical technique and complications there are substantial deficits. It has been proposed 
that the decision-making process donors go through may differ from “regular” patients. 
Instead of carefully balancing risks and benefits, many donors decide to donate upon 
the first moment of hearing of the possibility, and they hardly ever change their mind, 
regardless of what information is provided to them; they only hear what they need to 
hear to reaffirm their decision.6, 17, 18 This may be an explanation for the overall low donor 
scores that were encountered in this study.
A striking example was that although the risk of death was mentioned in all but four 
consults (91%), only ten donors (22%) reproduced this at the outpatient clinic, and even 
less at the time of admission for surgery (14%). It has been previously described that 
many living donors do not actively recall the risk of death. Gordon et al performed a 
study on informed consent in living liver donors: 18 of 30 living donors (60%) mentioned 
being told about the risk of death.19 Although this percentage is higher than the 14 and 
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22% found in our pilot study, it has to be taken into account that the risk of death in 
living liver donors itself is greater than in kidney donors; 0.2%20 versus 0.03%.21 Nonethe-
less, living kidney donor mortality does occur,21-23 and if this happens, it is disastrous 
not only for the donor and his loved ones, but also for the recipient (in case of specified 
donation). How this aspect can be improved is something that should be further inves-
tigated. We do want donors to be prepared and make an informed decision, but we do 
not want to scare them away by telling them repeatedly that they might die, therefore a 
fine balance has to be found.
Long-term complications were least recalled by donors. Similar findings have been 
reported; Valapour et al.11 demonstrated that 48% of donors in their cohort reported a 
lack of understanding of long-term complications. Timmerman et al. 16 tested donors on 
their general knowledge of live kidney donation using true/false questions, and dem-
onstrated that 32% answered the question about long-term complications incorrectly 
versus 12% for short-term complications. In our cohort, 35% of donors were aware of 
the possibility of long-term complications (versus 91% short-term complications). This 
finding is understandable, since long-term complications were also least mentioned 
by the informers in our study. It is challenging to present long-term risks, since many 
uncertainties and different views exist regarding this matter, and the opinions among 
health care professionals regarding these risks still vary.12, 24-26
We acknowledge that our study has a number of limitations. First, it has to be taken 
into account that our main outcome measure, the pop-quiz score, is not the same as 
actual comprehension of relevant details. It cannot be deducted with certainty if donors 
have actually understood all the given information, or whether they just have the ability 
to remember facts and words. Even if they answer a question correctly (for instance; the 
surgical technique with “laparoscopy”), we cannot check whether they actually compre-
hend the meaning of laparoscopy.
Another major limitation of this study is the use of unvalidated checklists and ques-
tionnaires. We created the pop-quiz ourselves, using information from currently avail-
able literature4 and expertise from our own group of transplant professionals. Although 
validated knowledge tests are available11, 16, these consist mainly of multiple-choice 
questions, and did not suit the purpose of our study. Our goal was to assess what donors 
pick up during the surgical consult, and we wanted them to describe this in their own 
words. The goal of this project was first and foremost to provide an overview of the 
current situation, and we believe that our pop-quiz was the best possible, and most 
detailed way to present this.
The scoring-system was developed alongside the checklist and the questionnaire. 
One point was awarded for each correctly mentioned or reproduced item. Not every 
item is equally important, from a medical viewpoint or from the donor’s perspective. 
Many donors mentioned “fatigue” or “deterioration of physical condition” as a complica-
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tion. We had not included these items in our checklist, and therefore, possibly wrongly, 
no points were awarded. The items on the checklist, and the scoring system will both be 
revised for the nationwide follow-up study. If the questionnaires will be used in a larger 
cohort, in multiple centers, they can eventually be validated, and more evidence-based 
conclusion can be drawn from the scores.
Our results demonstrated marked variations between information provided by trans-
plant professionals, and important complications were not always disclosed. Overall 
donor knowledge scores were low, and none of the donors could recall all provided in-
formation, but overall satisfaction with the informed consent procedure was high. These 
findings imply that donor knowledge might not be solely dependent on the information 
we provide (during the surgical consult), and that more knowledge does not necessarily 
improve donor satisfaction.
Still, satisfaction alone should not be enough to justify the procedure. Since it is not a 
medical necessity for the donor, for them not to be fully informed does not seem accept-
able. And even though most donors report a positive experience, the contrary is true for 
a minority. We believe that even one negative experience is one too many, especially if 
this could have been prevented by better information provision. Before we can speculate 
on how we can further improve the informed consent procedure, additional information 
is needed. A nationwide study covering all aspects of the informed consent procedure 
for live donor nephrectomy has been initiated.27 This will give us more insight on donors’ 
needs and wishes, and will assist us in creating a standardized, uniform informed con-
sent procedure to further optimize living kidney donor education.
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supplementary table 1. informer score per consult, compared between types of medical 
professional (mean, sd), maximum score indicated between brackets
attending surgeon
(n=4, 18 consults)
fellow
(n=3,
22 consults)
nurse
(n=2,
6 consults)
p-valuea
Overall score (max 20)
Technique (max 4)
Short term complications (max 9)
Long term complications (max 5)
Duration of admission (max 1)
Duration of convalescence (max 1)
14.7 (4.6)
3.6 (0.6)
6.6 (2.2)
2.7 (2.1)
0.9 (0.2)
00.2)
11.I1 (2.2)
3.4 (0.6)
5.7 (1.5)
0.6 (1.0)
1.0 (.02)
0.5 (0.5)
10.8 (1.0)
3.5 (0.5)
6.0 (0.6)
0.2 (0.4)
0.7 (0.5)
0.5 (0.5)
0.003
0.42
0.29
<0.001
0.07
0.008
SD – Standard Deviation; max – maximum score
a. P-values are calculated for mean scores, using the One-Way ANOVA
supplementary table 2. donor scores per group of medical professional (mean, sd), maximum 
scores per item indicated between brackets.
attending surgeon 
(n=18)a
fellow
(n=22)a
nurse
(n=6)a
p-valueb
outpatient score
Overall score (max 20)
 Technique (max 4)
 Short term complications (max 9)
 Long term complications (max 5)
 Duration of admission (max 1)
 Duration of convalescence (max 1)
6.4 (2.3)
1.4 (1.1)
2.5 (1.4)
0.6 (0.7)
1.0 (0.1)
0.9 (0.2)
5.0 (2.5)
1.0 (0.9)
1.9 (1.6)
0.3 (0.6)
0.8 (0.4)
0.9 (0.3)
7.7 (1.8)
1.7 (0.8)
3.8 (1.2)
0.2 (0.4)
1.0 (0.0)
1.0 (0.0)
0.03
0.3
0.02
0.35
0.08
0.44
admission score
Overall score (max 20)
 Technique (max 4)
 Short term complications (max 9)
 Long term complications (max 5)
 Duration of admission (max 1)
 Duration of convalescence (max 1)
5.6 (1.7)
1.6 (1.0)
2.0 (0.7)
0.1 (0.4)
0.9 (0.3)
0.9 (0.3)
5.1 (2.2)
1.3 (1.0)
1.6 (1.2)
0.4 (0.6)
0.9 (0.3)
0.9 (0.3)
7.5 (2.7)
2.3 (0.5)
3.0 (2.1)
0.9 (0.5)
1.0 (0.0)
0.8 (0.4)
0.07
0.1
0.06
0.46
0.82
0.82
a. Number of consults performed by this type of informer
b. P-values are calculated for mean scores, using One-Way ANOVA
Donor knowledge & satisfaction - PILOT
117
supplementary table 3. donor scores per group of medical professional (mean, sd), maximum scores per 
item indicated between brackets.
consultant 
(n=18)a
fellow
(n=22)a
nurse
(n=6)a
p-valueb
outpatient score
Overall score (max 20)
 Technique (max 4)
 Short term complications (max 9)
 Long term complications (max 5)
 Duration of admission (max 1)
 Duration of convalescence (max 1)
6.4 (2.3)
1.4 (1.1)
2.5 (1.4)
0.6 (0.7)
1.0 (0.1)
0.9 (0.2)
5.0 (2.5)
1.0 (0.9)
1.9 (1.6)
0.3 (0.6)
0.8 (0.4)
0.9 (0.3)
7.7 (1.8)
1.7 (0.8)
3.8 (1.2)
0.2 (0.4)
1.0 (0.0)
1.0 (0.0)
0.03
0.3
0.02
0.35
0.08
0.44
admission score
Overall score (max 20)
 Technique (max 4)
 Short term complications (max 9)
 Long term complications (max 5)
 Duration of admission (max 1)
 Duration of convalescence (max 1)
5.6 (1.7)
1.6 (1.0)
2.0 (0.7)
0.1 (0.4)
0.9 (0.3)
0.9 (0.3)
5.1 (2.2)
1.3 (1.0)
1.6 (1.2)
0.4 (0.6)
0.9 (0.3)
0.9 (0.3)
7.5 (2.7)
2.3 (0.5)
3.0 (2.1)
0.9 (0.5)
1.0 (0.0)
0.8 (0.4)
0.07
0.1
0.06
0.46
0.82
0.82
a. Number of consults performed by this type of informer
b. P-values are calculated for mean scores, using One-Way ANOVA
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appendix i - cHecKList outpatient cLinic
Study number:  
Initials:   
Date:   
Consult led by:  
Name:   
 Surgeon (consultant/attending)   Surgical Fellow   Resident   Specialized Nurse/
 Nurse Practitioner
checklist
1. surgical technique
Discussed  Yes   No
Side   Left   Right   Why?
Details   Laparoscopy  Robot   Open   Conversion
 
 
 
 
 
 
2. short term complications
Discussed  Yes   No
Details   Bleeding
   Infection      UTI      Pneumonia      Woundinfection / abscess
   Damage to other organs
   Pain
   Thromboembolic complications
   Cardiovascular complications
   Death
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3. Long term complications
Discussed  Yes   No
Details   Chronic pain
   Incisional hernia
   Hypertension/ cardiovascular complications
   Kidney failure
   Risks of living with one kidney (smoking, NSAIDS, etc)  
 
 
 
 
4. duration of admission
Discussed  Yes   No
Details  Stated duration:  
 
 
 
 
5. duration of convalescence
Discussed  Yes   No
Details  Stated duration:  
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appendix ii - prince – piLot – pop-quiZ – enGLisH transLation
1.   How well, on a scale of 1 – 10, do you feel to be prepared for the surgery 
and the convalescence period?
 (1 is absolutely not prepared and 10 = couldn’t have been prepared any better)
1 2 3 4 5 6 7 8 9 10
2.   How would you describe, in your own words, the technical procedure of 
the operation?
 
 
 
 
 How did you learn this information?
  Explained by surgeon
  Explained by nephrologist
  Explained by nurse/transplant coordinator
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
3.  which short-term problems and complications can occur?
 Please write down all answers you can think of
 
 
 
 
 How did you learn this information?
  Explained by surgeon
  Explained by nephrologist
  Explained by nurse/transplant coordinator
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
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4. which long-term problems and complications can occur?
 Please write down all answers you can think of
 
 
 
 
 How did you learn this information?
  Explained by surgeon
  Explained by nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
5. How long do you expect to be admitted in the hospital?
 
 
 
 
 How did you learn this information?
	  Explained by surgeon
	  Explained by nephrologist
	  Explained by nurse/transplant coordinator
	  Explained by family/friends
	  Read in information provided by the hospital
	  Read in information looked up myself
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6.  How long do you expect it will be before you can return to work / perform 
your normal daily activities?
 Please strikethrough as appropriate
 
 
 
 
 How did you learn this information? (Please choose all answers that apply)
	  Explained by surgeon
	  Explained by nephrologist
	  Explained by nurse/transplant coordinator
	  Explained by family/friends
	  Read in information provided by the hospital
	  Read in information looked up myself
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abstract
introduction Informed consent is mandatory for every (surgical) procedure, but is even 
more important when it comes to living kidney donors, undergoing surgery for the 
benefit of others. Donor education, leading to informed consent, needs to be carried out 
according to certain standards. Informed consent procedures for live donor nephrec-
tomy vary per center, even per individual healthcare professional. By assessing what 
information donors need to hear to prepare them for the operation and convalescence, 
the basis for a standardized, uniform surgical informed consent procedure for live donor 
nephrectomy can be created.
methods and analysis The PRINCE project is a prospective, multicenter cohort study, to 
be carried out in all eight Dutch kidney transplant centers. Donor knowledge of the pro-
cedure and postoperative course will be evaluated by means of pop quizzes. A baseline 
cohort (prior to receiving any information from a member of the transplant team in one 
of the transplant centers) will be compared to a control group, who receive the pop quiz 
on the day of admission for donor nephrectomy. Donor satisfaction will be evaluated for 
the last group. The primary endpoint is donor knowledge. In addition, those elements 
that have to be included in the standardized format informed consent procedure will 
be identified. Secondary endpoints are donor satisfaction, current informed consent 
practices in the different centers (e.g. how many visits, which personnel, what kind of 
information is disclosed, in which format, etc), and correlation of donor knowledge with 
surgeons’ estimation thereof.
ethics and dissemination Approval for this study was obtained from the medical ethi-
cal committee of the Erasmus MC, University Medical Center, Rotterdam, February 18th 
2015. Secondary approval has been obtained from the local ethics committees in six 
participating centers. Approval in the last center has been requested. Results will be 
published in a scientific journal.
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introduction
The Netherlands have a high rate of live kidney donation (31 living donors per million 
of population1), with more than half of all kidney transplants involving a living donor. 
In 2014, 534 live donor nephrectomies were performed out of a total of 1004 kidney 
transplantations (53.2%)2. One of the most successful paired kidney exchange (PKE) 
programs have been created in the Netherlands3, 4, and many trials assessing the surgical 
procedure for the live donor nephrectomy have been initiated here5-8. With very low 
complication and mortality rates, live donor nephrectomy is a safe, low-risk elective 
surgical procedure. In contrast to patients, living donors are (generally) healthy indi-
viduals, from whom an organ is removed foremost for the benefit of others, although 
donors may gain psychological benefit. It is of the utmost importance that any patient 
is correctly informed about the specific details, risks and alternatives of a procedure, 
but the unique character of the live donor nephrectomy may warrant an extra vigilant 
approach to the informed consent process. Informed consent practices and procedures 
vary per center, and even per individual health care professional9. Standardization of 
this procedure, with regard to format, and contents, will greatly aid the transplant com-
munity, and improve the quality of care for living kidney donors10, 11.
The need for a standardized format, ensuring disclosure of all important details and 
risks, further increases since extended criteria donors (e.g. overweight/obese donors, 
older donors, donors with hypertension and/or vascular multiplicity/anomalies) are 
increasingly being accepted12. These individuals could be more prone to complications, 
and potential donors must be well aware of the risks involved with their upcoming pro-
cedure, as well as future perspectives with only one kidney. These donors go through 
numerous steps during the informed consent procedure. In most Dutch centers, they 
are first seen by a nephrologist, transplant coordinator or nurse practitioner, who pro-
vide a lot of information about the donation procedure. In addition, most are evaluated 
by a social worker and some by a psychologist. The last person in the chain of infor-
mation provision is usually the surgeon, who is responsible for performing the donor 
nephrectomy. In addition, the relevance of uniform information provision is underlined 
by paired exchange procedures, which are more frequently employed these days. It is 
not uncommon in the Netherlands that donors receive their education/information 
in one center but surgery in another. They may receive different information in these 
centers, which may be confusing. The Dutch situation is herein quite unique and stands 
in contrast to PKE programs in some other countries where the donor and recipient 
both remain in their own centers but the donor organ is transported3, 4. It is therefore 
mandatory that the Dutch transplant centers adopt a standardized, uniform informed 
consent procedure. But even if donors do not travel between centers, as is the case in 
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many other countries, medical professionals as well as donors will still benefit greatly 
from a standardized format.
The question remains what this standardized format should comprise. The living do-
nor nephrectomy itself has become fully implemented in the general practice and much 
more information has become available regarding outcome and possible peri- and post-
operative complications (Kortram et al., submitted). Due to these developments living 
kidney donation has gained ground over the past decades, and numbers are increasing 
worldwide. This merits a revisited opinion on information disclosure and consent. Al-
though the informed consent process has evolved alongside the surgical procedure in 
an attempt to incorporate the most up to date knowledge and transfer it to potential 
donors in an understandable fashion, it has yet to be brought to perfection9.
Every physician, ethicist or legalist will agree that a person giving consent should 
be “fully informed”, “free of coercion” and “competent”13, but there is no consensus on 
details to be provided during the process, nor the manner in which these should be 
delivered. There are many different policies and guidelines outlining matters that should 
be disclosed to potential donors, but details are often not specified14, 15. These differences 
make it impossible for healthcare professionals to practice a uniform strategy and it is 
challenging to determine which patient has received which information. Recent data 
demonstrate that when tested on their knowledge, a large number of living kidney do-
nors underestimate the complications and risks of living donor nephrectomy16. Surman 
et al. published similar findings in renal and liver transplant patients, revealing significant 
conceptual limitations to their knowledge about their postoperative situation, underlin-
ing the importance of adequate preoperative education17. Recently, a study performed 
by Gordon et al. was published regarding informed consent in living liver donors, again 
demonstrating that a large number of donors report a lack of understanding of the 
provided information (40%)18. Comparable results are demonstrated in other studies, 
where donors report varying degrees of (dis)satisfaction with and misunderstanding of 
provided information10, 19, 20. The question is raised whether the necessary information 
has not been provided correctly, whether donors simply not understand or remember 
it, or, as has been proposed by some, whether they selectively filter information and thus 
miss particular risks associated with donation21-23. Standardizing the informed consent 
procedure will help us better understand and address this. Two studies have been per-
formed preceding the initiation of the PRINCE project of which the protocol is described 
in this article. One pilot project, to assess feasibility and design details, and a survey 
among Dutch kidney transplant surgeons to assess the current situation regarding live 
donor nephrectomy and informed consent practices in the Netherlands. These studies 
will be briefly highlighted in the following paragraph.
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pilot study
A pilot study was performed (Kortram et al, submitted), preoperative surgical outpatient 
clinic visits of 46 potential living kidney donors were observed and provided informa-
tion was scored. Immediately after giving consent for donor nephrectomy, and again 
on the day of admission for the operation, donors received a questionnaire testing 
their knowledge of the upcoming operation. They received an evaluation questionnaire 
regarding their satisfaction with and understanding of the informed consent procedure 
6-12 weeks postoperatively. After completion of the pilot study, pop quiz questions 
were rephrased where necessary, and the scoring system was adjusted.
survey
A web-based survey was created to assess the current situation in the eight Dutch trans-
plant centers24. All surgeons who were possibly involved, or had been so in the past, in 
live kidney donation were invited to complete the survey (n=50). The response rate was 
98% (N=49, of which 32 were still active in living donor education). Respondents were 
asked which complications they discussed with potential donors during the informed 
consent process for live donor nephrectomy. Important complications were not always 
disclosed: bleeding was the only complication every surgeon mentioned. Risk of death 
was always mentioned by 16 surgeons (50%), sometimes by 12 (37.5%), and four sur-
geons (12.5%) never disclosed this disastrous complication. Thus, some improvements 
can be made regarding information provision.
metHods and anaLysis
design
The PRINCE (Process of Informed Consent Evaluation) Inventory project is designed as a 
prospective, multicenter cohort study. The study is conducted in the eight Dutch kidney 
transplant centers, which are all University Medical Centers (to which transplantation is 
confined).
The study is divided into two parts: a cross-sectional study (Cohorts 1 & 3) and a 
longitudinal study (Cohort 2). Both parts are prospective studies. Figure 1 presents a 
schematic overview of the different cohorts.
The cross-sectional study comprises pop-quizzing two cohorts of donors at different 
stages during the pre-donation period. The cross-sectional design is chosen to include 
as many donors as possible. Cohort 1 will be included when the potential donors first 
present themselves to the hospital, at the outpatient nephrology clinic, prior to having 
spoken to any member of the transplant team. The second group will be included one 
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day preoperatively on admission for donor nephrectomy (Cohort 3). These donors will 
have received all information possible from diff erent members of the transplant team.
Both groups of donors will be asked to fi ll out a pop quiz regarding their knowledge 
of the donor nephrectomy procedure, the possible short- and long-term complications 
and details about hospital admission and convalescence (Appendix 1 – supplementary 
material). The second group of donors will receive an additional questionnaire three 
months after surgery to assess their satisfaction with the educational- and informed 
consent procedure retrospectively.
 The donors included in the longitudinal part of the study, i.e. Cohort 2, will be followed 
more closely to obtain a detailed conception of the informed consent process in the eight 
diff erent centers. The donors that are eligible for inclusion in Cohort 2 are those donors 
already included in Cohort 1, that are being referred to the surgical outpatient clinic. 
This will mainly be infl uenced by their recipient’s status (preemptive, comorbidity etc.), 
and whether the donor has been approved by the nephrologist. The surgical consult 
will be recorded (audio only). These recordings will be analyzed using a standardized 
 
figure 1 - Schematic overview of the three cohorts of the PRINCE study, and the questionnaires/
additional measurements they have to complete
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checklist, to assess which complications and other details are specifically disclosed by 
the surgeon. Donors in this cohort will be asked to fill out the same pop quiz as the first 
cohort, immediately after the surgical consult and again on the day of admission. They 
will also receive the evaluation questionnaire three months after surgery.
objectives
The primary objectives of this inventory project are to assess the current status of the in-
formed consent procedure for the live donor nephrectomy in all Dutch kidney transplant 
centers with regard to the procedure, donor knowledge and satisfaction. The ultimate 
objective is to eventually create a standardized format informed consent procedure.
study population
The study population is divided into three cohorts. Cohort 1 comprises all potential liv-
ing kidney donors that are seen at the outpatient nephrology clinic. Exclusion criteria for 
this cohort are: inability to understand the Dutch language, prior donation education in 
a kidney transplant center, age < 18 years and a mental illness prohibiting informed con-
sent. Cohort 2 is obtained from a sample of referred Cohort 1 donors. The first 10 donors 
in each center that are referred to the surgical outpatient clinic will be included. Cohort 
3 comprises all donors that are admitted to the surgical ward for live donor nephrec-
tomy. This includes those donors that have already been included in cohort 2. Exclusion 
criteria for the latter two cohorts are: inability to understand the Dutch language, age < 
18 years, and a mental illness prohibiting informed consent.
sample size calculation
Since this study is an inventory project, making a comparison of informative findings 
rather than performing one specific measurement, a sample size calculation is not ap-
plicable.
The total number of live donor nephrectomies differs between the eight centers 
(figure 2), and it is therefore unrealistic to set the same goal for every center. But it is 
necessary that all participating centers provide a large enough number of subjects, seen 
by preferably all, but at least a number of different members of the transplant team to 
eliminate, as much as possible, inter-observer and timing-related variations in donor 
education. The following inclusion aims are set: 400 donors for cohort 1 (50 donors in 
each center), 80 for cohort 2 (10 donors in each center) and 200 for cohort 3 (Number of 
donors per center calculated based on procedures performed in 2014).
primary & secondary endpoints
The first main study parameter is donor knowledge of the donation procedure. This 
will be assessed by means of a pop quiz score. Scores will be compared between the 
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different cohorts and/or time-intervals. The elements to be included in the standardized 
informed consent format comprise the second main study parameter. These items will 
be assessed by different means. Obviously, some items will have to be included, based 
on the knowledge we already have from experience and the currently available litera-
ture (Kortram et al., submitted). The audio recordings of the Cohort 2 donors will provide 
us with information about the currently disclosed items in each center. We will try to 
correlate this to donor knowledge of the individual items on our checklist. In addition; 
all Cohort 3 donors receive an evaluation questionnaire in which they are asked whether 
they’ve missed anything during the informational process.
The first secondary study parameter is the manner of obtaining informed consent and 
the contents hereof in the eight Dutch transplant centers. This parameter is a descrip-
tive parameter, which cannot be directly measured. This parameter will be assessed by 
interviews with the (para)medical staff in each transplant center, and by observation on 
site. Some aspects of the process itself will be collected and compared between centers: 
e.g. how many visits (on average) each donor has, the location where donors are seen 
(outpatient clinic, ward), the manner of obtaining consent (assumed, verbal, written), 
and who is responsible for obtaining consent (surgeon, nephrologist). These procedures 
will be compared to create the optimal format for all Dutch centers. In addition, provided 
information material (e.g. only orally distributed, leaflets, DVDs, websites, information 
evenings) will be assessed and compared between centers.
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figure 2 - Number of live donor nephrectomies per center in 2014
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Donor satisfaction will be measured using the visual analogue scale (VAS-score, 0-10) 
in addition to describing questions. The last secondary parameter that will be assessed 
is the correlation between the donor’s knowledge and the surgeon’s estimate thereof. 
Surgeons will be asked to “predict” their donor’s score after the consultation, using a 
0-10 scale, 0 meaning no knowledge whatsoever and 10 meaning perfect reproduction 
of all details. This will be correlated to the donor’s pop quiz scores.
data collection & follow-up
Each donor will receive an anonymous study number, which will be used for the data-
base. All subjects will be asked to fill out one or more, with a maximum of three pop 
quizzes. Donors included in cohort 3 will also be sent an evaluation questionnaire three 
months postoperatively. In addition, every donor is asked to fill out a baseline question-
naire with general questions regarding social economic status, religion and donation 
activities. The random sample of donors that will be followed longitudinally will be 
monitored more closely. The preoperative surgical consult at the outpatient clinic will be 
recorded (audio only), and these consults will be scored using a standardized checklist. 
These donors will receive one additional pop quiz immediately after the surgical consult. 
All other tests and procedures will be according to local protocol for the screening and 
treatment of living kidney donors.
statistical analyses
Statistical analysis will be performed using SPSS version 21 and R version 3.1.2. Di-
chotomous data and counts will be presented in frequencies. Continuous data will be 
presented in means with a standard deviation (SD) or median value with a range. In 
addition, some information will be presented in a literal descriptive fashion (i.e. specific 
answers to the pop-quiz questions).
Differences between scores will be compared by the independent sample t-test, the 
pairwise comparison t-test or One-Way ANOVA. To compare differences in mentioning 
frequencies of individual complications between Cohort 1 and Cohort 3, Chi2 tests will 
be performed. For the donors in Cohort 2 the McNemar test will be performed to com-
pare individual mentioning frequencies at the different time intervals. The McNemar 
test compares the number of those who first scored positive and then negative with the 
number who first scored negative and then positive: if these numbers differ significantly 
from each other an increase or decrease can be concluded. A p-value of <0.05 will be 
considered statistically significant. Multivariate analysis will be performed using linear 
regression. If necessary, bootstrapping will be applied. Stratification will be applied for 
center.
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feasibility
Approval from the medical ethical committee for the PRINCE project was obtained on 
February 8th 2015, and the first donor was included on March 30th 2015. At this moment 
approval of local ethical committees has been obtained in six of seven of the other 
participating centers, and donors are being included in the different cohorts in these 
centers. In the last center, approval from the local ethics committee has been requested.
etHics and dissemination
ethics
Approval for this study was obtained from the medical ethical committee of the Erasmus 
MC, University Medical Center, Rotterdam, The Netherlands, on February 18th 2015. 
Secondary approval has been obtained from six of seven local ethics committees in the 
participating centers, and has been requested in the last. Verbal informed consent will 
be obtained from (potential) donors prior to filling out the questionnaires.
dissemination
Results will be published in a scientific journal, and presented on national and inter-
national (medical) conferences. Data will be used to create a standardized surgical 
informed consent procedure for the live donor nephrectomy.
discussion
Informed consent is mandatory for every (surgical) procedure, but is even more impor-
tant when it comes to living kidney donors, undergoing surgery for the benefit of others. 
Donor education, leading up to informed consent, needs to be carried out according 
to certain standards. According to national guidelines, those complications with an 
incidence of >1% or those with severe consequences need to be disclosed to patients 
(or donors)25. But if we would adhere to that standard, only bleeding, ileus and wound 
infection would have to be mentioned, in addition to the small risk of mortality (Kortram 
et al, meta-analysis, unpublished).
A recent survey study among Dutch kidney transplant surgeons demonstrates that 
even these complications are not always disclosed to donors (Kortram et al, survey, 
unpublished). Moreover, it is questionable whether this information is sufficient for 
potential kidney donors. They are not patients, and they do not directly benefit from 
undergoing this procedure. Every complication is one too many, and donors need 
to be aware of the risks and details of the donation procedure. It is thus argued that 
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donors may need more and/or different information than the three most frequently 
encountered complications to be optimally prepared for donor nephrectomy and the 
postoperative course.
However, it has also been proposed that donors do not use the same decision-making 
strategy that patients use. Instead of carefully weighing all risks and benefits, many 
make their decision upon the first moment of hearing of the possibility, and many never 
change their mind, regardless of the information they receive during the educational 
and informed consent process21, 22, although more recent studies do bring in some nu-
ance26.
So how does the provided information relate to donor knowledge? And how does 
donor knowledge relate to donor satisfaction? After all, even if donor knowledge is lack-
ing, but satisfaction rates are high, is it even necessary to change our current policy? 
There have been a number of studies assessing donors’ knowledge of kidney donation 
and transplantation16, 19, but none of these tests were as specific as the pop quiz to be 
used in the PRINCE project. In addition, donors were only tested at one moment during 
the educational process. During the PRINCE project, donor knowledge will be measured 
before and after information provision in all Dutch transplant centers. The ideal design 
for the present study would be a longitudinal cohort study. To administer the first pop 
quiz at the moment a potential donor first comes to the outpatient nephrology clinic, 
then follow them through their educational course to the surgical outpatient clinic, 
the ward and postoperatively. However, in many cases, the time interval from the first 
donor contact to actual donor nephrectomy exceeds a year, if donor nephrectomy takes 
place at all. Of the 422 potential donors evaluated at our center in 2013, 227 were either 
rejected or decided not to proceed with the donation process themselves. In February 
2015, 136 of the remaining 195 donors had already undergone surgery, and 59 were still 
being evaluated, on the waiting list, or postponed because their recipient’s own kidney 
function was still good enough. Even though these numbers are from one center only, 
they do indicate that a longitudinal cohort, with the preferred sample size would take 
at least two years to complete follow-up. Comparing two different cohorts; a baseline 
group at the outpatient nephrology clinic and a control group on the surgical ward on 
the day of admission may provide us with the same information, especially since it will 
be a nationwide study with a large number of patients. Using a thorough baseline ques-
tionnaire for both groups will enable us to check whether the groups are indeed similar. 
By introducing an additional sample in the longitudinal cohort, with audio recordings 
of the surgical consultations, results of the two other cohorts can be compared to this 
group to verify reliability of the results.
Even though we believe that the current format for the PRINCE project is the best pos-
sible design to assess the informed consent procedure for the live donor nephrectomy, 
a number of limitations are foreseen.
138
Chapter 6    
First of all, there are no validated questionnaires to assess donor knowledge to the 
extent pursued in our study. Validation of a knowledge test with open questions instead 
of multiple- choice is virtually impossible, since donors may learn or forget specific 
information at different time points. Using multiple-choice questions is much easier to 
compare scores, but we believe an open question, requiring an answer in the donor’s 
own words provides more reliable information. This way, we can be sure that they actu-
ally know this information, and not just check the boxes of words that they vaguely 
recall having been told about.
The open questions do again pose as a possible limitation. Donors may misinterpret 
the question, as we have already seen during the PILOT project, in which some answered 
the question about the surgical technique with “good” or “very careful”. In addition, they 
may list one or two complications, and not everything they possibly know.
Last, a good pop-quiz score does not necessarily equal adequate donor comprehen-
sion. Donors may write down “hand-assisted laparoscopic donor nephrectomy” as the 
surgical technique, because they remember the surgeon talking about this, score 2 
points, but have no idea what this actually means. On the other hand, a donor may write 
down “key hole surgery”, score and score only one point, have a far better understanding 
of what is going to happen during the procedure.
Using the chosen approach for the PRINCE project will give us a clear overview of the 
actual gained knowledge during the educational process. In addition, donor satisfaction 
will be evaluated and related to donor knowledge. By assessing what information donors 
need, and want to hear to prepare them for surgery and convalescence, the basis for a 
standardized informed consent procedure for live donor nephrectomy can be created. It 
has to be taken into account that even in a small country as The Netherlands with gener-
ally harmonized protocols, details in local practice vary with regards to hospital logistics, 
but also with regards to the different techniques for live donor nephrectomy employed 
by each center. The standardized format will have to allow for (small) modifications to fit 
the situation in each individual kidney transplant center.
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appendix i - prince – inventory – pop-quiZ – enGLisH transLation
1.  How well, on a scale of 1 – 10, do you feel to be prepared for the surgery 
and the convalescence period?
  Please draw a vertical line on the rectangle below, in which 0 is absolutely not 
prepared and 10 = couldn’t have been any better prepared.
 
STUDIENUMMER: __________  
□
□
□
□
□
□
□
□
 
EXAMPLE 
0                      10
2. what type of surgery will you undergo?
  Think about surgical technique, the number of scars you will get, and where 
these scars will be.
 
 
 
 
 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
3. which short-term problems and complications can occur?
 Please write down all answers you can think of
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 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
4. which long-term problems and complications can occur?
 Please write down all answers you can think of
 
 
 
 
 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
5. How many days do you expect to be admitted in the hospital?
 Please write down the total number of days, before ánd after the surgery
 
 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
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6.  How long do you expect it will be before you can perform your work / your 
normal daily activities?
 Please strikethrough as appropriate
     Weeks/ Months
 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
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abstract
introduction Informed consent is mandatory for every (surgical) procedure, but is 
even more important when it comes to living kidney donors, undergoing surgery for 
the benefit of others. Donor education, leading to informed consent, needs to be car-
ried out according to certain standards. Informed consent procedures for live donor 
nephrectomy vary per center, even per individual healthcare professional. By assessing 
the information donors need to know, to prepare them for the operation and convales-
cence, the basis for a standardized, uniform surgical informed consent procedure for live 
donor nephrectomy can be created.
methods Donor knowledge of the procedure and postoperative course was prospec-
tively evaluated by means of pop quizzes in a multicenter national study. All potential 
donors who were seen for the first time at the transplant nephrology outpatient clinic 
(Cohort A) completed a pop-quiz about the details of the donation procedure, prior to 
receiving any information. A second group of donors completed the same pop-quiz 
on the day of admission for donor nephrectomy (Cohort B). The primary endpoint was 
donor knowledge. Secondary endpoints were donor satisfaction, and current informed 
consent practices in the different centers.
results A total of 604 pop-quizzes were completed; 378 in Cohort A and 226 in Cohort 
B. Average donor score was 6.9 out of 25 (±3.9, range 0-18) in Cohort A and 10.4 (±2.8, 
range 0-17.5) in Cohort B. Donors generally scored best on duration of admission and 
convalescence, and worst on long-term complications. Younger donors, donors with 
a higher educational level and those who were registered as deceased donors scored 
higher in Cohort A, , only donors who were registered as deceased donors scored higher 
in Cohort B. Donors felt relatively well prepared for surgery after receiving all informa-
tion: 8.3 (±1.3) out of 10, and average postoperative satisfaction with the informed 
consent procedure was 8.1 out of 10 (±1.6, range 0.6-10)).
conclusion Donor knowledge of the procedure and postoperative course improves 
during the informed consent process but is still low. Long-term complications deserve 
more attention during the preoperative educational process of living kidney donors. 
Incentives to standardize the informed consent procedure will further improve donor 
knowledge and satisfaction, and will benefit consult efficiency at the outpatient clinic.
Donor knowledge & satisfaction – Inventory
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introduction
Informed consent has been a topic of great interest in the surgical community. Although 
the idea of informed consent dates back many decades, it is becoming increasingly 
important in the current daily practice, in which shared decision-making and patient-
tailored healthcare- and education are gaining in popularity1.
It is of the utmost importance that any patient is correctly informed about the specific 
details, risks and alternatives of a procedure. First, to make a balanced decision whether 
or not to undergo this procedure, second to prepare them for the procedure itself, 
and the postoperative course. Living donors are (generally) healthy individuals, from 
whom an organ is removed foremost for the benefit of others, although they may gain 
psychosocial benefit. The unique character of the live donor nephrectomy may warrant 
an extra vigilant approach to the informed consent process. Previous research demon-
strates variations in informed consent practices and procedures per country, but also 
per center, and even per individual health care professional2, 3.
Every medical professional, ethicist or legalist will agree that a person giving consent 
should be “fully informed”, “free of coercion” and “competent” 4, but there is no consen-
sus on details to be provided during the process, nor the manner in which these should 
be delivered. There are many different policies and guidelines outlining matters that 
should be disclosed to potential donors, but details are often not specified, and vary per 
guideline 5-9. In addition, any conversation with a donor will be a momentary display of 
the medical professional’s routine, and with each consult, they will make an estimation 
as to how this particular donor should best be informed. These differences make it im-
possible for healthcare professionals to practice a uniform strategy and it is challenging 
to determine which donor has received which information.
Recent data demonstrate that when tested on their knowledge, a large number of 
living kidney donors underestimate the complications and risks of living donor nephrec-
tomy10. Surman et al. published similar findings in renal and liver transplant recipients, 
revealing significant conceptual limitations to their knowledge about their postopera-
tive situation, thereby underlining the importance of adequate preoperative education 
11. Recently, a study performed by Gordon et al. was published regarding informed 
consent in living liver donors, again demonstrating that quite a proportion of donors 
report a lack of understanding of the provided information (40%)12. Comparable results 
are demonstrated in other studies, where donors report varying degrees of (dis)satis-
faction with and misunderstanding of provided information13-15. The question is raised 
whether the necessary information has not been provided correctly, whether donors 
simply not understand or remember it, or, as has been proposed by some, whether 
they selectively filter information and may miss particular risks associated with dona-
tion16-18. Standardization of the informed consent procedure, with regard to format and 
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contents will greatly aid the transplant community, and improve the quality of care for 
living kidney donors 13, 19. Standardization however should not eliminate the possibil-
ity for donor-tailored education, thus the format should be a guideline with room for 
individual adjustments, rather than a strict law.
The question remains what this standardized format should encompass. The living 
donor nephrectomy itself has become fully implemented in transplant programs, and 
much more information has become available regarding possible peri- and postopera-
tive complications20, 21 and long-term outcome. Surgeons tend to disclose fewer long-
term then short-term outcomes3, and donor knowledge regarding long-term outcomes 
has been demonstrated to contain deficits 10, 14. Recent studies have demonstrated that 
long-term follow-up is absolutely necessary to detect, and possibly prevent, severe 
consequences. For one, it is suggested that in specific populations, the risk of ESRD is 
indeed significantly increased after donation22-24. Other long term risks, like cardiovas-
cular disease and gestational hypertension have recently received more attention, and 
more detailed information on these risks may have to be incorporated in the informed 
consent procedure for the live donor nephrectomy25, 26.
All this merits a revisited opinion on information disclosure and consent. Although the 
informed consent process has evolved alongside the surgical procedure in an attempt to 
incorporate the most up to date knowledge and transfer it to potential donors in an un-
derstandable fashion, it has yet to be brought to perfection2, 13. In a single center PILOT 
study preceding the present study, 46 donors were tested on their knowledge of the live 
donor nephrectomy and postoperative course (Kortram et al., unpublished). Knowledge 
scores were low, regardless of which, or how many details had been disclosed to them 
by the health care professional. This originated a fear that donors may not be informed 
sufficiently at the time of giving consent, a conclusion that had also been drawn by 
other authors in the past13, 27-30.
The objectives of this inventory project are to assess the current status of the informed 
consent procedure for the live donor nephrectomy in all Dutch kidney transplant cen-
ters with regard to the procedure, donor knowledge, and satisfaction. The goal is to 
eventually create a standardized format informed consent procedure, which will in turn 
help the transplant professional to provide adequate, donor-tailored information.
metHods
Approval for the study was obtained from the Medical Ethics Committee (MEC) of the 
Erasmus MC University Medical Center, Rotterdam, The Netherlands, on February 18th 
2015. Secondary approval was obtained from the MECs of the other seven participating 
centers. Potential donors were included between March 2015 – July 2016. The study is a 
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prospective, multicenter, observational study, conducted in all Dutch kidney transplant 
centers, which are all University Medical Centers. The detailed study protocol has been 
previously published31. This article reports on the two main cohorts of the study (Cohort 
s1 and 3 in the protocol).
The first group consists of potential living kidney donors  prior to their first visit to the 
nephrology outpatient clinic (Cohort A), the second entails a group of donors on the 
day of admission for donor nephrectomy (Cohort B). To ensure that the sample in each 
cohort portrays an adequate reflection of the general population, minimum sample sizes 
were calculated as follows: Cohort A – 50 donors per center, thus 400 donors, Cohort 
B – a set number of donors per center, based on each center’s volume in 2014, making for 
a minimum total of 200 donors (details described in the protocol31). Due to the duration 
of the inclusion period, some donors from Cohort A could also be included in Cohort B.
After obtaining informed consent for participation in the study, a potential donor was 
asked to complete a baseline questionnaire and a pop quiz. The baseline questionnaire 
consisted of questions regarding gender, relationship to the recipient32, education, employ-
ment, religion, household constitution and donation activities. The pop-quiz consisted of 
five open questions regarding surgical technique, complications, duration of admission 
and duration of convalescence (Appendix I – Supplementary material). In addition, donors 
were asked to indicate how well they felt to be prepared for the donation procedure by 
means of a visual analogue scale (VAS). A scoring system was developed to calculate the 
pop-quiz score. A maximum of five points were awarded for each of the five sections. All 
Cohort B donors received an evaluation and satisfaction questionnaire three months post-
operatively. If no response was obtained, a reminder was sent after another three months.
The primary outcome of this study was donor knowledge, measured by their pop-quiz 
scores. The secondary outcomes were the manner of obtaining consent for donor ne-
phrectomy in the different transplant centers and donor satisfaction with this procedure.
statistical analysis
Statistical analysis was performed using SPSS version 21 and R version 3.1.2. Dichoto-
mous data and counts are presented in frequencies. Continuous data are presented in 
means and standard deviation (SD) or median value and range.
Differences between scores and preparation values were compared by the indepen-
dent sample t-test, the pairwise comparison t-test or One-Way ANOVA. To compare 
differences in mentioning frequencies of individual complications between Cohort A 
and Cohort B, Chi2 tests were performed. To correct for overlapping donors, linear mixed 
effect models were used, to account for the correlation between the donors present in 
both Cohorts. Missing values were imputed using single imputation.
Additional McNemar tests were performed for the overlapping donors in both Co-
horts, to compare individual mentioning frequencies at the different time intervals. The 
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McNemar test compares the number of those who first scored positive (i.e. mentioned 
that specific complication) and then negative (i.e. did not mention that specific compli-
cation) with the number who first scored negative and then positive: if these numbers 
differ significantly from each other an increase or decrease can be concluded. A p-value 
of <0.05 was considered statistically significant. Multivariate analysis was performed 
to assess whether donor scores were influenced by specific characteristics. Linear 
regression was used. Every factor with a univariate p-value <0.1 was included in the 
multivariate model. To investigate potential differences between centers, center-specific 
estimates of the multivariable model were assessed.
informed consent procedure per center
The local situation in the eight participating centers varies, with regards to the donor 
nephrectomy itself, but also with regards to the specific set-up of the informed consent 
procedure. Table 1 provides an overview of the local preferences for each center.
resuLts
donors
A total of 604 pop-quizzes were completed. 378 Living kidney donors were included in 
Cohort A, and 226 in Cohort B. 29 Donors from Cohort A were also included in Cohort B, 
and completed the pop-quiz at both time intervals. Table 2 provides an overview of the 
baseline characteristics of each Cohort.
preparation for the donation procedure
Donors in Cohort A did not feel very well prepared yet; 5.6 (±2.5) out of 10. Donors in 
Cohort B, having received all possible information, reported a better feeling of prepara-
tion: 8.3 (±1.3) (p<0.001).
pop-quiz scores
Table 3 presents an overview of scores per cohort and per sub-division.
Cohort A
Mean overall score for Cohort A donors, prior to the first visit at the nephrology outpa-
tient clinic, was 6.9 (±3.9, range 0-18). Donors scored best on convalescence, and worst 
on long-term complications (table 3.)
Short-term complications: fatigue was mentioned most by donors in Cohort A (n=127, 
34%), followed by pain (n=70, 18%), infections (n=69, 18%) and wound infection (n=60, 
16%). The risk of death was mentioned by 19 donors (5%). Mentioning frequencies of all 
Donor knowledge & satisfaction – Inventory
153
table 1. Differences in techniques, information provision and informed consent procedures per center.
employed 
techniques
set-up preoperative visits & information informed consent
how/when/by whom
center 1 LD, Mini-open Consult with TC.
If approved: consult with nephrologist and surgeon 
on the same day (2-8 weeks prior to procedure)
Signed
Prior to screening
TC
center 2 HAL Consult with TC, nephrologist. If wish to continue: 
discussion in multidisciplinary meeting with surgeon.
If approved, last information from surgeon at the 
clinic (1-2 weeks prior to surgery) or on day of 
admission
Signed
Prior to screening
TC
center 3 LD, Mini-open Consult with SN (If unspecified donor: also consult 
psychiatrist)
Screening tests and consult social worker.
If approved, joint clinic consult with nephrologist and 
surgeon.
Signed
After screening and all 
consults
TC
center 4 LD, HARP, Robot Consult with nephrologist, then consult TC
If approved: consult with surgeon at outpatient clinic
On day of admission: last information from surgeon & 
SN on the ward
Signed
Prior to surgical consult
Nephrologist
center 5 HARP Consult with SN, then consult with nephrologist.
Two weeks prior to surgery consult with surgeon
Signed
Prior to surgical consult
Nephrologist
(Surgeon documents 
informed consent in EPF)
center 6 HAL, HARP First consult with TC
If donor wishes to continue: Two-day program, 
with screening tests and consult social worker, then 
nephrologist, SN, and surgeon in random order.
One month prior to surgery consult with TC
Last information from surgeon and TC on day of 
admission
Signed
Prior to screening
TC
center 7 LD, HAL, HARP First visit with TC, then consult with nephrologist, 
then with surgeon
Signed
Prior to surgical consult
Nephrologist
center 8 Mini-open Work up by SN, approved by nephrologist,
6-4 months prior to surgery consult with surgeon
Explicitly asked
SN
(Surgeon documents 
informed consent in EPF)
LD – laparoscopic donor nephrectomy; TC – Transplant coordinator; HAL – Hand-assisted laparoscopic; 
HARP – Hand-assisted retroperitoneoscopic; SN – Specialized nurse; EPF – Electronic Patient File
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table 2. Baseline characteristics of all (potential) living kidney donors included in this studied, specified 
for the two cohorts (percentages between brackets unless otherwise defined).a
cohort a
n=378
 cohort b
n=226
p-value
Gender (M:F) 157:219 (41.8:58.2) 102:124 (45.1:54.9) 0.45
age (mean, SD) 53.1 (12.5) 54.1 (12.1) 0.36
type of donation[32]
 Unspecified
 Specified
 Unknown
55 (14.6)
314 (83.1)
9 (2.3)
45 (19.9)
179 (79.2)
2 (0.8)
0.11
educational levelb
 Lower
 Higher
257 (68)
118 (32)
166 (73.5)
60 (26.5)
0.23
current employment
 Yes
 No
 Retired
232 (61.4)
67 (17.7)
76 (20.1)
137 (60.6)
37 (16.4)
52 (23)
0.90
income
 Below average
 Average
 Above average
88 (23.3)
214 (56.6)
58 (15.3)
46 (20.4)
128 (56.6)
40 (17.7)
0.59
religion
 None
 Catholicism
 Protestantism
 Islam
 Buddhism
 Hinduism 
 Other
178 (47.1)
88 (23.3)
64 (16.9)
16 (4.2)
1 (0.3)
5 (1.3)
22 (5.8)
108 (47.8)
60 (26.5)
33 (14.6)
8 (3.5)
3 (1.3)
3 (1.3)
9 (4.0)
0.59
Household constitution
 Alone
 With children <18
 Without children <18
76 (20.1)
73 (19.3)
223 (59.0)
39 (17.3)
47 (20.8)
139 (61.5)
0.53
registered donors
 Yes
 No
227 (60.1)
149 (39.4)
131 (58.0)
93 (24.6)
0.36
a. Not every donor completed every question, total numbers may not add up to 378/226 for each item
b. Lower: none or primary school, high school or secondary vocational education, higher: university of 
applied sciences or university
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complications are displayed in table 4. Aside from those complications included in the 
scoring system, donors mentioned additional problems that could occur. Nausea/vomit-
ing, and constipation were stated a number of times, as were emotional/psychological 
problems and problems with the recipient of the kidney. All additional complications 
mentioned are bundled in supplementary table 1.
Long-term complications: The eventual risk on developing end-stage renal disease 
was described by 62 Cohort A donors (16%). Other long-term complications were only 
mentioned incidentally (table 4).
Cohort B
Mean overall donor score for Cohort B donors, on the day of admission for donor ne-
phrectomy, was 10.4 (±2.8, range 0-17.5). Cohort B donors scored best on duration of 
admission, and again, worst on long-term complications (table 3).
Short-term complications: the order of most frequently mentioned complications 
remained the same, with the exception of infections overall, which was bypassed by 
bleeding. Each complication was mentioned more often than in Cohort A: fatigue (n=98, 
43%), pain (n=70, 31%), bleeding (n=67, 30%). The risk of mortality was mentioned by 
29 donors (13%) (table 4). Nausea was again often mentioned as an additional complica-
tion, as were emotional problems (supplementary table 1).
Long-term complications: the risk of renal failure was the most frequently mentioned 
long-term event, however, it was mentioned somewhat less often than at the clinic: 
n=32, 14%. The other complications were again only mentioned sporadically (table 4).
The average overall Cohort B score was significantly higher than the average Cohort 
A score (p<0.0001, table 3). This was also true for each of the individual item scores with 
the exception of long-term complications: average score was 0.2 for the outpatient as 
well as the admission Cohort (table 3).
table 3. Pop-quiz scores and item scores for donors in the two cohorts (mean, SD). Maximum overall 
score is 25 points, 5 points for each item score.
cohort a
n=378
cohort b
n=226
p-value
overall score
 Surgical techniquea
 Short-term complicationsa
 Long-term complicationsa
 Admissiona
 Convalescencea
6.9 (3.9)
0.6 (1.0)
0.6 (0.8)
0.2 (0.4)
2.5 (1.7)
2.9 (1.6)
10.4 (2.8)
2.2 (1.2)
1.0 (0.9)
0.2 (0.4)
3.6 (0.9)
3.4 (1.2)
<0.0001
<0.0001
<0.0001
0.73
<0.0001
<0.0001
a. For the item scores, the 29 overlapping donors were excluded from the analysis, and p-values were 
calculated using the independent samples t-test. The subscores are thus calculated for 349 versus 197 
donors.
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Overlapping donors
Donors who were included in Cohort A and Cohort B (n=29) scored, overall, significantly 
better the second time they completed the pop-quiz, on the day of admission for donor 
nephrectomy: 10.4 (±3.0) versus 8.6 (±3.3). However, six donors actually scored worse 
on admission than at the outpatient clinic, with a mean difference of 3.38 (±2.05, range 
0.75-6). This decrease was seen in all individual item scores. The risk of eventual ESRD 
was the only individual item that was mentioned significantly more often on admission 
than prior to the first outpatient consult: 29.6% versus 7.4% of donors recalled this risk 
on the Cohort B pop-quiz. Supplementary table 2 provides an overview of all individual 
complications, and their mentioning frequencies for the longitudinal Cohort.
Score Correlation
There was some variation in the baseline scores (Cohort A) per center. Scores ranged from 
6.4 (±3.1) in the lowest scoring center to 8.5 (±2.2) in the highest scoring center (overall 
p=0.01). Center volume (i.e. the number of donor nephrectomies performed per year) 
did not influence donor score. Younger donors scored better than older donors (p=0.02), 
table 4. Mentioning frequencies of the individual complications, per cohort. Percentages between 
brackets.
cohort a
n=378
cohort b
n=226
p-value
short-term complications
 Bleeding
 Wound infection
 Infection (NOS)
 Pain
 Fatigue
 Death
 Urinary tract infection
 Pneumonia
 Damage to other organs
 Thrombosis
 Cardiovascular complications
 Testicular complaints
 Neuropathy/neurapraxia
45 (11.9)
60 (15.9)
69 (18.3)
70 (18.5)
127 (33.6)
19 (5.0)
24 (6.3)
30 (7.9)
3 (0.8)
35 (9.3)
2 (0.5)
0
4 (1.1)
67 (29.6)
63 (27.9)
50 (22.1)
70 (31)
98 (43.4)
29 (12.8)
33 (14.6)
32 (14.2)
1 (0.4)
27 (11.9)
2 (0.9)
3 (2.9)a
5 (2.3)
0.047
0.007
0.637
<0.001
0.157
0.924
0.053
0.200
0.922
0.930
0.685
NAb
0.207
Long-term complications
 Chronic pain
 Incisional hernia
 ESRD
 Hypertension
 Medication (NSAIDs, AB)
11 (2.9)
4 (1.1)
62 (16.4)
8 (2.1)
1 (0.3)
6 (2.7)
4 (1.8)
32 (14.2)
12 (5.3)
3 (1.3)
0.666
0.925
0.281
0.076
0.834
NOS – not otherwise specified, ESRD – End Stage Renal Disease, NSAIDs – non steroidal anti-inflammatory 
drugs, AB – antibiotics; NA – Not applicable
a. Since testicular complaints is a relevant complication only in male donors, the relevant percentage is 
2.9% (3 out of 102 males in Cohort B) instead of 1.3% for the whole group of 226 donors
b. Because none of the Cohort A donors reported this complication, a p-value could not be computed 
using the generalized linear model
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as did donors with a higher educational level: 8.1 (±3.3) versus 6.4 (±4.0, (p<0.0001), 
and donors who were currently employed: 7.3 (±3.8) versus 5.4 (±3.9) for unemployed 
donors and 6.0 (±4.0) for retired donors, p=0.005. However, after multivariable analysis, 
only younger age, a higher educational level and registration as a confirmed (deceased) 
donor were of associated with higher pop-quiz scores. Table 5 presents the results of the 
multivariate analysis for both Cohorts.
In Cohort B, registered organ donors (10.8 (±2.8) versus 9.9 (±2.7), p=0.02), employed 
donors (10.9 (±2.5) versus 9.0 (±3.4), for unemployed and 9.5 (±2.8) for retired donors, 
p<0.001), and donors living with children under 18 (11.3 (±2.5) versus 10.2 (±2.8), 
p=0.02) scored significantly higher on univariate analysis than donors without these 
characteristics. After multivariate analysis, only registration as a confirmed (deceased) 
donor was related to a higher pop-quiz score. Differences per center were not observed 
in this Cohort (table 5).
table 5. Multivariate analysis for demographic characteristics, split fort the outpatient (Cohort A) and 
admission (Cohort B) cohort.
univariate
p-value
multivariate beta
(95% ci)
multivariate
p-value
cohort a (n=378)
factor
Gender
age
relation
educational level
employment
income
religion
Household
registered donor
center
0.15
0.02
0.27
<0.0001
0.003
1.0
0.68
1.0
<0.0001
0.01
-
-0.049 (-0.09 – -0.13)
-
1.35 (0.54 – 2.17)
0.32 (-0.54 – 2.17)
-
-
-
2.10 (1.32 – 2.87)
0.16 (-0.02 – 0.32)
-
0.008
-
0.001
0.47
-
-
-
<0.001
0.07
cohort b (n=226)
factor
Gender
age
relation
educational level
employment
income
religion
Household
registered donor
center
0.37
0.058
0.18
0.31
0.001
0.91
0.38
0.02
0.02
0.23
-
-0.02 (-0.06 - 0.02)
-
-0.31 (-0.90 – 0.83)
-
-
0.95 (0.00 – 1.90)
1.03 (0.29 – 1.76)
-
-
0.30
-
-
0.94
-
-
0.50
0.006
-
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descriptive results
In the pilot for this study (Kortram, unpublished), it was observed that quite a large 
proportion of donors had seemed to misinterpret the question regarding surgical tech-
nique. Fortunately, after reformulation, this was not the case in the nationwide PRINCE 
study. Only two donors stated that the technique had been explained to them, but did 
not elaborate on what this explanation entailed.
A large proportion of donors indicated that they did not know the answer to (some of 
the) question(s). In Cohort A this ranged from 28 (7.5%) for convalescence to 115 (31.2%) 
for long-term complications. In Cohort B, all donors gave an answer to the admission 
question, only two (0.9%) had no idea about convalescence, four regarding surgical 
technique, 14 (6.4%) for short- and 44 (20%) for long-term complications.
One donor in Cohort B answered the surgical technique question with “this is not 
important to me at all”, another donor answered something similar to the risks- and 
complications question: “I do not think about this, it is not important to me. I have been told 
about this, but risks and complications are minimal”, and yet a third said he had “intention-
ally forgotten” the details about long-term complications. In Cohort A, one donor said 
“I do not really care about long term consequences; if they occur, we will see what we can 
do about it then”. These answers, although given by a vast minority, pose the idea that 
maybe some donors do not want to know all the specific details and still feel informed 
and prepared.
evaluation and satisfaction
Evaluation questionnaires were returned by 158 Cohort B donors (72%). Overall average 
satisfaction with the informed consent procedure was 8.1 out of 10 (SD 1.6, range 0.6-
10). Although the majority of donors were positive and praised the transplant team for 
their services, some raised valid concerns.
One donor in a kidney pair exchange underlined the importance of standardization: 
“information provision was inadequate. It would be a suggestion to create a checklist with 
items that have and have not been discussed, and items that should still be addressed”. Some 
donors, who developed complications or problems like postoperative bleeding or pain 
claimed that this had not been disclosed to them during the informed consent process: 
“it was repeatedly stated that no complications were expected, but two out of three compli-
cations [that occurred] commonly known prior to surgery. Information was too optimistic, 
and not very realistic”. But also donors who had not experienced complications indicated 
that they had wished to hear more about potential complications prior to the donation 
procedure. On the other hand, some donors indicated that they had received too much 
information: “I received so much information that a possible shortage in knowledge is due 
to the amount of information”.
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Quite some donors addressed the fact that not enough attention had been paid 
to the convalescence period. Another recurring statement was that although donors 
remembered being told about certain risks or complications, they had assumed these 
would not occur: “I was stubborn, and did not believe that the provided information would 
apply to me” or “you always know that there can be complications, but you never think it will 
happen to you”.
discussion
The PRINCE study is, to the best of our knowledge, the largest available prospective 
nationwide Cohort study testing living kidney donors on their knowledge regarding the 
surgical procedure, postoperative course, possible complications and long term results. 
It is also the first study using open questions, prompting donors to describe the answers 
in their own words.
Baseline knowledge scores demonstrated some variation between centers. This could 
be due to the fact that some donors receive information in non-acadamic hospitals, 
where their recipient was treated by the nephrologist. There may be regional differences 
in the amount of details provided to potential donors in these centers. Although donor 
knowledge improves during the educational and informed consent process, average 
knowledge scores remain low, and large deficits are present. Previous studies have also 
demonstrated substantial gaps in donor knowledge10, 14, 15, but it has also been argued 
that their decision-making strategy differs from that in regular patients16, 17, 33. Donors 
may not even listen to provided information, but mainly focus on those statements that 
confirm their decision to donate. Their knowledge would not – or only slightly - improve 
during the preoperative work up and informed consent process. Our study demon-
strates that this is not entirely true; overall scores were significantly higher on admission 
(the day before surgery) than at the nephrology outpatient clinic, prior to receiving any 
information.
Even if decision-making strategies may differ between donors and “regular” patients, 
knowledge deficits are also encountered in other patient categories. Lee et al. published 
quite a similar study in breast cancer patients prior to undergoing a mastectomy, who 
received a validated test to assess their knowledge about breast reconstruction. The 
overall knowledge score was 58.5% (compared to 41.6% in Cohort B of the PRINCE 
study), but the score for the risk of complications was only 14.3% (compared to 22% in 
the PRINCE study for short-term complications and 4.8% for long-term complications)34. 
Amir et al found that, retrospectively, only 40.5% of all interviewed patients who had un-
dergone an elective surgical procedure actually understood the information provided to 
them during the informed consent process35.
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The large, multicenter Cohort and the prospective nature of the PRINCE study are defi-
nite strengths. The Netherlands is a leading country when it comes to live kidney dona-
tion (31 per million of population36), and the study, including all Dutch kidney transplant 
centers, provides a valid and reliable overview of the current national situation.
We acknowledge that our study has a number of limitations. First of all, as already 
discussed in the published protocol 31, un-validated questionnaires were used. Although 
there is a validated knowledge test available for living kidney donors10, this is much less 
specific than what we wanted to pursue in the PRINCE study. Validation of a knowledge 
test with open questions instead of multiple choice is virtually impossible, since donors 
may learn or forget specific information at different time points, and their knowledge is, 
at least partly, dependent on the information they have received from their transplant 
team. Using multiple-choice questions would be much easier to compare scores, but we 
believe an open question, requiring an answer in the donor’s own words provides more 
reliable information.
The second limitation is the fact that open questions and open answers leave room 
for interpretation. Some donors left questions unanswered or only stated one or two 
complications. It cannot be established with certainty whether this was all they knew or 
remembered, or that they thought this would be enough.
The risk of death for instance, was only mentioned in 48 pop-quizzes, equaling 8%. 
This is extraordinarily low, seeing that in the PILOT project, this was mentioned in 18% 
of pop-quizzes (but this was a single center study). Comparing this to the results of the 
nationwide survey, asking surgeons how often they disclosed the risk of mortality to 
donors, 50% said to always disclose it and an additional 37.5% said to do so in some of 
the cases3. An explanation for this phenomenon may be that donors may not want to 
know this risk, even though they might actually be aware of it, but writing it down makes 
it “real”. In addition, donors may not regard death as a realistic concern: they are focused 
on dealing with pain and fatigue, recovering and getting back to work. 
Donor satisfaction with the informed consent procedure was, with an average score 
of 8.1 out of 10, quite high, even though donor knowledge was lower than expected. 
This has been demonstrated before, in a study evaluating informed consent in elective 
surgical procedures: only 40.5% of patients understood the provided information, but 
93.5% were satisfied with the informed consent process35. It may thus be argued whether 
there is an actual need to improve the informed consent procedure. However, in our 
study, some donors raised valid points of criticism on the informed consent procedure, 
and stated items that could be improved. Moreover, satisfaction alone cannot justify 
informed consent. Even if a donor indicates that he is satisfied, and does not wish to 
receive any further details, we still have an obligation to provide all necessary informa-
tion, especially since some donors report, retrospectively, that they wish they had had 
more information going into the procedure15. Since we cannot predict which donor will 
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change their mind about their information wishes after they have undergone the donor 
nephrectomy, we have to fully inform each and every donor.
One of the main issues with a standardized format is that no donor is alike, and neither 
are their information needs and wishes. This has been demonstrated in other fields of 
preoperative surgical patient education. Beresford et al. interviewed 50 patients after 
cardiac surgery, and 25 of them indicated that they did not want to be advised of the 
risk of death. Forty-two percent (21 patients) did not want any risk information at all37. 
A more recent study assessing information needs in cancer patients prior to surgery 
demonstrated that patients were not so much interested in technical details and short-
term morbidity, but more so in survival data and long-term quality of life38. But it can be 
argued that these two types of surgery (cardiac and oncological) may not be directly 
comparable to living kidney donors, since these patients actually need the procedure to 
survive, or at least to extend their lives. They may see some of these risks and details as 
inevitable, and not see any added value in knowing (and worrying) about them. Another 
study performed in 190 patients undergoing cataract surgery, showed that 93.5% of pa-
tients would want to be informed about complications with a 1 in 50 risk, and still 62.4% 
would want to know about a complication with a 1 in 1000 risk39. These patients do not 
necessarily need this procedure, and they may thus be more critical about the possible 
consequences when it would go wrong. Donor priorities and information needs could 
be a topic for future research.
Providing additional information prior to the surgical consult may be a possible solu-
tion. In a study in cardiac surgery patients, those patients receiving extended written 
information were, overall, more satisfied with the informational process, and they also 
felt that they could discuss alternative options with their surgeons to a significantly 
higher degree than those patients who did not receive the extended information40. Liv-
ing donors already receive additional information, in the form of information leaflets, 
access to specific websites, and in some centers an informational DVD. In addition, 
some centers offer the possibility to attend multidisciplinary informational evenings. 
Taking this one step further, and creating an educational tool, enabling potential donors 
to test their own knowledge on the different aspects of the donation procedure and 
postoperative period, and indicate which aspect is more important to them, may be a 
key step in improving the informed consent process. The transplant surgeon can then 
focus his attention on those aspects in which the donor’s knowledge is still insufficient, 
and skip the parts that have already been covered by other team members or sources. 
This way, information provision will still be standardized, but the surgical consult will 
be donor-tailored, leading to better informed, and likely more satisfied, donors, and will 
help to further improve the efficiency of the outpatient consults.
The PRINCE study provides a basis to improve living donor education and the in-
formed consent process. One of the next steps could be to closely evaluate the available 
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guidelines 7-9, and update these where seen fit. For instance, although the BTS guideline 
provides a clear overview of the literature on perioperative mortality and morbidity, it 
does only specify overall percentages for a number of major complications7. It would be 
helpful to also include complications like pain, and fatigue, which appear to be impor-
tant to donors. The KDIGO guidelines9 provide ample information on long-term risks, but 
are less specific on perioperative complications, and state that transplant centers should 
“Evaluate and disclose risks to the best of currently available knowledge”. Incorporating 
additional, more specified data on perioperative morbidity and donors’ information 
needs and wishes into these guidelines would further aid transplant professionals in 
preoperative donor education.
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appendix i - prince – inventory – pop-quiZ – enGLisH transLation
1.  How well, on a scale of 1 – 10, do you feel to be prepared for the surgery 
and the convalescence period?
  Please draw a vertical line on the rectangle below, in which 0 is absolutely not 
prepared and 10 = couldn’t have been any better prepared.
STUDIENUMMER: __________  
□
□
□
□
□
□
□
□
 
EXAMPLE 
0                      10
2. what type of surgery will you undergo?
  Think about surgical technique, the number of scars you will get, and where 
these scars will be.
 
 
 
 
 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
3. which short-term problems and complications can occur?
 Please write down all answers you can think of
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 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
4. which long-term problems and complications can occur?
 Please write down all answers you can think of
 
 
 
 
 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
5. How many days do you expect to be admitted in the hospital?
 Please write down the total number of days, before ánd after the surgery
 
 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
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6.  How long do you expect it will be before you can perform your work / your 
normal daily activities?
 Please strikethrough as appropriate
     Weeks/ Months
 How did you learn this information? (Please choose all answers that apply)
  Explained by Surgeon/Urologist
  Explained by Nephrologist
  Explained by nurse/transplant coordinator
  Heard about it during information evening
  Explained by family/friends
  Read in information provided by the hospital
  Read in information looked up myself
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supplementary table 1. Additional complications mentioned by donors who completed the pop-quiz, 
and the number of times these complications were mentioned in the different cohorts.
complication cohort a cohort b
Nausea
Psyschological / Emotional problems
Inability to return to work
Not allowed to carry weight/exercise
Rejection in recipient
Increased risk of diabetes mellitus
Constipation
Allergic reaction
Lifestyle adjustmentsa
Problems with anaesthesia
Haematoma
Being involved in an accident
Increased risks during pregnancy
Diagnosing an illness during screening process
Infection with “hospital bacteria”
Need for information regarding recipient
Formation of adhesions (problem for future surgery)
Prostate problems
Proteinuria
Death of recipient
Increased risk of dehydration
Retained surgical equipment
Being rejected as a donor
Headache
Malignancy in remaining kidney
Fluid retention / edema
Urinary retention
Medication and side-effects thereof in recipient
Sexual disfunction
Dental injury during intubation
Inability to proceed with surgery due to intraoperative complication
Memory loss / disfunction
16
16
9
7
6
5
4
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
-
-
-
-
-
-
-
-
-
39
10
-
6
3
4
13
1
-
-
7
2
2
-
1
-
1
-
3
-
3
-
-
3
3
2
2
2
1
1
1
1
a. No alcohol consumption, no coffee consumption, staying fit, eating healthy were the specific adjustments 
named by (potential) donors.
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supplementary table 2. Mentioning frequencies of the individual complications, per cohort for the 29 
overlapping donors. Percentages between brackets.
cohort a cohort b p-value
short-term complications
 Bleeding
 Wound infection
 Infection (NOS)
 Pain
 Fatigue
 Death
 Urinary tract infection
 Pneumonia
 Thrombosis
 Cardiovascular    
complications
 Neuropathy/neurapraxia
4 (14)
4 (14)
8 (28)
10 (35)
12 (41)
3 (10)
2 (7)
3 (10)
5 (17)
0
0
9 (31)
9 (31)
7 (24)
9 (31)
17 (59)
3 (10)
8 (28)
5 (17)
5 (17)
1 (3)
3 (10)
0.13
0.13
1.00
1.00
0.18
1.00
0.07
0.50
1.00
1.00
0.25
Long-term complications
 Chronic pain
 ESRD
 Hypertension
1 (3)
2 (7)
0
1 (3)
8 (28)
2
1.00
0.03
0.50
NOS – not otherwise specified, ESRD – End-Stage Renal Disease
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discussion
informed consent for Live donor nephrectomy
The informed consent procedure for live donor nephrectomy is, to date, all but standard-
ized in many transplant centers. Many differences exist between centers (who is giving 
the information, what is being told, who is obtaining consent, and when, etc.) and even 
between individual transplant professionals within one center1-5. This is remarkable, 
since every transplant professional will agree that it is of vital importance that every 
kidney donor is well-educated and well-prepared for the donation procedure, and that 
they are fully informed at the time of giving consent for donating. Moreover, it is one 
of the official requirements of the EU Directive for living organ donation practice6. How 
is it still possible that relevant details, like complications, or even the risk of mortality, 
but also the expected duration of convalescence are not always disclosed during the 
informed consent process? A simple and logical answer may be that surgeons try to 
restrain from negative information that might be related to the procedure or, less likely, 
are not aware of the risks to the procedure themselves. Any conversation with a donor 
will be a momentary display of the surgeon’s routine, and not one consult will be the 
same as the other. No surgeon is the same as any other either: there will always be dif-
ferences in their manner of donor education. What they disclose, and in which format, is 
largely dependent on their own experience, and their own perception of specific events. 
If one has never encountered a neuropathy after donation in his career, one may not find 
it necessary to disclose this. Another may fear that talking about mortality might scare 
away the potential donor, and since this is an extremely rare event, they may choose to 
not bring this up. On the other hand, if just last month a donor actually did die after the 
procedure, the surgeon would, likely, be more tempted to disclose this devastating risk 
to each and every donor he informs at the clinic.
Then, there are differences in donors as well. The moment a donor enters the surgeon’s 
office, the latter will make a quick assessment of the person. All donor characteristics 
(e.g. age, gender, ethnicity, educational level) attribute to their capability and willing-
ness to understand the complexity of the procedure they are about to consent to. This 
quick assessment will influence what the surgeon discloses, how many details, and in 
which manner.
donor Knowledge and satisfaction
Donor knowledge of the procedure, the possible complications and the postoperative 
course was found to be surprisingly low in the studies published in this thesis: 5.9 out of 
20 in the pilot (±2.5) and 8.2 (±3.9) out of 25 in the national study. A handful of authors 
have previously demonstrated gaps in donor knowledge, either at the moment of giving 
consent or in retrospect, or have argued that donors may not be well enough informed 
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at the time of giving consent 7-12. This is a troubling finding, even more so because donor 
knowledge did not seem to be influenced by the specific details that were disclosed 
to them during the surgical outpatient clinic visit. Surgeons (i.e. consultant/attending) 
usually provided more details compared to fellows or specialized nurses, but donors 
informed by surgeons did not achieve the highest scores on the knowledge tests. It was 
also demonstrated, that donors do not recall all information provided to them, whether 
this was just one item or added up to 15; they always scored lower than their informer. 
This finding is in itself not new13. Anderson et al. demonstrated, in 1979, that patients 
in a Rheumatology clinic only remembered 40% of the information provided to them, 
and for patients over 70 years of age, this was only 24%14. More recently, Godwin et 
al. tested patients undergoing reduction mammoplasty on retained information, and 
found that, after giving consent, an average of three out of 12 items were recalled, and 
the maximum score was 6 out of 12; 50% 15. Information recollection is dependent on 
many factors, like the manner of information provision, age, and anxiety or distress13. It 
has been demonstrated that with an increase in information provision, a decrease oc-
curs in the proportion of information uptake14. Or maybe the information was presented 
in too difficult a manner for the donor to comprehend3. Many centers already provide 
additional sources of information to living donors, like information leaflets, DVDs, 
websites and sometimes informational evenings. Still, in light of the pop-quiz scores 
encountered in our studies, as a transplant team, we need to look for options to further 
improve information disclosure, and thus donor knowledge.
It can be argued though, that donors may not necessarily need or want more informa-
tion as they will not take into account this knowledge in the decision-making process. 
It has been previously proposed that donors do not use the same decision-making 
strategy as patients 16, 17, and had already made the choice to donate well before the 
informed consent was given, although more recent studies do bring in some nuance18. 
Some studies have been published regarding donor experience with the procedure, and 
the vast majority stated that it was (one of ) the best experience(s) in their lives, and 
that they would do it again if they could9, 16, 17, 19, 20. But negative experiences are still 
encountered, an although available evidence is quite subjective, if anything, it suggests 
that some donors report feeling misinformed, in a single incidence to such a degree that 
the donor felt the transplant team had withheld the truth about possible complications, 
long-term results and recipient outcome9.
In our studies, donor satisfaction was quite high: 8.4 out of 10 (±1.2) in the pilot and 
8.1 (±1.6) out of 10 in the national study. Still, some donors reported, in hindsight, that 
they were not well informed and/or prepared, now that the procedure was behind 
them. Since a donor is not a patient, and does not, for medical reasons, need to undergo 
surgery, any complication or adverse event should be seen in a different light. Moreover, 
the complication itself may not cause the overall negative experience, but the lack of 
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knowledge about, and/or preparation for this event may very well. We are indebted to 
donors that they are well-informed; how the information is valued is up to the donor.
informed consent in other areas of elective surgery
Although it has been suggested that living (kidney) donors use different decision-
making strategies than patients7, 16-18, 21, informed consent is a topic of interest in all fields 
involved in elective surgical procedures. The question was posed whether patients, who 
directly benefit from a procedure (as compared to donors, who undergo a procedure 
for someone else’s benefit), would have more knowledge of this procedure. To assess 
this, a fully elective, but highly beneficial procedure was chosen: the total knee arthro-
plasty (TKA). TKA candidates are, generally speaking, relatively fit, but their condition 
(i.e. gonarthrosis) has a severe impact on their daily life. The surgical procedure they 
consent to is not life-saving, but is intended to improve their quality of life. However, 
in 25% of TKAs, patients still experience pain 22-24, and other complications, some with 
substantial consequences, can occur. It is not inconceivable, that these patients make a 
more balanced risk-benefit decision, then when their loved one’s life is at stake, and they 
may thus want to know the exact details of the procedure.
Patient satisfaction after TKA has been demonstrated to be largely based on three 
aspects: 1. functional outcome, 2. level of residual pain, and 3. preoperative expecta-
tions 22. The first two cannot be completely influenced by medical practice; even after a 
seemingly uncomplicated TKA, up to 25% of patients still experience residual pain22-24. 
The majority mild (20%), but a small number of patients still reported moderate (3.7%) 
and severe (1.3%) pain after TKA23. Lingard et al tried to correlate psychological distress 
with functional outcome and postoperative pain. They found that distressed patients 
experienced significantly more postoperative pain than not-so distressed patients, but 
this difference could not be observed for functional outcome24. It could be hypothesized 
that adequate education could lead to less distress, and thus, better outcomes. It has 
been previously demonstrated that for instance perceived injustice, or catastrophic 
thinking may increase pain intensity25. The third factor influencing patient satisfaction, 
preoperative expectations, is within our control. We can, and must, do everything in 
our power to ensure that patients receive all necessary and correct information to fully 
prepare them for their surgery, possible complications and adverse events, and present 
them with adequate details regarding the expected outcome and possibility of remnant 
symptoms.
Stacey et al observed improved decision quality in TKA patients who received a 
standardized Patient Decision Aid (video and booklet) as compared to those receiving 
standard education26. Knowledge scores were also significantly higher in the first group: 
71.2% versus 46.6% (p<0.01). A randomized controlled trial conducted by Johnson et 
al, however, did not demonstrate significant differences in knowledge between three 
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groups of patients, educated in different manners (standard form, form and video or 
form, video and formal educational session with specialized nurse)27. Patients were 
tested on their knowledge by means of 13 multiple-choice questions. Out of a maximum 
of 13 points, patients in group 1 scored an average of 10.1 points, versus 10.8 and 11.1 
for groups 2 and 3 (p=0.11) after the outpatient clinic visit and 10.2 versus 10.3 and 11.0 
on the day of surgery (p=0.08). The authors conclude that standardized, or additional 
educational tools may not be necessary because knowledge scores did not differ be-
tween their study groups. But, when evaluating patient satisfaction with the informed 
consent process, 77% of patients in group 1 rated this with excellent/very good versus 
90% and 92% in groups 2 and 3 (postoperatively). This may imply that, even though 
knowledge did not significantly improve, patients may feel better prepared when they 
have received more, or more standardized information.
Legal consequences
The main motivation for adequate information provision and a comprehension check 
is donor and patient safety and satisfaction. If donors have a negative experience, this 
may influence other potential donors, and living donation rates may decrease. If these 
experiences can be prevented by an improved informed consent procedure, every effort 
should be made to do so. But there is yet another reason why informed consent is so 
important. Litigation claims are, to date, not very common in living kidney donation. But 
for the TKA, this figure is quite different28, 29. McWilliams et al. studied all claims made in 
1995/1996 and 2009/2010. These claims were based on a wide variety of causes, ranging 
from (minor) complications to alleged negligence (table 1)28.
Some claims are justified, and substantial payments have been made. Others are 
clearly unjust, and have been quickly discarded by the National Health Service Litigation 
Authority (NHSLA). But many claims fall within a grey area, and whether or not they are 
just can be debated. Examples hereof, based on McWilliam’s data, are infection, pain and 
thromboembolic complications. Obviously, a severe infection leading to amputation of 
the leg, even if it is not the surgeon’s fault per se, is a good cause for a claim. Whether this 
was discussed as a “very rare but possible” complication does not really matter: the con-
sequences are of such magnitude that a claim is justifiable. But what about infections 
leading to longer hospital admission, or longer duration of convalescence? What about 
deep vein thrombosis, for which additional medication has to be taken, and which may 
pose a risk for the development of a pulmonary embolism? Or prolonged pain after sur-
gery, not necessarily invalidating, but at least hindering the patient? These are all quite 
common complications, and the consequences are manageable. But, it is not inconceiv-
able that if a patient had no idea whatsoever that these complications could occur, even 
if only in a rare minority of cases, he might have reconsidered undergoing this procedure. 
In most TKA patients, pain is the main reason for having their knee replaced. In 20-25% 
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of patients pain persists after TKA22-24. If this possibility is not discussed preoperatively, 
patients may be unnecessarily worried and even a little disgruntled. However; had the 
surgeon explained to them that in some percentage of cases pain would still be present 
after surgery, they could have made a deliberate decision and taken this relatively small 
risk into account.
Even though we do not have insight in all claims that have been assessed by the medi-
cal sanctioning boards in the Netherlands, and we do not know how many of them were 
based on incomplete information provision, we hypothesize that a large number of 
claims can be prevented with adequate, uniform and complete information disclosure 
during the informed consent process. If the procedure itself is standardized, and ac-
curately documented, there will be no doubt whether a patient – or donor – has been 
told of certain risks, and such claims will be futile.
There is another field in modern day medicine in which information disclosure has a 
high priority: pharmacology. An informed consent format for a surgical procedure could 
in some way be compared to a Consumer Medicine Information (CMI) leaflet, in which 
the specific characteristics and risk of prescription drugs are described. The Food and 
Drug Authority has developed guidelines that include items to be incorporated in CMI, 
but these are, similarly to the guidelines for informed consent procedures, not well-
defined and lack details 30. Nonetheless, in these leaflets, every possible adverse event or 
complication, even if it has only been reported once, is usually described. The question 
remains whether this is desirable for information leaflets for (potential) living kidney 
donors, but it would be worth wile to further investigate this comparison.
The meta-analysis, published in this thesis (chapter 3), provides an overview of the 
reported incidence of individual complications in the available literature. Although 
this is a great basis, it is impossible to disclose every potential complication, and it is 
inevitable that every surgeon’s personal experience will influence the information he 
discloses. In addition, information needs vary among donors (chapter 7). Providing 
additional information, prior to the surgical consult, may greatly benefit donors and 
surgeons. All donors will have received standardized, uniform information, the surgical 
consult will serve to further elaborate on certain aspects, and to check whether the do-
nor has indeed received, and understood all vital details. Incorporating this strategy will 
ensure standardized information provision, while still leaving room for donor-tailored 
preoperative education.
In conclusion, informed consent for elective surgical procedures remains a topic of 
great interest and much debate. This thesis focused on the informed consent procedure 
for live kidney donation, and has provided handles to, first and foremost, create a stan-
dardized format informed consent procedure for the donor nephrectomy. In addition, 
it has also paved the way for a translation to other fields of elective surgery. In the next 
chapter, “Future Perspectives”, these two items will be discussed further.
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future perspectives
As of January 1st 2016, a new law has been instated in the Netherlands: “Wet kwalit-
eit, klachten en geschillen in de zorg (Wkkgz)”, roughly translated into “Law for quality, 
claims and conflicts in healthcare”1. This law covers numerous aspects of safe and high 
quality care, among which the item “patient rights of choice – information” (“Recht op 
keuze- informatie”). This item allows patients to choose between different healthcare 
professionals, and hereby mandates these professionals to provide information about 
the type of treatment, the quality thereof and its (scientifically proven) effectiveness, its 
costs and other patients’ experiences with this treatment.
As many other laws and available guidelines, this latest does not include specific 
details that have to be communicated, but it is not hard to imagine that guidelines and 
regulations regarding information provision and informed consent will only become 
more strict in the near future. It may be wise for medical professionals involved in 
elective surgical procedures to place themselves one step ahead of this development. 
Instead of waiting for a government issued standardized format, it may be profitable to 
develop such a format ourselves. This will, most likely, be more efficient, and easier to 
implement in daily clinical practice.
informed consent for Live donor nephrectomy
As we have demonstrated, the informed consent procedure for the live donor nephrec-
tomy can be improved. The results of the studies described in this thesis can be used to 
do so. However, some additional data can still be helpful to achieve an even better end 
result. The first goal is to develop a standardized format informed consent procedure. 
The data acquired in the meta-analysis have provided the medical evidence, and the 
data from mainly the nationwide PRINCE (chapter 7) study have demonstrated 1) what 
donors actually know and remember, and 2) what they would have wanted to hear. 
Combining these two perspectives will lead to an ideal concept. Since there are logistic 
and procedural differences between the centers, the standardized format will have to 
leave room for local adjustments.
There is one aspect of donor knowledge that still needs to be further explored. As we 
have demonstrated in the PRINCE PILOT study (chapter 5), donor knowledge did not 
seem to correlate with the amount of provided information. As previously described, it 
may be the case that donors do not actually listen to all information provided the same 
way “normal” patients do 2, 3. To further assess this, an additional cohort was included 
in the national PRINCE study. This cohort includes donors from the first cohort (Cohort 
A), at the transplant nephrology outpatient clinic. The first 10 (for high volume centers) 
and five (for low volume centers) donors in each center who are referred to the surgical 
outpatient clinic will be followed longitudinally (total sample size 60). The consult with 
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the surgeon at the outpatient clinic will be audio-recorded, and the donors receive the 
exact same pop-quiz at the end of the consult. At the time of donor nephrectomy, they 
will again receive the pop-quiz on the day of admission, as all Cohort B donors also have. 
By correlating their pop-quiz answers with the audio-recorded exact details, more infor-
mation can be learned about what they remember and what not. This will provide more 
insight in the manner of information provision, and will possibly give some handles as 
to how this should be employed in the standardized format.
To date, 37 donors have been included in this longitudinal cohort (62%). Of these, 
15 have completed their follow-up and three have been scheduled for surgery in the 
near future. Unfortunately, five donors are lost to follow-up for the admission cohort. 
Inclusion and follow-up for this cohort is expected to be completed by the end of 2017.
informed consent in other areas of elective surgery
Patients undergoing total knee replacement surgery fall within a second category of 
patients, undergoing an elective surgical procedure without a strict medical necessity 
but with an expected benefit for themselves. These patients could serve as a control 
group for living donors, with regard to information needs and desires and knowledge of 
their upcoming procedure and postoperative course.
To assess this, the PINK (Process of INformed consent in total Knee arthroplasty 
candidates) – study was initiated. This is a multicenter, prospective cohort study, with 
a design similar to that of the PRINCE-PILOT (chapter 5). Fifty total knee arthroplasty 
(TKA) candidates will be included in two large orthopedic surgery units; the Erasmus MC 
University Medical Center in Rotterdam, and the Reinier de Graaf Hospital in Delft. Pa-
tients will receive a pop-quiz immediately after the orthopedic consult at the outpatient 
clinic (Cohort A), and will repeat this on the day of admission for TKA (Cohort B). They 
will receive an evaluation and satisfaction questionnaire three months postoperatively, 
and knee function will be assessed according to national guidelines six months after 
surgery, by means of the Knee injury and osteoarthritis Outcome Score (KOOS) and 
Hospital for Special Surgery knee scoring system (HSS) scores, to correlate knowledge 
and satisfaction with functional outcome. After inclusion is completed, more detailed 
data will be available, and a comparison can be made with the living kidney donors from 
the PRINCE-PILOT study.
clinical implications
Patient tailored care – and thus education – is increasingly popular in modern day 
medicine. But to deliver patient- or donor- tailored education, a standardized format is 
necessary to build from. The basis for this standardized format has been provided in this 
thesis. It is essential that this information is implemented in the daily clinical practice. 
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Recent, evidence based data is available on the incidence of individual complications, 
and more data is acquired on donor knowledge and satisfaction.
One of the next steps could be to closely evaluate the available guidelines 4-6, and 
update these where seen fit. For instance, although the BTS guideline provides a clear 
overview of the literature on perioperative mortality and morbidity, it does only specify 
overall percentages for a number of major complications5. It would be helpful to also 
include complications like pain, and fatigue, which appear to be important to donors. 
The new KDIGO guidelines4, published in preliminary state, provide ample information 
on long-term risks, but are less specific on perioperative complications, and state that 
transplant centers should “Evaluate and disclose risks to the best of currently available 
knowledge”. Incorporating additional, more specified data on perioperative morbidity 
and donors’ information needs into these guidelines would further aid transplant pro-
fessionals in preoperative donor education.
Guidelines are usually lengthy and although they should be read by every medical 
professional involved in the field addressed in them, they are not the most convenient 
tool to guide the consults at a busy outpatient clinic, nor can they, in their current format, 
be provided to patients (or donors). Anno 2016, nearly every doctor and the majority of 
patients own a smartphone. It is the era of social media, and each day over 1,000 new 
applications are launched in the Apple store7. Herein lies a possibility for the surgical 
community. Let’s, for now, focus on living kidney donors, and create its design. After 
being approved by the nephrologist, and referred to the surgical outpatient clinic, they 
get access to this particular application. It contains detailed information on the surgical 
procedure, short- and long-term complications, the admission-, and the convalescence 
period. In addition, it will provide the donor with a test-your-knowledge menu, and after 
taking the test, they will immediately see their result, split over the different categories. 
They can either look up some extra information, or, already form questions they can 
ask the surgeon during their clinic visit. During this visit, the surgeon can also view the 
test results, and will focus his information on those aspects of which this donors’ knowl-
edge is insufficient, and skip the parts that have already been covered by other team 
members or sources. This way, information provision will still be standardized, but the 
surgical consult will be donor-tailored, and it will help to further improve the efficiency 
of the outpatient consults.
There have already been some initiatives to create tools to guide transplant profes-
sionals in delivering donor-tailored information. An example hereof is the End Stage 
Renal Disease (ESRD) Risk Tool for Kidney Donor Candidates8. This web-based risk calcu-
lator, based on a number of important studies regarding long-term ESRD risk in living 
donors9-13, allows you to enter a number of donor characteristics, and it then provides 
you with a 15-year risk projection of developing ESRD for this specific donor profile.
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It is quite easy to imagine a translation to other areas of (elective surgery), and, we are 
not the only ones to think of this idea. Recently, a project was initiated in the UK: “The 
Surgical Consent app”14. Although now in beta-testing and not yet publically available, 
the application promises to vastly improve the information doctors give to patients. 
Whether it is also suitable to provide to patients remains to be determined. It will be 
worthwhile to see whether this app fully suits our purposes, or that modifications or a 
completely different set-up would be in order.
research implications
There is still much to learn about informing donors/patients, their knowledge, needs 
and wishes, the ideal format of information provision, and then there is the matter of 
informed consent. This thesis provided the basis of medical data, and touched on the 
subject of donor knowledge. Future research projects should, in our opinion, mainly 
focus on donors’ needs and wishes, and establish ways to improve knowledge.
One Australian research group has already performed promising work, assessing which 
elements of information are valued most by living kidney donors. Time to recovery was 
ranked highest (i.e. donors found this the most important detail to know), followed by 
impact on family life, donor-recipient relationship and lifestyle restrictions. Surprisingly, 
the risk of eventual kidney failure and mortality were ranked 10th and 13th respectively. 
Possible impact on fertility and pregnancy were ranked as the least important elements 
(Hanson et al., as presented during the 26th international congress of the transplant 
society, Hong Kong, 2016). Further analysis of these data, and testing these factors in 
larger populations, will be very helpful for transplant professionals.
Finally, if an application such as mentioned in the previous paragraph would be 
developed and implemented, it may be wise to test this in a (pilot) intervention study. 
The ideal set-up for such a study would be a randomized controlled trial (RCT). Potential 
donors, prior to their preoperative surgical consult, could be randomized to receive ei-
ther the full content app, with detailed information and a quiz, or a dummy app, without 
detailed information, but with the same quiz at the end. During the outpatient clinic 
consult, surgeons could rate the efficiency of the consult, and donors could rate their 
understanding of the information, and their satisfaction. In addition, a section could be 
incorporated in this app where donors can make their preferences known with regard 
to specific information needs and wishes. This could be assessed pre- as well as postop-
eratively.
Future perspectives
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enGLisH summary
part i – the informed consent procedure
In the first part of this thesis, different aspects of the informed consent procedure for 
live donor nephrectomy are evaluated. The systematic review of the available literature 
(chapter 2) demonstrated great variations in informed consent procedures between 
transplant centers. Individual medical professionals also varied in the information they 
disclose to potential living kidney donors. Little research has been performed on donor 
comprehension of, and satisfaction with, the informed consent procedure. But some 
donors do report, retrospectively, feeling misinformed about, or unprepared for the 
donation procedure.
Many authors agree that there is a definite need for a standardized procedure to guide 
transplant professionals in their daily practice of education living kidney donors and ob-
taining informed consent. But the contents of this standardized procedure remain under 
discussion. What information do donors need, which details are vital in their educational 
process? There are some guidelines regarding informed consent for surgical procedures. 
General consensus is that every complication with an incidence of >1% should be dis-
closed, in addition to those complications, regardless of their frequency of occurrence, 
with severe consequences1. So, which complications would that be for the live donor 
nephrectomy? In chapter 3, the results from the meta-analysis assessing complications 
after minimally invasive live donor nephrectomy are described. Intraoperative complica-
tions occurred in 2.2% of live donor nephrectomies, postoperative complications in 7.0%. 
Infectious complications were most frequently encountered with an incidence of 2.6%, 
of which wound infections comprised the largest proportion (overall incidence 1.0%). 
Postoperative bleeding (1.0%) was the only additional complication with an incidence 
of >1%. The reported mortality rate was 0.02%, but an underestimation was suspected.
Does this mean that these are the only adverse events we should discuss with poten-
tial donors? Rare complications like damage to other organs, or cardiovascular events 
may or may not have “severe consequences”, so should these be mentioned or not? And 
even though many other complications are infrequent, and may not have significant 
medical consequences, they may be very relevant for donors. Prolonged pain, testicular 
complaints or for instance neuropathies can be quite disconcerting to a donor who has 
no idea these adverse events are in fact quite “normal”.
To assess which complications were actually mentioned to potential living donors by 
kidney transplant surgeons across the country, a web-based survey was created (chap-
ter 4). All surgeons possibly involved in kidney transplantation in the Netherlands were 
invited to complete this survey. A response rate of 98% was reached (N=49), including 
32 respondents that were actually still involved in preoperative living kidney donor 
education. The main finding in this project was the fact that information provision dif-
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fered enormously between transplant surgeons. Bleeding was the only complications 
always disclosed to potential donors. Only half of the respondents indicated that they 
always mentioned the risk of death, another 13 did so sometimes, but three surgeons 
never discussed this disastrous complication with potential living kidney donors. In ad-
dition, if mortality was discussed, varying rates were reported, ranging from 0.003% to 
0.1%. Mentioning frequencies for all other complications varied. In addition to variations 
in the contents of the informed consent procedure for live donor nephrectomy: even 
different respondents from the same center were not unanimous about the manner in 
which the procedure itself was employed in their hospital. Whether informed consent 
was obtained by a nephrologist or a surgeon, before or after the surgical consult, and in 
writing or oral after explicitly asking remained unclear.
The overall conclusion to be drawn from these results is that there is no consensus 
on the manner in which the informed consent procedure for live donor nephrectomy 
should be employed, by whom, and at which moment during the educational process 
consent should be obtained, and in which form this should be documented. These find-
ings further underline the need for a uniform, standardized format informed consent 
procedure for live donor nephrectomy.
part ii – donor Knowledge & satisfaction
Part II of this thesis focuses on donor knowledge of provided information during the 
educational process leading up to informed consent, and their satisfaction with the 
informed consent procedure. The first chapter describes the results of a pilot study on 
donor knowledge (chapter 5).
The study group consisted of 46 living kidney donors, whose preoperative surgical 
outpatient visit was observed. They were asked to fill out a pop quiz-style questionnaire 
directly after the consult, and again on the day of admission for surgery. None of the 
donors scored the maximum of 20 points, and none had reproduced all the information 
discussed with them by the surgeon. Average donor score was 5.8 (±2.4, range 2-11). 
Donors scored best on duration of admission and convalescence, and worst on long-
term complications. The risk of mortality was disclosed by 91% of informers, but only 
reproduced by 22% of donors at the outpatient clinic and 14% on the ward on the day 
of admission. Donors living with children under 18, donors with a higher educational 
level and registered (post-mortem) donors scored significantly better. Median donor 
satisfaction was 9 out of 10 (range 4-10). No significant differences were observed 
between donor characteristics, nor was the postoperative course of influence on donor 
satisfaction.
After completion of the single center pilot study, a nationwide, multicenter, prospec-
tive study was initiated to further assess donor knowledge. The protocol for this study 
is outlined in chapter 6. Donors were included in three cohorts; cohort 1 (Cohort A) 
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at the outpatient nephrology clinic, prior to receiving any information from transplant 
professionals, cohort 2 at the outpatient surgery clinic, after already being included in 
cohort 1, and on the ward on the day of admission for donor nephrectomy (cohort 3, 
Cohort B). All donors were asked to complete a similar pop-quiz as the one used in the 
pilot study. chapter 7 describes the results of cohorts A and B of this study. A total 
of 604 pop-quizzes were completed; 378 in Cohort A and 226 in Cohort B. There were 
29 donors who were included in both cohorts. Average donor score was 6.9 out of 25 
(±3.9, range 0-18) in Cohort A and 10.4 (±2.8, range 0-17.5) in Cohort B. Donors generally 
scored best on duration of admission and convalescence, and worst on long-term com-
plications. Donors who were younger, had a higher educational level or were registered 
deceased donors scored higher in Cohort A, donors who were currently employed, living 
with children under 18,  or were registered deceased donors scored higher in Cohort B. 
Donors felt relatively well prepared for surgery after receiving all information: 8.3 (±1.3) 
out of 10, and average postoperative satisfaction with the informed consent procedure 
was 8.1 out of 10 (±1.6, range 0.6-10). The postoperative evaluation led to some useful 
comments that could further improve the informed consent procedure for live donor 
nephrectomy in the future.
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deel i – de informed consent procedure
In het eerste deel van dit proefschrift worden verschillende aspecten van de informed 
consent procedure voor de levende donor nefrectomie geëvalueerd. De systematic re-
view van de beschikbare literatuur (hoofdstuk 2) liet zien dat er grote variaties bestaan 
tussen verschillende transplantatie centra. Ook individuele medici variëren in de infor-
matie die zij aan potentiele donoren verstrekken. Er is nog maar weinig onderzoek ver-
richt naar het begrip van donoren, en hun tevredenheid omtrent de informed consent 
procedure. Maar sommige donoren geven, in retrospectie, wel aan dat zij zich niet goed 
geïnformeerd over, of niet goed voorbereid voelden op de donatie procedure.
Veel auteurs zijn het eens over het feit dat er een absolute noodzaak is voor een ges-
tandaardiseerde informed consent procedure, om transplantatie chirurgen en anders 
medisch personeel te helpen in hun dagelijkse praktijk van het voorlichten van levende 
nierdonoren en het verkrijgen van informed consent. Maar de inhoud van deze gestan-
daardiseerde procedure blijft een onderwerp van discussie. Welke informatie hebben 
donoren nodig, welke details zijn essentieel gedurende hun voorlichtingstraject? Er 
bestaan enkele richtlijnen over informed consent voor chirurgische procedures. De 
algemene consensus is dat iedere complicatie met een incidentie van >1% vermeld di-
ent te worden, net zoals die complicaties, ongeacht de frequentie van voorkomen, met 
ernstige consequenties1. Dus, welke complicaties zouden dat zijn voor de levende donor 
nefrectomie? In hoofdstuk 3 worden de resultaten beschreven van de meta-analyse 
over complicaties na minimaal invasieve levende donor nefrectomie. Intra-operatieve 
complicaties traden op in 2.2% van de levende donor nefrectomieën, postoperatieve 
complicaties in 7.0%. Infectieuze complicaties werden het vaakst gezien met een inci-
dentie van 2.6%. Hiervan was het grootste deel wondinfecties (1.0% van alle patiënten). 
Postoperatieve bloeding (1.0%) was de enige andere complicatie met een incidentie van 
>1%. De beschreven mortaliteit was 0.02%, maar het werd vermoed dat dit berustte op 
een onderrapportage.
Betekent dit dat alleen deze adverse events met potentiele donoren moeten worden 
besproken? Zeldzame complicaties, zoals schade aan andere organen, of cardiovas-
culaire complicaties kunnen al dan niet “ernstige consequenties” hebben, dus moeten 
dezen worden vermeld of niet? En ondanks dat veel andere complicaties niet vaak 
voorkomen, en ook geen substantiële medische gevolgen hebben, kunnen deze voor 
donoren toch als relevant worden beschouwd. Langdurige pijn, testiculaire zwelling- of 
pijn, of bijvoorbeeld neuropathieën kunnen zeer verontrustend zijn voor een donor die 
geen idee heeft dat deze gebeurtenissen kunnen optreden, en “normaal” zijn na een 
ingreep als deze.
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Om een overzicht te krijgen van welke complicaties nu gemiddeld besproken worden 
met potentiele levende nierdonoren door niertransplantatie chirurgen in Nederland 
is een internet-survey opgesteld (hoofdstuk 4). Alle chirurgen die mogelijk niertrans-
plantaties uitvoerden werden uitgenodigd de survey in te vullen. Een response rate 
van 98% werd bereikt (N=49), waarvan 32 respondenten nog daadwerkelijk betrokken 
waren bij de voorlichting van levende nierdonoren. De belangrijkste bevinding in dit 
onderzoek was het feit dat informatie voorziening enorm varieerde tussen verschillende 
transplantatie chirurgen. Bloeding was de enige complicatie die altijd werd besproken 
met potentiele donoren. Slechts de helft van de respondenten gaf aan dat zij het risico 
op overlijden altijd besproken, 13 anderen bespraken dit soms, maar drie chirurgen ver-
melden deze desastreuze complicatie nooit gedurende de voorlichting aan potentiele 
levende nierdonoren. Daarbij werd gezien dat, wanneer mortaliteit besproken werd, het 
geschatte risico hierop varieerde van 0.003% tot 0.1%. De frequentie van het vermelden 
van de overige complicaties verschilde. Ook werden variaties gezien in de inhoud van 
de informed consent procedure voor de levende donor nefrectomie: zelfs verschillende 
respondenten uit hetzelfde centrum waren niet unaniem over de manier waarop deze 
procedure in hun ziekenhuis werd uitgevoerd. Of informed consent werd verkregen 
door een nefroloog of chirurg, vóór of na het chirurgische consult, en geschreven of 
mondeling na expliciet vragen, blijft onduidelijk.
De conclusie die uit deze resultaten kan worden getrokken is dat er geen consensus 
bestaat over de manier waarop de informed consent procedure voor de levende donor 
nefrectomie uitgevoerd zou moeten worden, door wie, en op welk moment gedurende 
het voorlichtingstraject consent moet worden verkregen en ik welke vorm dit zou 
moeten worden gedocumenteerd. Deze bevindingen onderstrepen de noodzaak voor 
een uniform, gestandaardiseerd format voor de informed consent procedure voor de 
levende donor nefrectomie.
deel ii – Kennis en tevredenheid van donoren
Deel 2 van dit proefschrift focust zich op de kennis van donoren over de verstrekte in-
formatie tijdens het voorlichtingstraject. Ook wordt hun tevredenheid over de informed 
consent procedure getest. Het eerste hoofdstuk beschrijft de resultaten van een pilot 
studie over donor kennis (hoofdstuk 5).
De studiegroep bestond uit 46 levende nierdonoren, van wie het preoperatieve 
chirurgische consult op de polikliniek werd geobserveerd. Zij werden gevraagd een 
kennistest in te vullen direct na het consult, en nogmaals op de dag van opname voor de 
donor nefrectomie. Geen van de donoren scoorde het maximum te behalen aantal van 
20 punten, en geen reproduceerde alle door de chirurg gegeven informatie. De mediane 
donorscore was 6 (range 2-11). Donoren scoorden het best op opname- en herstelduur, 
en het slechtst op lange termijn complicaties. Het risico op overlijden werd door 91% 
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van de chirurgen vermeld, en slechts door 22% van de donoren gereproduceerd op de 
polikliniek en 14% op de dag van opname. Donoren die in een huishouden woonden 
met kinderen onder de 18 jaar, donoren met een hoger opleidingsniveau en donoren 
die zich hadden geregistreerd als donor (na overlijden) waren scoorden significant beter 
dan de rest. Mediane donor tevredenheid was 9 uit 10 (range 4-10). Er werden geen 
significante verschillen gevonden tussen donor karakteristieken, en ook het postopera-
tieve beloop leek niet van invloed op donor tevredenheid.
Na het voltooien van de pilot studie werd een landelijke, multicenter, prospectieve 
studie geïnitieerd om de informed consent procedure en de kennis van levende nier 
donoren verder in kaart te brengen. Het protocol van deze studie is beschreven in 
hoofdstuk 6. Donoren werden geïncludeerd in drie cohorten: cohort 1 (Cohort A) op 
de polikliniek nefrologie, voordat zij ook maar enige informatie hebben ontvangen van 
transplantatie professionals, cohort 2 op de polikliniek chirurgie, nadat zij reeds zijn 
geïncludeerd in cohort 1, en cohort 3 op de verpleegafdeling op de dag van opname 
voor de donornefrectomie (Cohort B). Alle donoren werden gevraagd een soortgelijke 
pop-quiz in te vullen als degene die gebruikt was in de pilot studie. Hoofdstuk 7 beschri-
jft de resultaten van cohorten A en B van deze studie. In totaal werden 604 kennistesten 
ingevuld: 378 in Cohort A en 226 in Cohort B. 29 Donoren werden geïncludeerd in beide 
cohorten, en vulden de test op beide momenten in. . De gemiddelde donor score was 
6.9 uit 25 punten (±3.9, range 0-18) in Cohort A, en 10.4 (±2.8, range 0-17.5) in Cohort 
B. Donoren scoorden over het algemeen het beste op opname- en herstelduur, en het 
slechtste op lange-termijn complicaties. Jongere donoren, en donoren met een hoger 
opleidingsniveau of die zich hadden geregistreerd als donor (na overlijden) scoorden 
beter in Cohort A, donoren met thuiswonende kinderen onder de 18, donoren die mo-
menteel betaald werk hadden en wederom donoren die zich hadden geregistreerd als 
donor (na overlijden) scoorden hoger in Cohort B. Donoren voelden zich relatief goed 
voorbereid op de donatie procedure en de postoperatieve periode nadat zij alle infor-
matie ontvangen hadden: 8.3 (±1.3) uit 10. De gemiddelde postoperatieve tevredenheid 
was 8.1 uit 10 (±1.6, range 0.6-10). De postoperatieve evaluatie leverde een aantal bruik-
bare commentaren op, die kunnen worden gebruikt om de informed consent procedure 
voor de levende donornefrectomie in de toekomst nog verder te verbeteren.
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